10-Q

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2021

Or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from          to

Commission File Number: 333-161943

Better Choice Company Inc.

(Exact name of registrant as specified in its charter)

Delaware	83-4284557
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

12400 Race Track Road

Tampa, Florida 33626    

(Address of Principal Executive Offices) (Zip Code)

_______________________________________________

(Registrant’s Telephone Number, Including Area Code): (813) 659-5921

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on which Registered
Common Stock, $0.001 par value share	BTTR	NYSE American

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by checkmark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by checkmark whether the registrant is a large accelerated filer, accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐

If an emerging growth company, indicate by a check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes ☐ No ☒

The number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date was: 29,586,092 shares of $0.001 par value common stock outstanding as of August 9, 2021.

Table of Contents

Better Choice Company Inc.

Table of Contents

Item		Page
	PART I – FINANCIAL INFORMATION
1.	Financial Statements	4
2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
3.	Quantitative and Qualitative Disclosures About Market Risk	30
4.	Controls and Procedures	31
	PART II – OTHER INFORMATION
1.	Legal Proceedings	31
1A.	Risk Factors	31
2.	Unregistered Sales of Equity Securities and Use of Proceeds	31
3.	Defaults Upon Senior Securities	31
4.	Mine Safety Disclosures	31
5.	Other Information	31
6.	Exhibits	31
	Signatures	36

FORWARD-LOOKING STATEMENTS

This Quarterly Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q ("Quarterly Report") are “forward-looking statements” for purposes of federal and state securities laws, including statements regarding our expectations and projections regarding future developments, operations and financial conditions, and the anticipated impact of COVID-19 and our acquisitions, business strategy, and strategic priorities. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” or “continue,” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. The forward-looking statements in this Quarterly Report are only predictions and are based largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. Forward-looking statements contained herein include, among others, statements concerning management's expectations about future events and the Company’s operating plans and performance, the effects of the COVID-19 outbreak, including levels of consumer, business and economic confidence generally, the regulatory environment, litigation, sales, and the expected benefits of acquisitions, and such statements are based on the current beliefs and expectations of the Company’s management, as applicable, and are subject to known and unknown risks and uncertainties. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of known and unknown risks, uncertainties, and assumptions. Although we believe the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties.

These forward-looking statements present our estimates and assumptions only as of the date of this Quarterly Report. Accordingly, you are cautioned not to place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances, or otherwise.

2

Table of Contents

Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, those summarized below:

•the impact of COVID-19 on the U.S. and global economies, our employees, suppliers, customers and end consumers, which could adversely and materially impact our business, financial condition and results of operations

•our ability to successfully implement our growth strategy;

•failure to achieve growth or manage anticipated growth;

•our ability to achieve or maintain profitability;

•our significant indebtedness;

•the loss of key members of our senior management team;

•our ability to generate sufficient cash flow or raise capital on acceptable terms to run our operations, service our debt and make necessary capital expenditures;

•our ability to maintain effective internal control over financial reporting;

•our limited operating history;

•our ability to successfully integrate Halo’s and TruPet’s businesses and realize anticipated benefits with these acquisitions and with other acquisitions or investments we may make;

•our dependence on our subsidiaries for payments, advances and transfers of funds due to our holding company status;

•our ability to successfully develop additional products and services or successfully market and commercialize such products and services;

•competition in our market;

•our ability to attract new and retain existing customers, suppliers, distributors or retail partners;

•allegations that our products cause injury or illness or fail to comply with government regulations;

•our ability to manage our supply chain effectively;

•our or our third-party contract manufacturers’ and suppliers’ ability to comply with legal and regulatory requirements;

•the effect of potential price increases and shortages on the inputs, commodities and ingredients that we require;

•our ability to develop and maintain our brand and brand reputation;

•compliance with data privacy rules;

•our compliance with applicable regulations issued by the U.S. Food and Drug Administration (“FDA”), the U.S. Federal Trade Commission (“FTC”), the U.S. Department of Agriculture (“USDA”), and other federal, state and local regulatory authorities, including those regarding marketing pet food, products and supplements;

•risk of our products being recalled for a variety of reasons, including product defects, packaging safety and inadequate or inaccurate labeling disclosure;

•risk of shifting customer demand in relation to raw pet foods, premium kibble and canned pet food products, and failure to respond to such changes in customer taste quickly and effectively; and

•the other risks identified in this Quarterly Report including, without limitation, Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part II, Item 1A “Risk Factors” as such factors may updated from time to time in our other public filings.

Given these uncertainties, you should not place undue reliance on these forward looking statements. These forward looking statements represent our estimates and assumptions only as of the date of this report and, except as required by law, we undertake no obligation to update or revise publicly any forward looking statements, whether as a result of new information, future events or otherwise after the date of this report. We qualify all of our forward looking statements by these cautionary statements. You should, however, consult further disclosures we make in future filings and public disclosures, including without limitation, our Annual Report on Form 10-K ("Annual Report"), Quarterly Reports on Forms 10-Q, and Current Reports on Forms 8-K.

3

Table of Contents

PART I

ITEM 1.    FINANCIAL STATEMENTS

Better Choice Company Inc.

Condensed Consolidated Balance Sheets

(Dollars in thousands, except share and per share amounts)

	June 30, 2021		December 31, 2020
	Unaudited		Audited
Assets
Cash and cash equivalents	$	2,484	$	3,926
Restricted cash	63		63
Accounts receivable, net	5,189		4,631
Inventories, net	5,201		4,869
Deferred IPO costs	882		—
Prepaid expenses and other current assets	4,040		4,074
Total Current Assets	17,859		17,563
Property and equipment, net	149		252
Right-of-use assets, operating leases	94		345
Intangible assets, net	12,350		13,115
Goodwill	18,614		18,614
Other assets	114		1,364
Total Assets	$	49,180	$	51,253
Liabilities & Stockholders’ Equity (Deficit)
Current Liabilities
Term loans, net	$	704	$	7,826
Line of credit	222		—
PPP loans	—		190
Accrued and other liabilities	2,231		3,400
Accounts payable	4,758		3,137
Operating lease liability	56		173
Warrant liability	16,977		39,850
Total Current Liabilities	24,948		54,576
Non-current Liabilities
Notes payable, net	—		18,910
Term loans, net	4,999		—
Lines of credit, net	4,935		5,023
PPP loans	—		662
Operating lease liability	38		184
Total Non-current Liabilities	9,972		24,779
Total Liabilities	34,920		79,355
Stockholders’ Equity (Deficit)
Common Stock, $0.001 par value, 200,000,000 shares authorized, 15,821,559 and 8,651,400 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	16		9
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, 17,294 shares and 21,754 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	—		—
Additional paid-in capital	263,361		232,530
Accumulated deficit	(249,117)		(260,641)
Total Stockholders’ Equity (Deficit)	14,260		(28,102)
Total Liabilities and Stockholders’ Equity (Deficit)	$	49,180	$	51,253

See accompanying notes to the unaudited condensed consolidated financial statements.

4

Table of Contents

Better Choice Company Inc.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(Dollars in thousands, except share and per share amounts)

	Six Months Ended June 30,				Three Months Ended June 30,
	2021		2020		2021		2020
Net sales	$	21,819	$	22,167	$	10,989	$	9,941
Cost of goods sold	13,645		13,886		7,089		5,817
Gross profit	8,174		8,281		3,900		4,124
Operating expenses:
General and administrative	8,081		19,551		3,530		11,551
Sales and marketing	5,571		4,258		3,235		2,053
Share-based compensation	2,857		5,504		332		3,020
Total operating expenses	16,509		29,313		7,097		16,624
Loss from operations	(8,335)		(21,032)		(3,197)		(12,500)
Other expense (income):
Interest expense	3,069		4,731		2,234		2,430
Gain on extinguishment of debt, net	(457)		—		(851)		—
Change in fair value of warrant liabilities	(22,873)		2,095		(29,356)		3,474
Total other (income) expense, net	(20,261)		6,826		(27,973)		5,904
Net and comprehensive income (loss)	11,926		(27,858)		24,776		(18,404)
Preferred dividends	—		68		—		34
Net and comprehensive income (loss) available to common stockholders	$	11,926	$	(27,926)	$	24,776	$	(18,438)
Weighted average number of shares outstanding, basic	10,361,462		8,122,176		11,126,909		8,156,618
Weighted average number of shares outstanding, diluted	20,498,829		8,122,176		21,389,413		8,156,618
Earnings (loss) per share, basic	$	1.11	$	(3.44)	$	2.23	$	(2.26)
Earnings (loss) per share, diluted	$	0.56	$	(3.44)	$	1.19	$	(2.26)

See accompanying notes to the unaudited condensed consolidated financial statements.

5

Table of Contents

Better Choice Company Inc.

Unaudited Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(Dollars in thousands except shares)

	Common Stock			Series F Convertible Preferred Stock
	Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ (Deficit) Equity
Balance as of December 31, 2020	8,651,400	$	9	21,754	$	—	$	232,530	$	(260,641)	$	(28,102)
Shares and warrants issued pursuant to private placement	546,733	1		—	—		4,071		—		4,072
Share-based compensation	17,537	—		—	—		2,544		—		2,544
Warrant exercises	297,383	—		—	—		1,310		—		1,310
Shares issued to third-party for services	5,000	—		—	—		46		—		46
Warrant modifications	—	—		—			402		(402)		—
Conversion of Series F shares to common stock	1,482,672	1		(4,448)	—		(1)		—		—
Net and comprehensive loss available to common stockholders	—	—		—	—		—		(12,850)		(12,850)
Balance as of March 31, 2021	11,000,725	$	11	17,306	$	—	$	240,902	$	(273,893)	$	(32,980)
Warrant exercise	83,333	—		—	—		375		—		375
Conversion of Series F shares to common stock	4,000	—		(12)	—		—		—		—
Conversion of convertible notes to common stock	4,732,420	5		—	—		21,771		—		21,776
Share-based compensation	—	—		—	—		313		—		313
Shares issued in lieu of fractional shares due to reverse stock split	1,081	—		—	—		—		—		—
Net and comprehensive income available to common stockholders	—	—		—	—		—		24,776		24,776
Balance as of Balance as of June 30, 2021	15,821,559	$	16	17,294	$	—	$	263,361	$	(249,117)	$	14,260

6

Table of Contents

	Common Stock									Redeemable Series E Convertible Preferred Stock
	Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Deficit		Shares	Amount
Balance as of December 31, 2019	7,996,232	$	8	$	194,190	$	(201,269)	$	(7,071)	1,387,378	$	10,566
Shares issued pursuant to a private placement	51,440	—		500		—		500		—	—
Share-based compensation	75,993	1		2,484		—		2,485		—	—
Shares and warrants issued to third party for contract termination	12,120	—		198		—		198		—	—
Shares issued to third parties for services	20,833	—		125		—		125		—	—
Warrants issued to third parties for services	—	—		2,594		—		2,594		—	—
Net and comprehensive loss available to common stockholders	—	—		—		(9,488)		(9,488)		—	—
Balance as of March 31, 2020	8,156,618	$	9	$	200,091	$	(210,757)	$	(10,657)	1,387,378	$	10,566
Warrants issued to third parties for services	—	—		7,390		—		7,390		—	—
Share-based compensation	—	—		3,020		—		3,020		—	—
Warrants issued in connection with June 2020 Notes	—	—		337		—		337		—	—
Beneficial conversion feature of June 2020 Notes	—	—		1,163		—		1,163		—	—
Modification of conversion feature for November 2019 Notes, Seller Notes, and ABG Notes	—	—		528		—		528		—	—
Modification of warrants	—	—		43		—		43		—	—
Net and comprehensive loss available to common stockholders	—	—		—		(18,438)		(18,438)		—	—
Balance as of June 30, 2020	8,156,618	$	9	$	212,572	$	(229,195)	$	(16,614)	1,387,378	$	10,566

See accompanying notes to the unaudited condensed consolidated financial statements.

7

Table of Contents

Better Choice Company Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(Dollars in thousands)

	Six Months Ended June 30,
	2021		2020
Cash Flow from Operating Activities:
Net and comprehensive income (loss) available to common stockholders	$	11,926	$	(27,926)
Adjustments to reconcile net and comprehensive income (loss) to net cash used in operating activities:
Shares and warrants issued to third parties for services	46		10,182
Depreciation and amortization	824		866
Amortization of debt issuance costs and discounts	1,777		2,353
Share-based compensation	2,857		5,504
Change in fair value of warrant liabilities	(22,873)		2,095
PIK interest expense on notes payable	1,110		939
Other	(930)		689
Changes in operating assets and liabilities:
Accounts receivable, net	(558)		1,621
Inventories, net	(332)		1,161
Prepaid expenses and other assets	1,256		92
Accounts payable and accrued liabilities	328		5
Other	(93)		251
Cash Used in Operating Activities	$	(4,662)	$	(2,168)
Cash Flow from Investing Activities
Acquisition of property and equipment	$	(54)	$	(6)
Cash Used in Investing Activities	$	(54)	$	(6)
Cash Flow from Financing Activities
Proceeds from shares and warrants issued pursuant to private placement, net	$	4,012	$	—
Proceeds from issuance of debt	—		2,352
Proceeds from revolving lines of credit	5,155		1,075
Payments on revolving lines of credit	(5,214)		(300)
Proceeds from term loan	6,000		—
Payments on term loans	(8,229)		—
Cash received for warrant exercises	1,685		—
IPO costs	(19)		—
Debt issuance costs	(116)		—
Cash Provided by Financing Activities	$	3,274	$	3,127
Net (decrease) increase in cash and cash equivalents and restricted cash	$	(1,442)	$	953
Total cash and cash equivalents and restricted cash, beginning of period	3,989		2,534
Total cash and cash equivalents and restricted cash, end of period	$	2,547	$	3,487

Supplemental cash flow information:

	Six Months Ended June 30,
	2021		2020
Cash paid during the period for:
Interest	$	221	$	1,319
Non-cash financing and investing transactions
Stock issued for services	$	—	$	125

See accompanying notes to the unaudited condensed consolidated financial statements.

8

Table of Contents

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Note 1 - Nature of business and summary of significant accounting policies

Nature of the business

Better Choice Company Inc. is a growing animal health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. The Company sells its product offerings under the Halo and TruDog brands, which have a long history of providing high quality products to pet parents. The Company believes its portfolio of brands are well-positioned to benefit from the trends of growing pet humanization and an increased consumer focus on health and wellness, and the Company has adopted a laser focused, channel-specific approach to growth that is driven by new product innovation. The Company has a broad portfolio of over 100 active premium and super-premium animal health and wellness products for dogs and cats sold under its Halo and TruDog brands across multiple forms, including foods, treats, toppers, dental products, chews, grooming products and supplements. The products consist of naturally formulated premium kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products, supplements and grooming aids. The core products sold under the Halo brand are sustainably sourced, derived from real whole meat and no rendered meat meal and include non-genetically modified fruits and vegetables. The core products sold under the TruDog brand are made according to the Company's nutritional philosophy of fresh, meat-based nutrition and minimal processing.

Reverse stock split

On May 28, 2021, stockholders of the Company holding a majority of the voting power of the Company entitled to vote approved by way of a written consent resolution the authorization of the Company's board of directors, in its sole and absolute discretion, and without further action of the stockholders, to file an amendment to the Company’s amended and restated certificate of incorporation to affect a reverse stock split of its common stock at a ratio in the range of 1-for-3 to 1-for-10 at any time prior to December 31, 2021. On June 10, 2021 the Company's board of directors set the reverse stock split ratio at 1-for-6 (the "Reverse Stock Split") and approved the Reverse Stock Split to be effectuated by the Company immediately following the effectiveness of the Company's registration statement related to the Company's IPO (as defined below), which became effective on June 28, 2021.

As a result of the Reverse Stock Split, every six shares of the Company’s common stock was combined and converted into one share of the Company’s common stock as of June 28, 2021. In addition, the conversion rates of the Company's outstanding preferred stock and convertible notes and the exercise prices of the Company’s underlying common stock purchase warrants and stock options were proportionately adjusted at the applicable reverse stock split ratio in accordance with the terms of such instruments. Proportionate voting rights and other rights of common stockholders were not affected by the Reverse Stock Split, other than as a result of the rounding up of fractional shares. The Company issued 1,081 shares of common stock in lieu of fractional shares in connection with the Reverse Stock Split.

Accordingly, all share and per share amounts related to the Company's common stock and underlying derivatives for all periods presented in the accompanying unaudited condensed consolidated financial statements and notes thereto have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split. The number of authorized shares and the par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.

Initial public offering

On June 28, 2021, the Company’s registration statement on Form S-1 for its underwritten initial public offering (the “IPO”) was declared effective by the SEC, and the Company's common stock commenced trading on the NYSE American ("NYSE") on June 29, 2021. Upon commencement of the trading of the Company's common stock on the NYSE on June 29, 2021, all of the Company's outstanding convertible notes payable automatically converted into 4,732,420 shares of common stock.

In connection with the IPO, which closed on July 1, 2021, the Company issued and sold 8,000,000 shares of its common stock at a price of $5.00 per share. The total net proceeds from the IPO were approximately $36.2 million, after deducting underwriting discounts and commissions of $2.8 million, and offering costs of approximately $1.0 million, of which $0.9 million was incurred as of June 30, 2021. The Company plans to use the net proceeds of this IPO for general corporate purposes. The Company may also elect to use proceeds from the IPO to acquire complimentary technologies, products or businesses, although the Company is not a party to any letters of intent or definitive agreements for any such acquisition. The Company granted the underwriters an option for a period of 30 days from June 29, 2021 to purchase up to 1,200,000 shares of common stock (the "Underwriter Shares") at the public offering price, less the underwriting discounts and commissions, to cover over-allotments, if any. No Underwriter Shares were purchased during the 30 day period.

9

Table of Contents

Upon the consummation of the IPO on July 1, 2021, all shares of the Series F convertible preferred stock were converted into 5,764,533 shares of common stock. Additionally, since the anti-dilution provision of the Series F Warrants were no longer effective upon consummation of the Company's IPO, these warrants met the requirements to be considered equity and the outstanding Series F Warrants were reclassified as such.

The following unaudited pro forma condensed consolidated balance sheet data is presented as if the IPO closed on June 30, 2021, by applying adjustments to the Company’s condensed consolidated balance sheet. It reflects (1) the issuance of 8,000,000 shares of common stock for estimated net proceeds of $36.2 million (of which $0.9 million of offering costs were already included in the June 30, 2021 current asset balance), (2) the conversion of all Series F convertible preferred stock into an aggregate of 5,764,533 shares of common stock and (3) the reclassification of the Series F Warrant liability to equity:

	Actual		Pro Forma Adjustments		Pro Forma
	June 30, 2021				June 30, 2021
Assets
Total Current Assets	$	17,859	$	36,168	$	54,027
Total Non-Current assets	31,321		—		31,321
Total Assets	$	49,180	$	36,168	$	85,348
Liabilities & Stockholders’ Equity (Deficit)
Total Liabilities	$	34,920	$	(16,977)	$	17,943
Common Stock	16		14		30
Series F Preferred Stock	—		—		—
Additional paid-in capital	263,361		53,131		316,492
Accumulated deficit	(249,117)		—		(249,117)
Total Stockholders’ Equity (Deficit)	14,260		53,145		67,405
Total Liabilities and Stockholders’ Equity (Deficit)	$	49,180	$	36,168	$	85,348

Basis of presentation

The Company’s condensed consolidated financial statements are prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reports and accounting principles generally accepted in the United States ("GAAP"). Results of operations for interim periods may not be representative of results to be expected for the full year.

Certain reclassifications have been made to conform the prior period data to the current presentation. These reclassifications had no material effect on the reported results.

These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company’s Annual Report for the year ended December 31, 2020, filed with the SEC.

Consolidation

The financial statements are presented on a consolidated basis subsequent to acquisitions and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Use of estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.

In the opinion of management, the condensed consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations and comprehensive income (loss) for the periods ended June 30, 2021 and 2020, the financial position as of June 30, 2021 and December 31, 2020 and the cash flows for the periods ended June 30, 2021 and 2020.

10

Table of Contents

Summary of significant accounting policies

For additional information, please refer to the most recently filed Annual Report regarding the Company's summary of significant accounting policies.

New accounting standards

Recently adopted

ASU 2020-03 “Codification Improvements to Financial Instruments”

In March 2020, FASB issued Accounting Standards Update ("ASU") 2020-03, Codification Improvement to Financial Instruments. This ASU improves and clarifies various financial instruments topics, including the current expected credit losses standard issued in 2016. The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments have different effective dates, some of which were effective for the Company beginning on January 1, 2021. The amendments adopted did not have a material impact on the Company’s condensed consolidated financial statements.

ASU 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This new guidance was effective for the Company beginning on January 1, 2021 and did not have an impact on the Company’s condensed consolidated financial statements.

Issued but not yet adopted

ASU 2016-13 “Financial Instruments – Credit Losses (Topic 326)”

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326),” a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard is effective for the Company on January 1, 2023, and early adoption is permitted. The Company is currently evaluating the impact the new standard will have on its consolidated financial statements.

ASU 2020-04 “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting”

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional expedient and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. In response to the concerns about structural risks of interbank offered rates (IBORs) and, particularly, the risk of cessation of the London Interbank Offered Rate (LIBOR), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is currently evaluating the impact the standard will have on its consolidated financial statements and related disclosures.

ASU 2020-06 "Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

In August 2020, FASB issued ASU 2020-06, Debt - Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Accounting for Convertible Instruments and Contracts in an Entity's Own Equity. This ASU reduces the number of accounting models for convertible instruments, amends diluted EPS calculations for convertible instruments, and amends the requirements for a contract (or embedded derivative) that is potentially settled in an entity’s own shares to be classified in equity. This standard is effective for the Company beginning on January 1, 2024 with early adoption permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

Note 2 - Revenue

The Company records revenue net of discounts, which primarily consist of early pay discounts, general percentage allowances and contractual trade promotions.

The Company excludes sales taxes collected from revenues. Retail-partner based customers are not subject to sales tax.

11

Table of Contents

The Company’s direct-to-consumer ("DTC") loyalty program enables customers to accumulate points based on their spending. A portion of revenue is deferred at the time of sale when points are earned and recognized when the loyalty points are redeemed.

Shipping costs

Shipping costs associated with moving finished products to customers were $0.9 million and $0.7 million for the six months ended June 30, 2021 and 2020, respectively, and $0.4 million and $0.3 million for the three months ended June 30, 2021 and 2020, respectively. Such shipping costs are recorded as part of general and administrative expenses.

Revenue channels

The Company groups its revenue channels into four distinct categories: E-Commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick & Mortar, which includes the sale of product to pet specialty chains such as Petco, PetSmart, select grocery chains, and neighborhood pet stores; DTC, which includes the sale of product through the Company's online web platform to more than 20,000 unique customers; and International, which includes the sale of product to foreign distribution partners and to select international retailers (transacted in U.S. dollars). Information about the Company’s net sales by revenue channel is as follows (in thousands):

	Six Months Ended June 30,								Three Months Ended June 30,
	2021				2020				2021				2020
E-commerce	$	6,902	32	%	$	7,459	34	%	$	2,892	26	%	$	2,978	30	%
Brick & Mortar	3,592		16	%	4,772		22	%	1,698		16	%	1,875		19	%
DTC	4,777		22	%	5,526		25	%	2,341		21	%	2,722		27	%
International	6,548		30	%	4,410		19	%	4,058		37	%	2,366		24	%
Net Sales	$	21,819	100	%	$	22,167	100	%	$	10,989	100	%	$	9,941	100	%

Note 3 - Inventories

Inventories are summarized as follows (in thousands):

	June 30, 2021		December 31, 2020
Food, treats and supplements	$	5,129	$	4,987
Inventory packaging and supplies	499		596
Total Inventories	5,628		5,583
Inventory reserve	(427)		(714)
Inventories, net	$	5,201	$	4,869

Note 4 - Prepaid expenses and other current assets

	June 30, 2021		December 31, 2020
Prepaid advertising contract with iHeart (1)	$	2,985	$	1,788
Other prepaid expenses and other current assets (2)	1,055		2,286
Total Prepaid expenses and other current assets	$	4,040	$	4,074

(1) On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. and issued 166,667 shares of common stock valued at $3.4 million for future advertising services. The Company issued an additional 20,834 shares valued at $0.1 million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. There was a long-term portion of $1.2 million recorded in other non-current assets as of December 31, 2020.

(2) As of June 30, 2021, this amount includes various other prepaid contracts. In December 2020, the Company entered into an agreement for access to an investment platform in exchange for 83,334 shares of common stock valued at $0.6 million and also entered into an agreement for marketing services in exchange for 83,334 shares of common stock valued at $0.5 million, both of which are being amortized over 12 months.

12

Table of Contents

Note 5 - Accrued and other liabilities

Accrued and other liabilities consist of the following (in thousands):

	June 30, 2021		December 31, 2020
Accrued professional fees	$	503	$	704
Accrued sales tax	215		1,009
Accrued payroll and benefits	1,018		913
Accrued trade promotions	57		106
Accrued interest	24		86
Deferred revenue	257		350
Other	157		232
Total accrued liabilities	$	2,231	$	3,400

Note 6 - Intangible assets, royalties, and goodwill

Intangible assets

The Company’s intangible assets (in thousands) and related useful lives (in years) are as follows:

				June 30, 2021				December 31, 2020
	Estimated useful life	Gross carrying amount		Accumulated amortization		Net carrying amount		Accumulated amortization		Net carrying amount
Customer relationships	7	$	7,190	$	(1,574)	$	5,616	$	(1,059)	$	6,131
Trade name	15	7,500		(766)		6,734		(516)		6,984
Total intangible assets		$	14,690	$	(2,340)	$	12,350	$	(1,575)	$	13,115

Amortization expense was $0.4 million and $0.8 million for both the three and six months ended June 30, 2021 and 2020, respectively.

The estimated future amortization of intangible assets over the remaining weighted average useful life of 9.8 years is as follows (in thousands):

Remainder of 2021	$	764
2022	1,527
2023	1,527
2024	1,527
2025	1,527
Thereafter	5,478
	$	12,350

There were no indicators or impairment of the intangible assets as of June 30, 2021.

Goodwill

Goodwill was $18.6 million as of June 30, 2021 and December 31, 2020, respectfully. The Company performed a quantitative assessment for its annual impairment test as of October 1, 2020. Under the quantitative approach, the Company makes various estimates and assumptions to determine the estimated fair value of the reporting unit using a combination of a discounted cash flow model and earnings multiples for guideline public companies. As of June 30, 2021, there was no accumulated impairment loss and no impairment expense related to goodwill.

13

Table of Contents

Note 7 - Debt

The components of the Company’s debt consist of the following (in thousands):

Dollars in thousands	June 30, 2021					December 31, 2020
	Amount		Rate		Maturity Date	Amount		Rate		Maturity Date
Term loan, net	$	5,703	(1)		1/6/2024	$	7,826	(2)		1/15/2021
Line of credit, net	5,157		(1)		1/6/2024	5,023		(3)		7/5/2022
November 2019 notes payable, net (November 2019 Notes)	—		10	%	6/30/2023	2,830		10	%	6/30/2023
December 2019 senior notes payable, net (Senior Seller Notes)	—		10	%	6/30/2023	10,332		10	%	6/30/2023
December 2019 junior notes payable, net (Junior Seller Notes)	—		10	%	6/30/2023	4,973		10	%	6/30/2023
ABG Notes	—		10	%	6/30/2023	687		10	%	6/30/2023
June 2020 notes payable, net (June 2020 Notes)	—		10	%	6/30/2023	88		10	%	6/30/2023
Halo PPP Loan	—		1	%	5/3/2022	431		1	%	5/3/2022
TruPet PPP Loan	—		0.98	%	4/6/2022	421		0.98	%	4/6/2022
Total debt	10,860					32,611
Less current portion	926					8,016
Total long term debt	$	9,934				$	24,595

(1)Interest at a variable rate of LIBOR plus 250 basis points with an interest rate floor of 2.50% per annum

(2)Interest at Bank of Montreal Prime plus 8.05%

(3)Interest at a variable rate of LIBOR plus 250 basis points with an interest rate floor of 3.25% per annum

Term loans and lines of credit

On December 19, 2019, the Company entered into a Loan Facilities Agreement (the “Facilities Agreement”) by and among the Company, as the borrower, the several lenders from time to time parties thereto (collectively, the “Lenders”) and a private debt lender, as agent (the “Agent”). The Facilities Agreement provided for (i) a term loan facility of $20.5 million and (ii) a revolving loan facility not to exceed $7.5 million. The term loan was scheduled to mature on December 19, 2020 or such earlier date on which a demand was made by the Agent or any Lender, and was extended as discussed below. The remaining revolving credit facility balance of $5.1 million was repaid in full with a portion of the proceeds from the ABL Facility, discussed below, and resulted in a loss on debt extinguishment of $0.1 million.

Certain directors and shareholders of the Company (“Shareholder Guarantors”) agreed to guarantee the Company’s obligations under the Facilities Agreement up to an aggregate amount of $20.0 million pursuant to a Continuing Guarantee between the Shareholder Guarantors and the lender under the Facilities Agreement (the "Shareholder Guaranties"). As consideration for the Shareholder Guaranties, the Company issued common stock purchase warrants to the Shareholder Guarantors in an amount equal to 0.055 warrants for each dollar of debt guaranteed by such Shareholder Guarantors (the “Guarantor Warrants”).

On July 16, 2020, the Company entered into a revolving line of credit with Citizens Business Bank in the aggregate amount of $7.5 million (the “ABL Facility”). The proceeds of the ABL Facility were used (i) to repay all principal, interest and fees outstanding under the Company’s previous revolving credit facility and (ii) for general corporate purposes. Debt issuance costs of less than $0.1 million were incurred related to the Company entering into this revolving line of credit.

The ABL Facility was scheduled to mature on July 5, 2022 and accrued interest at a variable rate of LIBOR plus 250 basis points, with an interest rate floor of 3.25% per annum. Accrued interest on the ABL Facility was payable monthly commencing on August 5, 2020. The ABL Agreement provided for customary financial covenants, such as maintaining a specified adjusted EBITDA and a maximum senior debt leverage ratio, that commenced on December 31, 2020 and customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company prepaid all of the outstanding principal and accrued interest under the ABL Facility in full and did not incur any prepayment charges.

The ABL Facility was secured by a general security interest on the assets of the Company and was personally guaranteed by a member of the Company’s board of directors.

14

Table of Contents

On October 5, 2020, the Company paid down the term loan by $11.0 million using proceeds from the Series F Private Placement. On October 29, 2020, the Company made an additional pay down on the term loan of $1.0 million using additional proceeds from the Series F Private Placement.

On November 25, 2020, the Company entered into the fifth amendment to the Facilities Agreement, extending the maturity date of the term loan to January 15, 2021.

On January 6, 2021, Halo, Purely for Pets, Inc., a wholly owned subsidiary of Better Choice Company Inc. ("Halo") entered into a credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A. (“Wintrust”) consisting of a $6.0 million term loan and a $6.0 million revolving line of credit, each scheduled to mature on January 6, 2024 and each bear interest at a variable rate of LIBOR plus 250 basis points, with an interest rate floor of 2.50% per annum (the "Wintrust Credit Facility"). Accrued interest on the Wintrust Facility is payable monthly commencing on February 1, 2021. Principal payments are required to be made monthly on the term loan commencing February 2021 with a balloon payment upon maturity. The proceeds from the Wintrust Credit Facility were used (i) to repay the principal, interest and fees outstanding under the ABL Facility and (ii) for general corporate purposes. The Company applied extinguishment accounting to the outstanding balances of the ABL Facility and term loan and recorded a loss on extinguishment of debt of $0.4 million during the three months ended March 31, 2021. Debt issuance costs of $0.1 million were incurred related to the Wintrust Credit Facility.

The Wintrust Credit Facility subjects the Company to certain financial covenants, including the maintenance of a fixed charge coverage ratio of no less than 1.25 to 1.00, tested as of the last day of each fiscal quarter. The numerator in the fixed charge coverage ratio is the operating cash flow of Halo, defined as Halo EBITDA less cash paid for unfinanced Halo capital expenditures, income taxes and dividends. The denominator is fixed charges such as interest expense and principal payments paid or payable on other indebtedness attributable to Halo.

The Wintrust Credit Facility is secured by a general guaranty and security interest on the assets, including the intellectual property, of the Company and its subsidiaries. The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral. Furthermore, the Wintrust Credit Facility is supported by a collateral pledge by a member of the Company’s board of directors.

As of June 30, 2021, the term loan and line of credit outstanding under the Wintrust Credit Facility were $5.7 million and $5.2 million, respectively, net of debt issuance costs of less than $0.1 million, respectively. As of December 31, 2020, the previous term loan and line of credit outstanding were $7.8 million and $5.0 million, respectively, net of debt issuance costs and discounts of less than $0.2 million and $0.2 million, respectively. The debt issuance costs and discounts are amortized using the effective interest method.

As of June 30, 2021 and December 31, 2020, the Company was in compliance with its debt covenants.

Notes payable

On November 4, 2019, the Company issued $2.8 million of subordinated convertible notes (the “November 2019 Notes”) which carried a 10% interest rate and mature on November 4, 2021. The interest was payable in kind, in arrears on March 31, June 30, September 30 and December 31 of each year. Payment in kind ("PIK") interest was payable by increasing the aggregate principal amount of the November 2019 Notes. The November 2019 Notes were convertible any time from the date of issuance and carried an initial conversion price of the lower of (a) $24.00 per share or (b) the IPO Price.

The November 2019 Notes were amended on January 6, 2020. The amendment incorporates only the preferable terms of the Seller Notes as noted below, and all other terms and provisions of the November 2019 Notes remained in full force and effect. As amended, for so long as any event of default (as defined in the November 2019 Notes) exists, interest shall accrue on the November 2019 Notes principal at the default interest rate of 12.0% per annum, and such accrued interest shall be immediately due and payable.

The November 2019 Notes were amended for the second time on June 24, 2020 in connection with the issuance of the June 2020 Notes. The amendment lowered the maximum conversion price applicable to the conversion of these notes from $24.00 per share to $22.50 per share and extended the maturity date from November 4, 2021 to June 30, 2023. Under the applicable accounting guidance, the Company accounted for the change in conversion price as a modification of the debt instrument. The Company recognized the increase in the fair value of the conversion option of $0.3 million as a reduction to the carrying amount of the debt instrument by increasing the associated debt discount with a corresponding increase in Additional paid-in capital.

As of June 30, 2021, the November 2019 Notes outstanding were $0 since they were automatically converted to common stock in connection with the Company's IPO, at a price of $5.00 per share. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information. As of December 31, 2020, the November 2019 Notes outstanding were $2.8 million, net of discounts of less than $0.3 million. The discounts were being amortized over the life of the November 2019 Notes using the effective interest method.

15

Table of Contents

On December 19, 2019, the Company issued $10.0 million and $5.0 million in senior subordinated convertible notes (the “Senior Seller Notes”) and junior subordinated convertible notes (the “Junior Seller Notes” and together with the Senior Seller Notes, the “Seller Notes”), respectively, to the sellers of Halo. The Seller Notes were convertible any time from the date of issuance and carried a 10% interest rate and mature on June 30, 2023. Interest was payable in kind, in arrears on March 31, June 30, September 30 and December 31 of each year. PIK interest was payable by increasing the aggregate principal amount of the Seller Notes. The Seller Notes carried a conversion price of the lower of (a) $24.00 per share or (b) the IPO Price. 

The Seller Notes were amended on June 24, 2020 in connection with the issuance of the June 2020 Notes. The amendment lowered the maximum conversion price applicable to the conversion of these notes from $24.00 per share to $22.50 per share. The Company accounted for the change in the conversion price as a modification of the debt instrument. The Company recognized the increase in the fair value of the conversion option of less than $0.3 million as a reduction to the carrying amounts of the debt instruments by increasing the associated debt discounts with a corresponding increase in Additional paid-in capital.

As of June 30, 2021, the Senior Seller Notes and Junior Seller Notes outstanding were $0 since they were automatically converted to common stock in connection with the Company's IPO, at a price of $5.00 per share. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information. As of December 31, 2020, the Senior Seller Notes outstanding were $10.3 million, net of discounts of $0.8 million, and the Junior Seller Notes outstanding were $5.0 million, net of discounts of $0.5 million. The discounts were being amortized over the life of the Seller Notes using the effective interest method.

On January 13, 2020, the Company issued $0.6 million in senior subordinated convertible notes to Authentic Brands and Elvis Presley Enterprises (“ABG”) in connection with the termination of a previous licensing agreement (the "ABG Notes"). The terms of the ABG Notes match those of the Seller Notes, including conversion features convertible any time after the date of issuance, a 10% interest rate and maturity date of June 30, 2023. The interest was payable in kind, in arrears on March 31, June 30, September 30 and December 31 of each year. PIK interest was payable by increasing the aggregate principal amount of the ABG Notes. The ABG Notes carried an initial conversion price of the lower of (a) $24.00 per share or (b) the IPO Price.

In addition to issuing the ABG Notes, as part of the ABG termination on January 13, 2020, the Company paid ABG $0.1 million in cash, issued ABG 12,120 shares of the Company’s common stock, agreed to pay ABG $0.1 million in cash in four equal installments each month from July 31, 2020 through October 31, 2020 and issued ABG common stock purchase warrants (the “ABG Warrants”) equal to a fair value of $0.2 million.

The ABG Notes were amended on June 24, 2020 in connection with the issuance of the June 2020 Notes. The amendment lowered the maximum conversion price applicable to the conversion of these notes from $24.00 per share to $22.50 per share. The Company accounted for the change in the conversion price as a modification of the debt instrument. The Company recognized the increase in the fair value of the conversion option of less than $0.1 million as a reduction to the carrying amount of the debt instrument by decreasing the associated debt premium with a corresponding increase in Additional paid-in capital.

As of June 30, 2021, the ABG Notes outstanding were $0 since they were automatically converted to common stock in connection with the Company's IPO, at a price of $5.00 per share. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information. As of December 31, 2020, the ABG Notes outstanding were $0.7 million, including a debt premium of less than $0.1 million. The debt premium was being amortized over the life of the ABG Notes using the effective interest method.

On June 24, 2020, the Company issued $1.5 million in subordinated convertible promissory notes (the “June 2020 Notes”) which carried a 10% interest rate and matures on June 30, 2023. The interest was payable quarterly in kind, in arrears on March 31, June 30, September 30, and December 31 of each year. PIK interest was payable by increasing the aggregate principal amount of the June 2020 Notes. The June 2020 Notes were convertible any time from the date of issuance and carried a conversion price $4.50 per share.

The Company evaluated the conversion option within the June 2020 Notes to determine whether the conversion price was beneficial to the note holders. The Company recorded a beneficial conversion feature (“BCF”) related to the issuance of the June 2020 Notes. The BCF for the June 2020 Notes was recognized and measured by allocating a portion of the proceeds to the beneficial conversion feature, based on relative fair value, and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion feature limited to the proceeds amount allocated to the instrument. The discount recorded in connection with the BCF valuation was being accreted as interest expense over the term of the June 2020 Notes, using the effective interest rate method. Upon the conversion of the June 2020 Notes discussed below, the remaining discount of $1.4 million associated with the June 2020 Notes was fully accreted through interest expense.

16

Table of Contents

As of June 30, 2021, the June 2020 Notes outstanding were $0 since they were automatically converted to common stock in connection with the Company's IPO, at a price of $4.50 per share. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information. As of December 31, 2020, the June 2020 Notes outstanding were less than $0.1 million, net of discounts of less than $1.5 million. The discounts were being amortized over the life of the June 2020 Notes using the effective interest method.

Previously, $0.1 million of the Seller Notes were held by an executive of the Company; these convertible notes were converted to common stock as described above. Additionally, $2.2 million of the subordinated convertible notes were held by a member of the board of directors and were converted to common stock as described above. PIK interest related to these notes was less than $0.1 million and $0.1 million for both the three and six months ended June 30, 2021 and 2020, respectively.

As of June 30, 2021 and December 31, 2020, the Company was in compliance with all covenant requirements and there were no events of default.

PPP loans

On April 10, 2020, TruPet, LLC, a wholly owned subsidiary of Better Choice Company Inc., was granted a loan from JPMorgan Chase Bank, N.A. in the aggregate amount of $0.4 million, pursuant to the Paycheck Protection Program ("PPP") under Division A, Title I of the CARES Act (the “TruPet PPP Loan”). The loan matured on April 6, 2022 and had an interest rate of 0.98% per annum, with interest and principal payable monthly, commencing on November 6, 2020. During the three months ended June 30, 2021, the TruPet PPP loan was fully forgiven and the Company recognized a gain on extinguishment of debt of $0.4 million.

On May 7, 2020, Halo, Purely for Pets, Inc., a wholly owned subsidiary of Better Choice Company Inc., was granted a loan from Wells Fargo Bank, N.A. in the aggregate amount of $0.4 million, pursuant to the PPP (the “Halo PPP Loan”). The loan matured on May 3, 2022 and had an interest rate of 1.00% per annum, with interest and principal payable monthly, commencing on November 1, 2020. During the three months ended June 30, 2021 the Halo PPP loan was fully forgiven and the Company recognized a gain on extinguishment of debt of $0.4 million.

The Company recorded interest expense related to its outstanding indebtedness of $3.1 million and $4.7 million for the six months ended June 30, 2021 and June 30, 2020, respectively, and $2.2 million and $2.4 million for the three months ended June 30, 2021 and June 30, 2020, respectively.

The carrying amount for the Company’s term loan and line of credit approximate fair value as the instruments have variable interest rates that approximate market rates.

Note 8 - Commitments and contingencies

The Company had no material purchase obligations as of June 30, 2021 or December 31, 2020.

The Company may be involved in legal proceedings, claims, and regulatory, tax, or government inquiries and investigations that arise in the ordinary course of business resulting in loss contingencies. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability. Legal costs such as outside counsel fees and expenses are charged to expense in the period incurred and are recorded in general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The Company does not accrue for contingent losses that are considered to be reasonably possible, but not probable; however, the Company discloses the range of such reasonably possible losses. Loss contingencies considered remote are generally not disclosed. 

Litigation is subject to numerous uncertainties and the outcome of individual claims and contingencies is not predictable. It is possible that some legal matters for which reserves have or have not been established could result in an unfavorable outcome for the Company and any such unfavorable outcome could be of a material nature or have a material adverse effect on the Company's consolidated financial condition, results of operations and cash flows. Management is not aware of any claims or lawsuits that may have a material adverse effect on the consolidated financial position or results of operations of the Company.

Note 9 - Convertible preferred stock

During October, 2020, the Company consummated an insider-led equity financing, including the transactions contemplated by a securities purchase agreement (the “Securities Purchase Agreement”) between the Company and certain accredited and sophisticated investors (the “Purchasers”) and an exchange agreement (the “Series E Exchange Agreement”) between the Company and Cavalry Fund LP ("Cavalry"), the holder of all of the Company’s previously outstanding Series E preferred stock.

17

Table of Contents

Pursuant to the Securities Purchase Agreement, the Company, in a private placement (the “Series F Private Placement”), issued and sold units (the “Series F Units”) to the Purchasers for a purchase price of $1,000 per Unit. Each Unit consists of: (i) one share of the Company’s Series F convertible preferred stock, par value $0.001 per share (the “Series F Preferred Stock”), which is convertible into shares of the Company’s common stock, par value $0.001 per share, at a value per share of common stock of $3.00; and (ii) a warrant to purchase for a six year period such number of shares of common stock (the “Series F Warrant Shares”) into which such share of Series F Preferred Stock is convertible at an exercise price per Warrant Share of $4.50. Pursuant to the Series F Private Placement, the Company raised approximately $18.2 million in gross cash proceeds, approximately $6.5 million of which was invested by certain officers, directors, employees and associated related parties thereto of the Company. The Series F Shares were recorded at fair value on the date of issuance on an as converted basis.

Concurrently with the execution of the Securities Purchase Agreement, the Company and the Purchasers entered into a registration rights agreement, (as amended by a certain first amendment dated October 29, 2020, the "Registration Rights Agreement"), pursuant to which the Company filed a registration statement which was declared effective by the SEC on February 16, 2021 to register the Warrant Shares and the shares of common stock issuable upon conversion of the Series F Preferred Stock.

In connection with the consummation of the Series F Private Placement, on October 1, 2020, the Company filed with the Secretary of State of Delaware a Certificate of Designations which authorizes a total of 30,000 shares of Series F Preferred Stock and sets forth the designations, preferences, and rights of the Company's Series F Preferred Stock.

On October 1, 2020, the Company issued 14,264 Series F Units in conjunction with money received for the Series F Private Placement. In addition, pursuant to the Series E Exchange Agreement, on October 1, 2020, the Company issued 3,500 Series F Units to Cavalry in exchange for all of its outstanding Series E Preferred Stock. The exchange of Series E Preferred Shares resulted in a $5.4 million gain and was recorded to Accumulated deficit on the Company's Condensed Consolidated Balance Sheets.

On October 12, 2020 and October 23, 2020, the Company issued 1,106 and 2,832 Series F Units, respectively, in conjunction with the Series F Private Placement. In addition, on October 23, 2020, the Company issued an additional 100 shares of Series F Preferred Stock in conjunction with a marketing agreement.

The Company evaluated the conversion option within the Series F Preferred Stock on the dates of issuance to determine whether the conversion price was beneficial to the holders. The Company recorded a BCF related to the issuance of the Series F Preferred Stock. The BCF was recognized and measured by allocating a portion of the proceeds to the beneficial conversion feature, based on fair value and was recorded to Accumulated deficit on the Company's Condensed Consolidated Balance Sheets limited to the proceeds amount allocated to the instrument.

On July 1, 2021, all outstanding shares of convertible preferred stock were converted to common stock in connection with the consummation of the Company's IPO. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information.

Note 10 - Stockholders’ equity (deficit)

On January 22, 2021, the Company consummated a private placement of common stock units (the “January 2021 Private Placement”) in which the Company raised approximately $4.1 million, including an investment by certain officers, directors, employees and associated related parties thereto of approximately $1.6 million. Each common stock unit was sold at a per unit price of $7.50 and consisted of (i) one share of the Company’s common stock, par value $0.001 per share; and (ii) a warrant to purchase one share of common stock. The proceeds were used to pay expenses related to the offering and for general corporate purposes. In connection with the January 2021 Private Placement, the Company entered into a registration rights agreement (the “January 2021 Registration Rights Agreement”) pursuant to which the Company filed a registration statement that was declared effective by the SEC on February 16, 2021 to register the shares of common stock issued, and issuable upon the exercise of the warrants issued, in the January 2021 Private Placement.

See "Note 1 - Nature of business and summary of significant accounting policies" for additional information regarding the impacts to the Company's Stockholders’ equity (deficit) related to the commencement of its common stock trading on the NYSE and the consummation of its IPO.

18

Table of Contents

The Company has reserved common stock for future issuance as follows:

	June 30, 2021	December 31, 2020
Conversion of Series F Preferred Stock	5,764,533	7,251,189
Exercise of options to purchase common stock	2,200,244	1,302,574
Exercise of warrants to purchase common stock	9,433,584	9,916,997
Conversion of notes payable	—	1,255,039
Total	17,398,361	19,725,799

Note 11 - Warrants

The following summarizes the Company's outstanding warrants to purchase shares of the Company's common stock as of and for the periods ended June 30, 2021 and December 31, 2020:

	Warrants	Exercise Price
Warrants outstanding as of December 31, 2019	2,830,309	$	19.38
Issued	8,321,412	$	4.62
Exercised	(322,949)	$	3.48
Terminated/Expired	(911,776)	$	18.42
Warrants outstanding as of December 31, 2020	9,916,996	$	7.32
Issued	548,111	$	8.70
Exercised	(389,881)	$	4.52
Terminated/Expired	(641,642)	$	24.64
Warrants outstanding as of June 30, 2021	9,433,584	$	5.92

The intrinsic value of outstanding warrants was $0.0 million and $23.8 million as of June 30, 2021 and December 31, 2020, respectively. The following discussion provides details on the various types of outstanding warrants and the related relevant disclosures around each type.

Warrant derivative liability

During May 2019, the Company acquired 118,804 warrants with a weighted average exercise price of $23.40 (the "May Acquisitions Warrants"). These warrants included an option to settle in cash in the event of a change of control of the Company and a reset feature if the Company issues shares of common stock with a strike price below the exercise price of the warrants, which required the Company to record the warrants as a derivative liability. The Company calculates the fair value of the derivative liability through a Monte Carlo Model that values the warrants based upon a probability weighted discounted cash flow model.

During January 2020, the Company issued shares below the exercise price of the May Acquisitions Warrants. As such, the Company issued an additional 167,206 warrants on March 17, 2020 to certain of its warrant holders at an exercise price of $9.72 and modified the exercise price of the existing May Acquisitions Warrants to $9.72.

During June 2020, the Company issued common stock equivalents below the exercise price of the warrants issued on March 17, 2020. As such, the Company issued an additional 331,771 warrants to certain of its warrant holders at an exercise price of $4.50 and modified the exercise price of the existing warrants to $4.50.

During September 2020, the Company amended all of these warrants to eliminate certain anti-dilution rights, fix the number of shares of common stock purchasable under each warrant, and set the exercise price thereof at $3.90 per share. As such, the Company issued an additional 95,043 warrants to certain of its warrant holders at an exercise price of $3.90.

During the fourth quarter of 2020, holders exercised a total 281,282 warrants for which the Company issued shares of common stock. During December 2020, 418,721 of these warrants expired and an immaterial amount remained outstanding as of December 31, 2020, all of which expired during January 2021.

19

Table of Contents

The following schedule shows the fair value of the warrant derivative liability as of June 30, 2021 and December 31, 2020, and the change in fair value during the periods ended June 30, 2021 and year ended December 31, 2020 (in thousands):

	Warrant Derivative Liability
Balance as of December 31, 2019	$	2,220
Change in fair value of  warrant derivative liability	(2,220)
Balance as of December 31, 2020	$	—
Change in fair value of  warrant derivative liability (1)	—
Balance as of June 30, 2021	$	—

(1) All of the May Acquisition Warrants expired during January 2021.

Series F warrant liability

During October 2020, the Company issued 7,233,855 warrants to purchase common stock in connection with the Series F Private Placement (defined below) with an exercise price of $4.50 (the "Series F Warrants"). The warrants are exercisable commencing on the date of issuance and expire 72 months after the date of issuance. These warrants included a reset feature if the Company issues common stock, options, or convertible securities with a strike price below the exercise price of the warrants. During the second quarter of 2021, a Series F warrant holder exercised 83,334 warrants, resulting in the Company’s receipt of approximately $0.4 million. Initially, these warrants did not meet the definition of a derivative or the requirements to be considered equity; as such, the Company recorded these as a liability. Due to changes in certain terms of the warrant agreements in connection with the Company's IPO whereby the warrants did meet the requirements to be considered equity, the outstanding Series F warrants were reclassified to equity upon consummation of the IPO on July 1, 2021. See "Note 9 - Convertible preferred stock" for more information on Series F and see "Note 1 - Nature of business and summary of significant accounting policies" for additional information on the Company's IPO.

The warrant liability was remeasured at fair value each reporting period and upon the Company's IPO and represented a Level 3 financial instrument. The Company calculates the fair value of the warrant liability through a Monte Carlo Model and a Black Scholes Option Model. The total value of the consideration received in connection with the Series F Private Placement was first allocated to the warrant liability at fair value, with the remainder allocated to the preferred stock, which led to a discount ascribed to the Series F Preferred Stock. Accordingly, the Company recorded a discount of $14.6 million on the Series F Preferred Stock by adjusting Additional paid-in capital.

The following schedule shows the fair value of the warrant liability upon issuance, and the change in fair value during the periods ended June 30, 2021 and December 31, 2020 (in thousands):

	Warrant liability
Issuance of Series F warrants	$	14,952
Change in fair value of  warrant liability	24,898
Balance as of December 31, 2020	$	39,850
Change in fair value of warrant liability	(22,873)
Balance as of June 30, 2021	$	16,977

The following schedule shows the inputs used to measure the fair value of the warrant liability:

Warrant Liability	June 30, 2021	December 31, 2020
Stock Price	$4.30	$7.62
Exercise Price	$4.50	$4.50
Expected remaining term (in years)	5.25 - 5.31	5.75 - 5.81
Volatility	60.0%	67.5%
Risk-free interest rate	0.92%	0.5%

The valuation of the warrants is subject to uncertainty as a result of the unobservable inputs. If the volatility rate or risk-free interest rate were to change, the value of the warrants would be impacted.

20

Table of Contents

Equity-classified warrants

On May 6, 2019, the Company issued 957,499 warrants to purchase common stock with an exercise price of $25.50 (the "May 2019 PIPE Warrants"). Additionally, in connection with the May 2019 PIPE transaction, the Company issued 36,757 warrants to brokers with an exercise price of $18.00. The warrants were exercisable commencing on the issuance date and expire 24 months after the issuance date. In March 2021, the Company offered to a limited number of holders the opportunity to exercise, in full or in part, these warrants to purchase shares of Common Stock at a reduced exercise price of $7.50 per share. The Company received exercise notices for a total of 174,602 warrants, resulting in the Company’s receipt of approximately $1.3 million. The Company recognized the increase in the fair value of the modified warrants on the date of exercise of $0.2 million as a deemed dividend through Accumulated deficit with a corresponding increase in Additional paid-in capital. The remainder of the outstanding and unexercised May 2019 PIPE Warrants expired during May 2021.

On November 4, 2019, the Company issued 1,834 warrants in connection with the November 2019 Notes. The warrants are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of an IPO, which commenced on June 29, 2021. The warrants carried an initial exercise price equal to the greater of (i) $30.00 per share or (ii) the price at which the common stock of the Company was sold in the IPO.

On December 19, 2019 the Company issued 1,083,334 warrants with an exercise price of $10.92 in conjunction with the term loan (the "Guarantor Warrants"), which are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of an IPO, which commenced on June 29, 2021. The Guarantor Warrants had a fair value of $4.2 million on the date of issuance.

On December 19, 2019, the Company issued 156,250 warrants in connection with the Seller Notes. The warrants are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of an IPO, which commenced on June 29, 2021. The warrants carried an initial exercise price equal to the greater of (i) $30.00 per share or (ii) the price at which the common stock of the Company was sold in the IPO.

On January 13, 2020, the Company issued the ABG Warrants, which are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of an IPO, which commenced on June 29, 2021 and carried an initial exercise price equal to the greater of (i) $30.00 per share or (ii) the price at which the common stock was sold in the IPO.

On June 24, 2020, the warrants related to the November 2019 Notes, the Seller Notes and the ABG Notes were amended in connection with the issuance of the June 2020 Notes to lower the maximum exercise price applicable to these warrants from $30.00 to $25.50 per share. The decrease in the exercise price resulted in an increase to the fair value of the warrants of $0.1 million which the Company recognized in general and administrative expense.

On June 24, 2020, the Company issued 166,667 warrants to a member of the board of directors with an exercise price of $7.50 per share in connection with the June 2020 Notes (the “June 2020 Warrants”), which are exercisable commencing on the date of issuance and expire 84 months from the date of the consummation of an IPO, which commenced on June 29, 2021.

On July 20, 2020, the Company issued 50,000 warrants to a member of the board of directors with an exercise price of $6.30 per share in consideration for a personal guarantee by a member of the Company's board of directors on the ABL Facility (the "July 2020 Guarantor Warrants"), which are exercisable commencing on the date of issuance and expire 84 months from the date of the consummation of an IPO, which commenced on June 29, 2021.

On January 22, 2021, the Company issued 548,067 warrants in connection with the January 2021 PIPE transaction. The warrants are exercisable at an exercise price per share of $8.70 commencing on the date of issuance and expire after a six year period, subject to beneficial ownership limitations (the “January 2021 Warrants”). Due to the discounted warrant exercise associated with the May 2019 PIPE warrants as discussed above, the down round provision on the January 2021 Warrants was triggered such that these warrants could be exercised at a price of $7.50 per share. The Company recognized the increase in the fair value of the modified warrants of $0.2 million as a deemed dividend through Accumulated deficit with a corresponding increase in Additional paid-in capital.

Warrants issued as compensation

On September 17, 2019, a Company advisor was issued 416,667 warrants with an exercise price of $0.60 per share and 250,000 warrants with an exercise price of $60.00 per share; 208,334 of the $0.60 exercise price warrants (the "Tranche 1 Warrants") were exercisable on the earlier of twelve-months after issuance date or immediately prior to a change in control subject to the advisor’s continued service and 208,334 of the $0.60 exercise price warrants (the "Tranche 2 Warrants") and the 250,000 warrants with the $60.00 exercise price (the "Tranche 3 Warrants") were exercisable on the earlier of eighteen-months after issuance or immediately prior to a change in control subject to the advisor’s continued service.

21

Table of Contents

On June 1, 2020, the Company entered into a termination agreement (the “Termination Agreement”) with the advisor. Pursuant to the terms of the Termination Agreement, the Tranche 1 Warrants were amended to reduce the number of shares of common stock purchasable thereunder to 173,611 shares, and the Tranche 2 Warrants and Tranche 3 Warrants were cancelled. The Tranche 1 Warrants (as amended pursuant to the Termination Agreement) were fully vested as of the date of the termination of the agreement and will remain exercisable until September 17, 2029. Furthermore, if the Company engages in any restricted business line as defined in the Termination Agreement, the Company will issue to the former advisor additional shares of common stock based on formulas intended to compensate the former advisor for the warrants that were reduced or terminated. In connection with the Termination Agreement, the Company recorded expense of $5.7 million during the year ended December 31, 2020 in general and administrative expense. During the first quarter of 2021, the former advisor exercised 131,945 of his remaining warrants outstanding in a cashless exercise resulting in 122,782 shares of common stock issued.

On June 24, 2020, the Company issued 166,667 warrants with an exercise price of $7.50 per share to two non-employee directors, which are exercisable commencing on the date of issuance and expire 84 months from the date of the consummation of an IPO, which commenced on June 29, 2021. On July 20, 2020, the Company issued 33,334 warrants to two non-employee directors at a price of $6.30 per share (the "July 2020 Director Warrants"), which are exercisable commencing on the date of issuance and expire 84 months from the date of the consummation of an IPO, which commenced on June 29, 2021. The warrants issued to the non-employee directors were immediately vested and as such, the Company recorded $1.0 million of share-based compensation expense upon issuance.

On November 30, 2020, the Company issued 66,667 warrants to a third-party for services with an exercise price of $6.00 and an expiration date 72 months after issuance. These warrants were immediately vested and as such, the Company recorded $0.1 million in general and administrative expense.

Note 12 - Share-based compensation

During the three and six months ended June 30, 2021 the Company recognized $0.3 million and $2.9 million, respectively, of share-based compensation expense. During the three and six months ended June 30, 2020, the Company recognized $3.0 million and $5.5 million, respectively, of share-based compensation expense.

On November 11, 2019, the Company received shareholder approval for the Amended and Restated 2019 Incentive Award Plan (the “Amended 2019 Plan”). The Amended 2019 Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, other stock or cash-based awards or a dividend equivalent award. The Amended 2019 Plan authorized the issuance 1,083,334 shares of common stock which was increased to 1,500,000 after the Halo acquisition; the Amended 2019 Plan also provides for an annual increase on the first day of each calendar year beginning on January 1, 2021 and ending on and including January 1, 2029, equal to the lesser of (A) 10% of the shares of common stock outstanding (on an as-converted basis) on the last day of the immediately preceding fiscal year and (B) such smaller number of shares of common stock as determined by the Board. The total number of shares currently authorized for issuance under the Amended 2019 Plan is 2,700,000.

Stock options

During the six months ended June 30, 2021 and June 30, 2020, the Company granted 955,688 and 50,002 stock options, respectively. During the three months ended June 30, 2021 and June 30, 2020, the Company granted 25,834 and 33,334 stock options, respectively.

Restricted stock

In March 2020, the Company issued 75,000 shares of restricted common stock to three non-employee directors in return for services provided in their capacity as directors and issued 993 restricted shares of common stock to an officer of the Company. The restricted shares were immediately vested and as such, the Company recorded share-based compensation expense of $0.5 million upon issuance.

Note 13 - Income taxes

For the three and six months ended June 30, 2021, and June 30, 2020, the Company recorded no income tax expense. For the three and six months ended June 30, 2021 and June 30, 2020, the Company’s effective tax rate was 0%. The Company’s effective tax rate of 0% differs from the United States federal statutory rate of 21% due to permanent differences attributable to the change in the fair value of the warrant liabilities and because the Company’s losses have been fully offset by a valuation allowance due to uncertainty of realizing the tax benefit of net operating losses ("NOLs”) for the six months ended June 30, 2021, and year ended December 31, 2020.

22

Table of Contents

Note 14 - Concentrations

Major suppliers

The Company sourced approximately 68% of its inventory purchases from two vendors for the six months ended June 30, 2021. The Company sourced approximately 77% of its inventory purchases from three vendors for the six months ended June 30, 2020.

Major customers

Accounts receivable from three customers represented 72% of accounts receivable as of June 30, 2021. Accounts receivable from two customers represented 72% of accounts receivable as of December 31, 2020. Three customers represented 50% of gross sales for the six months ended June 30, 2021. Two customers represented 39% of gross sales for the six months ended June 30, 2020. 

Credit risk

At June 30, 2021 and December 31, 2020, the Company’s cash and cash equivalents were deposited in accounts at several financial institutions and may maintain some balances in excess of federally insured limits. The Company maintains its cash and cash equivalents with high-quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses historically in these accounts and believes it is not exposed to significant credit risk in its cash and cash equivalents.

Note 15 - Net income (loss) per share

The Company presents earnings (loss) per share on a basic and diluted basis. Basic earnings (loss) per share is computed by dividing net and comprehensive income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share includes the dilutive effect of common stock equivalents, consisting of stock options and warrants using the treasury stock method and convertible notes and preferred stock using the if-converted method. Under the treasury stock method, the amount the holder must pay for exercising stock options or warrants and the amount of average compensation cost for future service that has not yet been recognized are collectively assumed to be used to repurchase shares.

As the Company reported net income for the three and six months ended June 30, 2021, basic and diluted earnings per share are calculated as outlined above. For the three and six months ended June 30, 2021, the weighted average diluted common shares had 3,471,245 and 4,474,577 common stock equivalents excluded, respectively, based on the fact that their inclusion would have had an anti-dilutive effect on earnings per share. For the three and six months ended June 30, 2020, the Company’s basic and diluted net and comprehensive loss per share attributable to common stockholders are the same because the Company generated a net loss and common stock equivalents are excluded from diluted net loss per share as they have an antidilutive impact.

23

Table of Contents

The following table sets forth basic and diluted net income (loss) per share attributable to common stockholders for the three and six months ended June 30, 2021 and 2020 (in thousands, except share and per share amounts):

	Six Months Ended June 30,				Three Months Ended June 30,
Common stockholders	2021		2020		2021		2020
Basic net income (loss) per share:
Numerator:
Net and comprehensive income (loss)	$	11,926	$	(27,858)	$	24,776	$	(18,404)
Less: Preferred stock dividends	—		68		—		34
Less: Adjustment due to warrant modifications	402		—		—		—
Adjusted net and comprehensive income (loss) available to common stockholders	$	11,524	$	(27,926)	$	24,776	$	(18,438)
Denominator:
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, basic	10,361,462		8,122,176		11,126,909		8,156,618
Net earnings (loss) per share attributable to common stockholders, basic	$	1.11	$	(3.44)	$	2.23	$	(2.26)
Dilutive net income (loss) per share:
Numerator:
Net and comprehensive income (loss)	$	11,926	$	(27,858)	$	24,776	$	(18,404)
Less: Preferred stock dividends	—		68		—		34
Less: Adjustment due to warrant modifications	402		—		—		—
Add: Interest expense on convertible notes, net	—		—		656		—
Adjusted net and comprehensive income (loss) available to common stockholders	$	11,524	$	(27,926)	$	25,432	$	(18,438)
Denominator:
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, diluted	20,498,829		8,122,176		21,389,413		8,156,618
Net earnings (loss) per share attributable to common stockholders, diluted	$	0.56	$	(3.44)	$	1.19	$	(2.26)

24

Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion includes forward-looking statements about our business, financial condition and results of operations, including discussions about management’s expectations for our business. The financial condition, results of operations and cash flows discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations are those of Better Choice Company Inc. and its consolidated subsidiaries, collectively, the “Company,” “Better Choice Company,” “we,” “our,” or “us”. These statements represent projections, beliefs, and expectations based on current circumstances and conditions and in light of recent events and trends, and you should not construe these statements either as assurances of performance or as promises of a given course of action. Instead, various known and unknown factors are likely to cause our actual performance and management’s actions to vary, and the results of these variances may be both material and adverse. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We undertake no obligation to publicly release the results of any revision to these forward-looking statements which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Overview and outlook

We are an animal health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. Our mission is to become the most innovative premium pet food company in the world, and we are motivated by our commitment to making products with integrity and treating pets and their parents with respect. We believe our portfolio of brands are well positioned to benefit from the trends of growing pet humanization and an increased consumer focus on health and wellness, and we have adopted a laser focused, channel-specific approach to growth that is driven by new product innovation. Our executive team has a proven history of success in both pet and consumer-packaged goods, and has over 50 years of combined experience in the pet industry and over 100 years of combined experience in the consumer-packaged goods industry.

Our product offering is sold today under the Halo and TruDog brands and has enabled us to penetrate multiple channels of trade, which we believe enables us to deliver on core consumer needs and respond to changing channel dynamics that have accelerated as a result of the COVID-19 pandemic. We group these channels of trade into four distinct categories: E-Commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick & Mortar, which includes the sale of product to pet specialty chains such as Petco, PetSmart, select grocery chains and neighborhood pet stores; DTC, which includes the sale of product through our online web platform; and International, which includes the sale of product to foreign distribution partners and to select international retailers. We believe our omni-channel approach is a significant competitive advantage, as it allows us to design and sell products purpose-built for success in specific channels while maintaining our ability to leverage marketing and sales resources cross-channel.

Although the COVID-19 pandemic has dramatically changed the U.S. retail landscape, the pet industry has proven to be resilient, with Packaged Facts recently increasing their projected 2021 growth rate for U.S. retail sales of pet food and supplies from 5.3% to 7.6%. While the industry-wide E-Commerce sales have retreated somewhat following the March 2020 pantry stocking, the sale of pet food and supplies online has increased 35% year-over-year according to Packaged Facts, with subscription sales nearly equal to the March 2020 peak. We anticipate our ability to reach a growing base of diverse customers online will increase as the majority of our sales are derived from our DTC and E-Commerce channels. At the same time, we believe that our long-established relationships with key Brick & Mortar customers will enable us to jointly launch new products in the future that are designed for in-store success.

In addition to our domestic sales channels, the Halo brand’s international sales grew by 95% in 2020, driven primarily by Halo’s ability to secure Product Import Registrations for 15 dog and cat food diets from the Ministry of Agriculture and Rural Affairs of China (“MOA”) in June 2020. We believe that our growth in Asia is fueled by increasing levels of economic financial status and demand for premium, western manufactured products, with China representing the largest market opportunity for growth and 48% of Better Choice’s international sales in 2020. According to Euromonitor, the Chinese market for premium dry dog and cat food is anticipated to grow at a 20% CAGR and 28% CAGR, respectively, from 2015 through 2025. This growth rate is driven by dramatic increases in pet ownership, which has seen the number of dog-owning Chinese households increase from 12% in 2015 to 20% in 2020. On a relative basis, 67% of U.S. households owned a pet in 2020 according to the American Pet Products Association, suggesting that the Chinese pet market has significant room to grow in the foreseeable future.

New product innovation, through our own research and development activities as well as through acquisitions, represents the cornerstone of our growth plan, and our established supply and distribution infrastructure allows us to develop, manufacture and bring new products to market in generally under nine months. Our flexible and scalable outsourced manufacturing model also promotes innovation, as we are able to offer a wide variety of dog and cat food products under the Halo and TruDog brands that serve many different consumer needs. Founded in 1986, the Halo brand consists of a diversified, premium natural dog and cat portfolio, with products derived from real whole meat, no rendered meat meal and non-genetically modified (non-"GMO") fruits and vegetables, unlike many other kibble and canned products currently in the marketplace.

25

Table of Contents

In addition to its dry kibble and canned wet food offering, Halo also has a successful line of freeze-dried treats for dogs and cats and a growing line of award-winning vegan products for dogs. Founded in 2013, the TruDog brand offers ultra-premium, freeze-dried raw dog food, toppers, treats and supplements sold predominantly on its DTC website. Freeze-dried raw dog food is one of the fastest growing sub-categories of premium pet food, with Packaged Facts reporting 39% year-over-year growth in the sub-category in 2019. We believe that both brands are positioned to take advantage of pet parents’ increasing desire to feed only the highest quality ingredients to their pets, and that there will continue to be innovative opportunities for brand consolidation over time.

Our marketing strategies are designed to clearly communicate to consumers the benefits of our products and to build awareness of our brands. We deploy a broad set of marketing tools across various forms of media to reach consumers through multiple touch points and engage with a number of marketing agencies to develop content and product packaging. Our marketing initiatives include the use of social and digital marketing, Search Engine Optimization, email and SMS marketing, and paid media (Facebook, Instagram & YouTube), among other proven strategies to generate and convert sales prospects into loyal, satisfied customers. In addition to directly targeting and educating consumers of our products, we partner with both E-commerce platforms and retailers such as Amazon, Chewy and Petco to develop joint sales and marketing initiatives to increase sales and acquire new customers.

On February 2, 2019 and February 28, 2019, respectively, we entered into definitive agreements to acquire through stock exchange agreements, approximately 93% of the outstanding interest of TruPet LLC and all of the outstanding shares of Bona Vida, Inc., an emerging hemp-based CBD platform focused on developing a portfolio of brand and product verticals within the animal health and wellness space. On May 6, 2019, Better Choice Company consummated the stock exchange transactions whereby TruPet LLC and Bona Vida, Inc. became wholly owned subsidiaries of Better Choice Company. For accounting and financial reporting purposes, the transaction was treated as a reverse acquisition whereby TruPet is considered the acquiror of Better Choice Company and Bona Vida, Inc. Thus, the historical financial information of the registrant is that of TruPet even though the legal registrant remains Better Choice Company.

On December 19, 2019, we acquired 100% of the issued and outstanding capital stock of Halo, Purely for Pets, Inc., in exchange for a combination of cash consideration, shares of our common stock, and convertible subordinated notes and accompanying stock purchase warrants.

Although Bona Vida remains a wholly owned subsidiary, we do not currently sell or market any CBD products, we do not currently own any CBD related inventory or raw materials and we do not currently have plans to re-enter the CBD market at this time.

The impact that COVID-19 will have on our consolidated results of operations is uncertain. Although we have not observed a material reduction in sales as of June 2021 as a result of the COVID-19 pandemic, we will continue to evaluate the nature and extent of COVID-19’s impact to our business, consolidated results of operations, financial condition, and liquidity. Our results presented herein are not necessarily indicative of the results to be expected for future periods in 2021 or the full fiscal year. Management cannot predict the full impact of the COVID-19 pandemic on our sourcing, manufacturing and distribution of its products or to economic conditions generally, including the effects on consumer spending. The ultimate extent of the effects of the COVID-19 pandemic on us is highly uncertain and will depend on future developments, and such effects could exist for an extended period of time even after the pandemic might end.

Results of operations for the three and six months ended June 30, 2021 and 2020

The following table sets forth our consolidated results for the periods presented (in thousands):

	Three Months Ended June 30,								Six Months Ended June 30,
	2021		2020		Change		%		2021		2020		Change		%
Net sales	$	10,989	$	9,941	$	1,048	11	%	$	21,819	$	22,167	$	(348)	(2)	%
Cost of goods sold	7,089		5,817		1,272		22	%	13,645		13,886		(241)		(2)	%
Gross profit	3,900		4,124		(224)		(5)	%	8,174		8,281		(107)		(1)	%
Operating expenses:
General and administrative	3,530		11,551		(8,021)		(69)	%	8,081		19,551		(11,470)		(59)	%
Sales and marketing	3,235		2,053		1,182		58	%	5,571		4,258		1,313		31	%
Share-based compensation	332		3,020		(2,688)		(89)	%	2,857		5,504		(2,647)		(48)	%
Total operating expenses	7,097		16,624		(9,527)		(57)	%	16,509		29,313		(12,804)		(44)	%
Loss from operations	$	(3,197)	$	(12,500)	$	9,303	74	%	$	(8,335)	$	(21,032)	$	12,697	60	%

26

Table of Contents

Net sales

We sell our products through online retailers, pet specialty retailers, our online portal directly to our consumers and internationally to foreign distribution partners (transacted in U.S. dollars). For many customers, sales transactions are single performance obligations that are recorded at the time the product is shipped from our distribution centers and when control transfers. We record a revenue reserve based on historical return rates to account for customer returns. We offer a variety of promotions and incentives to our customers including daily discounts, multi-bag purchase discounts and coupon codes for initial purchases. DTC net sales include revenue derived from shipping fees and are net of loyalty points earned (a portion of revenue is deferred at the time of the sale as points are earned and not recognized until the redemption of the points, estimated based on historical experience).

Information about our revenue channels is as follows (in thousands):

	Three Months Ended June 30,								Six Months Ended June 30,
	2021				2020				2021				2020
E-commerce	$	2,892	26	%	$	2,978	30	%	$	6,902	32	%	$	7,459	34	%
Brick & Mortar	1,698		16	%	1,875		19	%	3,592		16	%	4,772		22	%
DTC	2,341		21	%	2,722		27	%	4,777		22	%	5,526		25	%
International	4,058		37	%	2,366		24	%	6,548		30	%	4,410		19	%
Net Sales	$	10,989	100	%	$	9,941	100	%	$	21,819	100	%	$	22,167	100	%

Net sales increased $1.1 million, or 11%, to $11.0 million for the three months ended June 30, 2021 compared to $9.9 million for the three months ended June 30, 2020. The increase was driven by a significant increase in our International sales, offset by a decrease in each of our other revenue channels.

Net sales decreased $0.4 million, or 2%, to $21.8 million for the six months ended June 30, 2021 compared to $22.2 million for the six months ended June 30, 2020. The decrease was driven by lower E-Commerce sales due to higher than normal orders during the first quarter of 2020 due to increased warehouse stocking orders in March 2020 associated with the COVID-19 pandemic. The decrease was also driven by lower Brick & Mortar sales due to the discontinuation of products with one of our pet specialty customers and lower DTC sales driven by a decrease in marketing spend with low return on investment. These decreases were offset by continued growth in our International channel.

Key factors that affect our future sales growth include new product innovation and expansion in each of the sales channels.

Cost of goods sold and Gross profit

Our products are manufactured to our specifications by contracted manufacturing plants using raw materials sourced by our contracted manufacturers. We design our packaging in-house for manufacture by third parties, and packaging is shipped directly to contracted manufacturing plants. We work with our co-manufacturers to secure a supply of raw materials that meet our specifications, such as USA farm-raised beef, GAP 2 certified cage-free whole chicken and associated broths, GAP 2 certified cage-free whole turkey and associated broths, MSC certified wild-caught salmon and MSC certified wild-caught whitefish and associated broths, and select non-GMO fruits and vegetables, such as peas, sweet potatoes and lentils. In addition to procuring raw materials that meet our formulation requirements, our contract manufacturers manufacture, test and package our products.

Cost of goods sold consists primarily of the cost of product obtained from third-party contract manufacturing plants, packaging materials, inventory freight for shipping product from third-party contract manufacturing plants to our warehouse and third-party fulfillment and royalties. We review inventory on hand periodically to identify damages, slow moving inventory, and/or aged inventory. Based on the analysis, we record inventories at the lower of cost or net realizable value, with any reduction in value expensed as cost of goods sold.

We calculate gross profit as net sales, including any shipping revenue collected from our customers, less cost of goods sold. Our gross profit has been and will continue to be affected by a variety of factors, primarily product sales mix, volumes sold, discounts offered to newly acquired and recurring customers, the cost of our manufactured products, and the cost of freight from the manufacturer to the warehouse.

27

Table of Contents

Cost of goods sold increased $1.3 million, or 22%, to $7.1 million for the three months ended June 30, 2021 compared to $5.8 million for the three months ended June 30, 2020. As a percentage of revenue, cost of goods sold increased to 65% during the three months ended June 30, 2021 compared to 59% for the three months ended June 30, 2020, respectively. The increase was driven by cost increases from our primary suppliers as a result of broad-scale inflation in the industry, as well as an increased inventory reserve. We are actively working with our co-manufacturing and freight partners to generate cost savings during the second half of 2021.

Cost of goods sold decreased $0.3 million, or 2%, to $13.6 million for the six months ended June 30, 2021 compared to $13.9 million for the six months ended June 30, 2020. As a percentage of revenue, cost of goods sold remained flat at 63% during the six months ended June 30, 2021 and June 30, 2020, respectively. These results were driven by the increase during the second quarter as described above, offset by $0.9 million of non-cash expense related to the amortization of a purchase accounting adjustment to inventory recorded in connection with the Halo acquisition in the first quarter of 2020 and decrease in net sales.

Operating expenses

General and administrative expenses include management and office personnel compensation and bonuses, warrant expense, corporate level information technology related costs, rent, travel, professional service fees, costs related to merchant credit card fees, insurance, product development costs, shipping DTC orders to customers, customer service and warehousing costs and general corporate expenses. During the three months ended June 30, 2021, general and administrative expenses decreased $8.1 million, or 69%, to $3.5 million compared to $11.6 million for the three months ended June 30, 2020. During the six months ended June 30, 2021, general and administrative expenses decreased $11.5 million, or 59%, to $8.1 million compared to $19.6 million for the six months ended June 30, 2020. The decrease was driven by a reduction in warrant expense ($7.5 million during the three months ended and $10.0 million during the six months ended June 30), contract termination costs incurred during the first quarter of 2020 of $1.1 million, a non-cash reduction of our sales tax liability and a decrease in professional fees, all of which was partially offset by higher headcount related costs.

Sales and marketing expenses include costs related to compensation for sales personnel, other costs related to the selling platform, as well as marketing, including paid media and content creation expenses. Marketing expenses consist primarily of Facebook, Amazon and other media ads, as well as other advertising and marketing costs, all geared towards acquiring new customers and building brand awareness. During the three months ended June 30, 2021, sales and marketing expenses, including paid media, increased $1.1 million, or 58%, to $3.2 million from $2.1 million during the three months ended June 30, 2020. During the six months ended June 30, 2021, sales and marketing expenses, including paid media, increased $1.3 million, or 31%, to $5.6 million from $4.3 million during the six months ended June 30, 2020. These increases were driven primarily by increased promotional spend in our E-Commerce and International sales channels and higher advertising and market research costs related to developing our new product line.

Share-based compensation includes expenses related to stock options and certain warrants issued to employees and non-employee directors. During the three months ended June 30, 2021, share-based compensation decreased $2.7 million, or 89%, to $0.3 million as compared to $3.0 million for the three months ended June 30, 2020. During the six months ended June 30, 2021, share-based compensation decreased $2.6 million, or 48%, to $2.9 million compared to $5.5 million for the six months ended June 30, 2020. The decrease was driven by a lower monthly expense due to an overall decrease in the fair value of the outstanding options in 2021 as compared to 2020, as well as certain restricted stock and warrant grants for which compensation expense was recognized immediately during the six months ended June 30, 2020 with no similar equity grants during the 2021 period.

Interest expense

Interest expense relates primarily to existing and prior indebtedness including term loans, lines of credit and subordinated convertible notes and during the three months ended June 30, 2021 includes $1.4 million associated with the remaining discount on the June 2020 Notes, which was fully accreted to interest expense in connection with the conversion to common stock resulting from the commencement of the trading of our common stock on the NYSE. During the three months ended June 30, 2021, interest expense decreased $0.2 million to $2.2 million from $2.4 million for the three months ended June 30, 2020. During the six months ended June 30, 2021, interest expense decreased $1.6 million to $3.1 million from $4.7 million for the six months ended June 30, 2020. The overall reduction in interest expense was driven by a decrease in outstanding debt balances as well as a more favorable interest rate on our new Wintrust Credit Facility.

28

Table of Contents

Gain on extinguishment of debt, net

During the three months ended June 30, 2021, we incurred a gain on extinguishment of debt of $0.9 million, while there was no corresponding activity for the three months ended June 30, 2020. Gain on extinguishment of debt for the three months ended June 30, 2021 relates to extinguishment accounting applied in connection with the forgiveness of our PPP Loans. During the six months ended June 30, 2021, we incurred a gain on extinguishment of debt, net of a loss on extinguishment of debt, of $0.5 million, while there was no corresponding activity for the six months ended June 30, 2020. Gain on extinguishment of debt for the six months ended June 30, 2021 relates to extinguishment accounting applied in connection with forgiveness of our PPP Loans, partially offset by the loss on termination of a term loan and ABL Facility. See "Note 7 - Debt" for additional information.

Change in fair value of warrant liabilities

Common stock warrants classified as liabilities are revalued at each balance sheet date subsequent to the initial issuance and changes in the fair value are reflected in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) as change in fair value of warrant liability. The change in fair value for the three and six months ended June 30, 2021 relates to the decrease in the fair value of the Series F Warrants. See "Note 11 - Warrants" for additional information.

Income taxes

Our income tax provision consists of an estimate of federal and state income taxes based on enacted federal and state tax rates, as adjusted for any allowable credits, deductions and uncertain tax positions as the arise. No provision has been made for federal and state income taxes prior to the date of the May Acquisitions as the proportionate share of TruPet’s income or loss was included in the personal tax returns of its members as TruPet was a limited liability company. Subsequent to the acquisitions, we, as a corporation are required to provide for income taxes.

During the three and six months ended June 30, 2021 and 2020, respectively, we did not record income tax expense due to the continued losses incurred by us. The effective tax rate is 0%, which differs from the U.S. Federal statutory rate of 21% due to permanent differences attributable to the change in the fair value of the warrant liabilities and because our deferred tax assets arising from operating losses are offset by a valuation allowance due to uncertainty as to the realization of those deferred tax assets.

Liquidity and capital resources

Since our founding, we have financed our operations primarily through sales of member units while a limited liability company, and since becoming a corporation, through the sales of shares of our common stock, warrants, preferred stock, and loans. On June 30, 2021 and December 31, 2020, we had cash and cash equivalents and restricted cash of $2.5 million and $4.0 million, respectively. On August 9, 2021, we had cash and cash equivalents and restricted cash of $37.1 million.

In connection with our IPO, we issued and sold 8,000,000 shares of common stock at a price of $5.00 per share. On July 1, 2021 we received total net proceeds of approximately $36.2 million from the IPO, after deducting underwriting discounts and commissions of $2.8 million, and offering costs of approximately $1.0 million, of which $0.9 million was incurred during the period ending June 30, 2021. Upon commencement of our common stock trading on the NYSE, all outstanding convertible notes were converted into 4,732,420 shares of common stock and upon consummation of the IPO, all shares of convertible preferred stock were converted into 5,764,533 shares of common stock.

We are subject to risks common in the pet wellness consumer market including, but not limited to, dependence on key personnel, competitive forces, successful marketing and sale of its products, the successful protection of its proprietary technologies, ability to grow into new markets, and compliance with government regulations. As of June 30, 2021, we have not experienced a significant adverse impact to our business, financial condition or cash flows resulting from the COVID-19 pandemic. However, uncertainties regarding the continued economic impact of COVID-19 are likely to result in sustained market turmoil, which could negatively impact our business, financial condition, and cash flows in the future.

We have historically incurred losses and expect to continue to generate operating losses and consume significant cash resources for the foreseeable future; however, due to our high level of working capital and minimal debt after the IPO, we do not anticipate substantial doubt about our ability to continue as a going concern. We have implemented and continue to implement plans to achieve cost savings and other strategic objectives, including realized cost savings from the consolidation of our third-party logistics operations and reduction of overhead costs and we expect to achieve further cost savings from the consolidation of third-party manufacturers and optimization of shipping costs. The business is focused on growing the most profitable channels while reducing investments in areas that are expected to have lower long-term benefits.

29

Table of Contents

A summary of our cash flows is as follows (in thousands):

	Six Months Ended June 30,
	2021		2020
Cash flows (used in) provided by:
Operating activities	$	(4,662)	$	(2,168)
Investing activities	(54)		(6)
Financing activities	3,274		3,127
Net increase (decrease) in cash and cash equivalents and restricted cash	$	(1,442)	$	953

Cash flows from operating activities

Cash used in operating activities increased $2.5 million, or 115%, during the six months ended June 30, 2021 compared to the six months ended June 30, 2020. The increase in cash used in operating activities was driven by a comparative increase in accounts receivable balances of $2.2 million due to the timing of sales and collections and higher inventory spend of $1.5 million to maintain a steady level of inventory as compared to 2020, where a large reduction in inventory occurred due to the March 2020 pantry stocking related to the COVID-19 pandemic, partially offset by the reduction in prepaid expenses and other assets of $1.2 million.

Cash flows from investing activities

Cash used in investing activities was less than $0.1 million during the six months ended June 30, 2021 and less than $0.1 million during the six months ended June 30, 2020. The cash used in investing activities for is related to the purchase of property and equipment.

Cash flows from financing activities

Cash provided by financing activities was $3.3 million for the six months ended June 30, 2021 compared to cash provided by financing activities of $3.1 million during the six months ended June 30, 2020. The cash provided by financing activities for the six months ended June 30, 2021 was related to proceeds from the January Private Placement of $4.1 million and cash received from warrant exercises of $1.7 million, partially offset by net payments on the term loans of $2.2 million, net payments on the revolving line of credit of $0.1 million, $0.1 million in debt issuance costs, and less than $0.1 million of IPO related costs. Net cash provided by financing activities during the six months ended June 30, 2020 was related to proceeds from the revolving line of credit, proceeds related to the June 2020 Notes and proceeds related to the PPP Loans. As discussed above, we received net proceeds of $36.2 million from the consummation of the IPO on July 1, 2021.

Indebtedness

As of June 30, 2021, our indebtedness consisted of a term loan and a revolving credit facility. For additional details about the terms, covenants and restrictions contained in the Wintrust Credit Facility, see "Note 7 - Debt" to our interim condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

Off-balance sheet arrangements

We do not have any off-balance sheet arrangements, as defined by applicable regulations of the SEC, that are reasonably likely to have a current or future material effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.

Critical accounting policies and significant estimates

In connection with the preparation of our unaudited condensed consolidated financial statements prepared in accordance with GAAP, we are required to make assumptions and estimates about future events, and apply judgments that affect the reported amount of assets, liabilities, revenues, expenses and the related disclosures. We have identified critical accounting policies and significant estimates that, as a result of the judgments, uncertainties, uniqueness and complexities of the underlying accounting standards and operations involved could result in material changes to its financial condition or results of operations under different conditions or using different assumptions. Our most critical accounting policies are related to accounting for warrants, share-based compensation, accounting for convertible notes, goodwill impairment, revenue recognition, accounting for business combinations and income taxes. There have been no material changes to our critical accounting policies and estimated compared to the descriptions in our Annual Report for the year ended December 31, 2020.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information under this Item.

30

Table of Contents

ITEM 4.    CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

Management evaluated its internal control over financial reporting for the quarter ended June 30, 2021. Based upon that evaluation and as a result of the remediation of previously identified material weaknesses, as described in our most recent Annual Report, our Chief Executive Officer and Principal Financial and Accounting Officer concluded that our disclosure controls and procedures were effective as of June 30, 2021.

Changes in internal control over financial reporting

As of June 30, 2021, management concluded that the remediated controls were operating effectively. There were no other changes in internal control over financial reporting during the fiscal quarter ended June 30, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II

ITEM 1.    LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results.

ITEM 1A.    RISK FACTORS

There have been no material changes from the risk factors described under the heading “Risk Factors” in the Registration Statement on Form S-1/A filed on June 16, 2021 (the "IPO Registration Statement"). While we believe there have been no material changes from the risk factors previously disclosed, you should carefully consider, in addition to the other information set forth in this report, the risk factors discussed in our IPO Registration Statement that could materially affect our business, financial condition or future results. The risks described in our IPO Registration Statement are not the only risks facing our Company. In addition to risks and uncertainties inherent in forward-looking statements contained in this Report on Form 10-Q, additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

We have previously disclosed all sales of securities without registration under the Securities Act of 1933, as amended.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5    OTHER INFORMATION

None.

ITEM 6.    EXHIBITS

The following exhibits are filed herewith.

EXHIBIT INDEX

Exhibit	Exhibit Description	Form	File No.	Exhibit	Filing date
2.1	Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc. and Bona Vida, Inc.	8-K	333-161943	2.1	05/10/2019
2.2	First Amendment to Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc., and Bona Vida, Inc., dated May 3, 2019	8-K	333-161943	2.2	05/10/2019
2.3	Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC	8-K	333-161943	2.3	05/10/2019

31

Table of Contents

Exhibit	Exhibit Description	Form	File No.	Exhibit	Filing date
2.4	First Amendment to Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC, dated May 6, 2019	8-K	333-161943	2.4	05/10/2019
2.5	Amended and Restated Stock Purchase Agreement, dated December 18, 2019, by and among the Company, Halo, Purely For Pets, Inc., Thriving Paws, LLC and HH-Halo LP	8-K	333-161943	2.1	12/26/2019
3.1	Certificate of Incorporation, dated January 1, 2019	10-Q	333-161943	3.1	04/15/2019
3.2	Certificate of Amendment to Certificate of Incorporation, dated February 1, 2019	10-Q	333-161943	3.2	04/15/2019
3.3	Certificate of Amendment to Certificate of Incorporation, dated March 13, 2019	8-K	333-161943	3.1	03/20/2019
3.4	Certificate of Amendment to Certificate of Incorporation, dated April 18, 2019	10-KT	333-161943	3.5	07/25/2019
3.5	Certificate of Amendment to Certificate of Incorporation, dated July 30, 2020	8-K	333-161943	99.1	07/30/2020
3.6	Certificate of Merger of Sport Endurance, Inc. with and into the Company	10-Q	333-161943	3.4	04/15/2019
3.7	Bylaws	10-Q	333-161943	3.5	04/15/2019
3.8	Amended and Restated Certificate of Designation for Series E Convertible Preferred Stock	8-K	333-161943	3.1	05/23/2019
3.9	Certificate of Designation for Series F Convertible Preferred Stock	8-K	333-161943	3.1	10/02/2020
3.10	Certificate of Cancellation of the Amended and Restated Certificate of Designation Preference and Rights of the for Series E Convertible Preferred Stock	S-1/A	333-256405	3.9	06/16/2021
4.1	Form of Common Stock Purchase Warrant in connection with the May 2019 private placement	8-K	333-161943	4.1	04/30/2019
4.2	Form of Tranche 1 Common Stock Purchase Warrant, dated September 17, 2019, by and between the Registrant and Bruce Linton	8-K	333-161943	4.1	09/23/2019
4.3	Form of Tranche 2 Common Stock Purchase Warrant, dated September 17, 2019, by and between the Company and Bruce Linton	8-K	333-161943	4.2	09/23/2019
4.4	Form of Additional Common Stock Purchase Warrant, dated September 17, 2019, by and between the Company and Bruce Linton	8-K	333-161943	4.3	09/23/2019
4.5	Form of Subordinated Convertible Promissory Note in connection with the November 2019 private placement	8-K	333-161943	4.1	11/15/2019
4.6	Form of Common Stock Purchase Warrant in connection with the November 2019 private placement	8-K	333-161943	4.2	11/15/2019
4.7	Form of Subscription Agreement, dated December 19, 2019, by and among the Company and the Halo Sellers	10-Q	333-161943	10.6	01/31/2020
4.8	Form of Subordinated Convertible Promissory Note, dated December 19, 2019, by and among the Company and the Halo Sellers listed on the signature pages thereto	10-Q	333-161943	4.7	01/31/2020
4.9	Form of Common Stock Purchase Warrant, dated December 19, 2019, by and among the Company and the Halo Sellers	10-Q	333-161943	4.8	01/31/2020
4.10	Form of Common Stock Purchase Warrant, dated December 19, 2019, by and among the Company and the Shareholder Personal Guarantors	10-Q	333-161943	4.10	01/31/2020
4.11	Form of Common Stock Purchase Warrant Agreement in connection with the December 2018 private placement	8-K	333-161943	4.1	12/13/2018
4.12	Registration Rights Agreement, dated May 6, 2019, by and among the Company and the persons listed on the signature pages thereto in connection with the May 2019 private placement	S-1	333-234349	10.2	10/28/2019
4.13	First Amendment, dated June 10, 2019, to Registration Rights Agreement, dated May 6, 2019, by and among the Company and the stockholders party thereto	S-1	333-234349	10.3	10/28/2019
4.14	Form of Subscription Agreement dated April 25, 2019 in connection with the May 2019 private placement	8-K	333-161943	10.1	04/30/2019

32

Table of Contents

Exhibit	Exhibit Description	Form	File No.	Exhibit	Filing date
4.15	Registration Rights Agreement, dated as of May 6, 2019, by and among Better Choice Company Inc. and the former stockholders of Bona Vida listed on the signature pages thereto	8-K	333-161943	4.1	05/10/2019
4.16	Registration Rights Agreement, dated as of May 6, 2019, by and among Better Choice Company Inc. and the former member of TruPet listed on the signature pages thereto	8-K	333-161943	4.2	05/10/2019
4.17	Form of Registration Rights Agreement by and among the Company and the persons listed on the signature pages thereto in connection with the November 2019 private placement	8-K	333-161943	4.3	11/15/2019
4.18	Form of Subscription Agreement in connection with the November 2019 private placement	8-K	333-161943	10.1	11/15/2019
4.19†	Better Choice Company Inc. Amended and Restated 2019 Incentive Award Plan	10-K	333-161943	10.19	05/04/2020
4.20†	Form of 2019 Incentive Aware Plan Stock Option Agreement	S-1	333-234349	10.7	10/28/2019
4.21	Form of Common Stock Purchase Warrant in connection with the June 2020 private placement.	10-Q	333-161943	4.11	06/25/2020
4.22	Form of Subordinated Convertible Promissory Note in connection with the June 2020 private placement.	10-Q	333-161943	4.12	06/25/2020
4.23	Form of Subscription Agreement in connection with the June 2020 private placement.	10-Q	333-161943	4.13	06/25/2020
4.24	Form of Registration Rights Agreement by and among the Company and the persons listed on the signature pages thereto in connection with the June 2020 private placement.	10-Q	333-161943	4.14	06/25/2020
4.25	Form of Amendment to November 2019 Notes, Seller Notes and ABG Notes	10-Q	333-161943	4.15	8/14/2020
4.26	Form of July 2020 Common Stock Purchase Warrants	8-K	333-161943	10.5	07/21/2020
4.27	Form of Warrant in connection with the October 2020 Series F Private Placement	8-K	333-161943	4.1	10/02/2020
4.28	Form of Securities Purchase Agreement in connection with the October 2020 Series F Private Placement	8-K	333-161943	10.1	10/2/2020
4.29	Form of Registration Rights Agreement in connection with the October 2020 Series F Private Placement	8-K	333-161943	10.2	10/2/2020
4.30	Exchange Agreement by and between the Company and Cavalry Fund LP dated September 30, 2020	8-K	333-161943	10.3	10/2/2020
4.31	Form of First Amendment to Registration Rights Agreement in connection with the October 2020 Series F Private Placement	10-Q	333-161943	10.40	11/16/2020
4.32	Form of warrant in connection with the January 2021 Private Placement	S-1/A	333-251241	4.22	2/16/2021
4.33	Form of Securities Purchase Agreement in connection with the January 2021 Private Placement	S-1/A	333-251241	4.23	2/16/2021
4.34	Form of Registration Rights Agreement in connection with the January 2021 Private Placement	S-1/A	333-251241	4.24	2/16/2021
10.1†	Form of Indemnification Agreement by and among the Company and its officers and directors	S-1	333-234349	10.8	10/28/2019
10.2†	Employment Agreement, dated February 1, 2019, for David Lelong	8-K	333-161943	10.1	02/07/2019
10.3†	Employment Agreement, dated as of May 6, 2019, by and between the Company and Damian Dalla-Longa	10-Q	333-161943	10.6	10/09/2019
10.4†	Resignation Letter from Damian Dalla-Longa, dated February 5, 2020	8-K	333-161943	10.3	02/11/2020
10.5†	Amendment to Employment Agreement, dated February 10, 2020, by and between Damian Dalla-Longa and the Company	8-K	333-161943	10.4	02/11/2020
10.6†	Employment Agreement, dated as of May 6, 2019, by and between the Company and Lori Taylor	10-Q	333-161943	10.7	10/09/2019
10.7†	Separation Agreement, dated as of September 13, 2019, by and between the Company and Lori Taylor	10-K	333-161943	10.28	05/04/2020
10.8†	Employment Agreement, dated May 6, 2019, by and among the Company and Anthony Santarsiero	S-1	333-234349	10.11	10/28/2019

33

Table of Contents

Exhibit	Exhibit Description	Form	File No.	Exhibit	Filing date
10.9†	Employment Agreement, dated June 29, 2019, by and among the Company and Andreas Schulmeyer	S-1	333-234349	10.12	10/28/2019
10.10†	Employment Agreement, dated December 19, 2019, by and between the Company, Werner von Pein, and Halo	8-K	333-161943	10.1	02/11/2020
10.11†	Amendment to Employment Agreement, dated February 10, 2020, by and between Werner von Pein and the Company	8-K	333-161943	10.2	02/11/2020
10.12†	Employment Agreement, dated October 8, 2020, by and between Sharla Cook and the Company	10-K	333-161943	10.12	3/30/2021
10.13†	Employment Agreement, dated September 27, 2020, by and between Robert Sauermann and the Company	10-K	333-161943	10.13	3/30/2021
10.14†	Employment Agreement, dated January 1, 2021, by and between Donald Young and the Company	10-K	333-161943	10.14	3/30/2021
10.15†	Separation and Retirement Agreement, Dated December 28, 2020 by and between Werner von Pein and the Company	8-K/A	333-161943	10.1	1/5/2021
10.16†	Employment Agreement, Dated December 28, 2020 by and between Scott Lerner and the Company	8-K/A	333-161943	10.2	1/5/2021
10.17	Loan and Security Agreement, dated as of January 6, 2021, by and between Old Plank Trail Community Bank, N.A. ("Lender") and Halo, Purely for Pets, Inc., a Delaware corporation ("Halo")	8-K	333-161943	10.1	1/11/2021
10.18	Revolving Promissory Note, dated as of January 6, 2021, issued by Halo in favor of Lender	8-K	333-161943	10.2	1/11/2021
10.19	Term Note A, dated as of January 6, 2021, issued by Halo in favor of Lender	8-K	333-161943	10.3	1/11/2021
10.20	Guaranty and Security Agreement, dated as of January 6, 2021, made by Better Choice Company Inc. (the "Company"), TruPet LLC, a Delaware limited liability company ("TruPet") and Bona Vida, Inc., a Delaware corporation ("Bona Vida"), in favor of Lender	8-K	333-161943	10.4	1/11/2021
10.21	Intellectual Property Security Agreement, dated as of January 6, 2021, executed and delivered by the Company, TruPet and Bona Vida in favor of Lender	8-K	333-161943	10.5	1/11/2021
10.22	Stock Pledge Agreement, dated as of January 6, 2021, executed and delivered by the Company in favor of Lender	8-K	333-161943	10.6	1/11/2021
10.23	Collateral Pledge Agreement, dated as of January 6, 2021, executed and delivered by John M. Word, III in favor of Lender	8-K	333-161943	10.7	1/11/2021
10.24	Agreement effective as of February 23, 2021 by and between Emerging Media Consulting, a Florida limited liability company, and Better Choice Company, Inc.	8-K	333-161943	10.1	2/18/2021
10.25	Terms and Conditions for Winning Media LLC effective as of February 17, 2021 by and between Winning Media LLC and Better Choice Company, Inc.	8-K	333-161943	10.2	2/18/2021
21.1	Subsidiaries of the Company	S-1	333-256405	21.1	5/21/2021
31.1*	Certification of Principal Executive Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
31.2*	Certification of Principal Financial Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
32.1*	Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002

34

Table of Contents

Exhibit	Exhibit Description	Form	File No.	Exhibit	Filing date
101*	The following materials from the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021 formatted in Inline Extensible Business Reporting Language ("iXBRL"): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss), (iii) the Condensed Consolidated Statements of Stockholders Equity (Deficit), (iv) the Condensed Consolidated Statements of Cash Flows and (v) related notes, tagged as blocks of text and including detailed tags
104*	Cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, formatted in iXBRL (included as Exhibit 101)

†    Indicates a management contract or any compensatory plan, contract or arrangement.

*    Filed or furnished herewith.

#    Certain schedules and similar attachments to this agreement have been omitted in accordance with Item 601(b)(5) of Regulation S-K. The Company will furnish copies of any schedules or similar attachments to the SEC upon request.

***    Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.

35

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BETTER CHOICE COMPANY INC.
Date: August 12, 2021	By:	/s/ SCOTT LERNER
		Scott Lerner
		Chief Executive Officer (Principal Executive Officer)
Date: August 12, 2021	By:	/s/ SHARLA A. COOK
		Sharla A. Cook
		Chief Financial Officer (Principal Financial and Accounting Officer)

36

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13a-14(a) / RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Scott Lerner, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Better Choice Company Inc.;

2.Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;l

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 12, 2021

/s/ SCOTT LERNER

Scott Lerner

Chief Executive Officer

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a) / RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED 

I, Sharla Cook, certify that: 

1.I have reviewed this Quarterly Report on Form 10-Q of Better Choice Company Inc.; 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

Dated: August 12, 2021 

/s/ SHARLA A. COOK

Sharla A. Cook

Chief Financial Officer

(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1 

CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

In connection with the Quarterly Report of Better Choice Company Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officers hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 12, 2021

/s/ SCOTT LERNER

Scott Lerner

Chief Executive Officer
(Principal Executive Officer)

/s/ SHARLA A. COOK

Sharla A. Cook

Chief Financial Officer
(Principal Financial and Accounting Officer)

XML

Cover - shares	6 Months Ended
	Jun. 30, 2021	Aug. 09, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	333-161943
Entity Registrant Name	Better Choice Company Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-4284557
Entity Address, Address Line One	12400 Race Track Road
Entity Address, City or Town	Tampa
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33626
City Area Code	(813)
Local Phone Number	659-5921
Title of 12(b) Security	Common Stock, $0.001 par value share
Trading Symbol	BTTR
Security Exchange Name	NYSEAMER
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		29,586,092
Entity Central Index Key	0001471727
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Assets
Cash and cash equivalents	$ 2,484	$ 3,926
Restricted cash	63	63
Accounts receivable, net	5,189	4,631
Inventories, net	5,201	4,869
Deferred IPO costs	882	0
Prepaid expenses and other current assets	4,040	4,074
Total Current Assets	17,859	17,563
Property and equipment, net	149	252
Right-of-use assets, operating leases	94	345
Intangible assets, net	12,350	13,115
Goodwill	18,614	18,614
Other assets	114	1,364
Total Assets	49,180	51,253
Current Liabilities
Term loans, net	704	7,826
Line of credit	222	0
PPP loans	0	190
Accrued liabilities	2,231	3,400
Accounts payable	4,758	3,137
Operating lease liability	56	173
Warrant liability	16,977	39,850
Total Current Liabilities	24,948	54,576
Non-current Liabilities
Notes payable, net	0	18,910
Term loans, net	4,999	0
Lines of credit, net	4,935	5,023
PPP loans	0	662
Operating lease liability	38	184
Total Non-current Liabilities	9,972	24,779
Total Liabilities	34,920	79,355
Stockholders’ Equity (Deficit)
Common Stock, $0.001 par value, 200,000,000 shares authorized, 15,821,559 and 8,651,400 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	16	9
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, 17,294 shares and 21,754 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	0	0
Additional paid-in capital	263,361	232,530
Accumulated deficit	(249,117)	(260,641)
Total Stockholders’ Equity (Deficit)	14,260	(28,102)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 49,180	$ 51,253

XML

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	200,000,000	200,000,000
Common stock, issued (in shares)	15,821,559	8,651,400
Common stock, outstanding (in shares)	15,821,559	8,651,400
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	30,000	30,000
Preferred stock, issued (in shares)	17,294	21,754
Preferred stock, outstanding (in shares)	17,294	21,754

XML

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Net sales	$ 10,989	$ 9,941	$ 21,819	$ 22,167
Cost of goods sold	7,089	5,817	13,645	13,886
Gross profit	3,900	4,124	8,174	8,281
Operating expenses:
General and administrative	3,530	11,551	8,081	19,551
Sales and marketing	3,235	2,053	5,571	4,258
Share-based compensation	332	3,020	2,857	5,504
Total operating expenses	7,097	16,624	16,509	29,313
Loss from operations	(3,197)	(12,500)	(8,335)	(21,032)
Other expense (income):
Interest expense	2,234	2,430	3,069	4,731
Gain on extinguishment of debt, net	(851)	0	(457)	0
Change in fair value of warrant liabilities	(29,356)	3,474	(22,873)	2,095
Total other (income) expense, net	(27,973)	5,904	(20,261)	6,826
Net and comprehensive income (loss)	24,776	(18,404)	11,926	(27,858)
Preferred dividends	0	34	0	68
Net income (loss) available to common stockholders, basic	24,776	(18,438)	11,926	(27,926)
Net income (loss) available to common stockholders, diluted	$ 24,776	$ (18,438)	$ 11,926	$ (27,926)
Weighted average number of shares outstanding, basic (in shares)	11,126,909	8,156,618	10,361,462	8,122,176
Weighted average number of shares outstanding, diluted (in shares)	21,389,413	8,156,618	20,498,829	8,122,176
Earnings (loss) per share, basic (in dollars per share)	$ 2.23	$ (2.26)	$ 1.11	$ (3.44)
Earnings (loss) per share, diluted (in dollars per share)	$ 1.19	$ (2.26)	$ 0.56	$ (3.44)

XML

Unaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	June 2020 notes payable, net (June 2020 Notes)	Seller Notes and ABG Notes	Series F Convertible Preferred Stock	Redeemable Series E Convertible Preferred Stock	Common Stock	Common Stock Series F Convertible Preferred Stock	Series F Convertible Preferred Stock Series F Convertible Preferred Stock	Additional Paid-In Capital	Additional Paid-In Capital June 2020 notes payable, net (June 2020 Notes)	Additional Paid-In Capital Seller Notes and ABG Notes	Additional Paid-In Capital Series F Convertible Preferred Stock	Accumulated Deficit
Balance at Dec. 31, 2019	$ (7,071)					$ 8			$ 194,190				$ (201,269)
Balance (in shares) at Dec. 31, 2019						7,996,232
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares and warrants issued pursuant to private placement	500								500
Shares and warrants issued pursuant to private placement (in shares)						51,440
Share-based compensation	2,485					$ 1			2,484
Share-based compensation (in shares)						75,993
Shares and warrants issued to third party for contract termination	198								198
Shares and warrants issued to third party for contract termination (in shares)						12,120
Shares issued to third parties for services	125								125
Stock issued to third parties for services (in shares)						20,833
Warrants issued to third parties for services	2,594								2,594
Net and comprehensive loss available to common stockholders	(9,488)												(9,488)
Balance at Mar. 31, 2020	(10,657)					$ 9			200,091				(210,757)
Balance (in shares) at Mar. 31, 2020						8,156,618
Balance at Dec. 31, 2019					$ 10,566
Balance (in shares) at Dec. 31, 2019					1,387,378
Balance at Mar. 31, 2020					$ 10,566
Balance (in shares) at Mar. 31, 2020					1,387,378
Balance at Dec. 31, 2019	(7,071)					$ 8			194,190				(201,269)
Balance (in shares) at Dec. 31, 2019						7,996,232
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net and comprehensive loss available to common stockholders	(27,926)
Balance at Jun. 30, 2020	(16,614)					$ 9			212,572				(229,195)
Balance (in shares) at Jun. 30, 2020						8,156,618
Balance at Dec. 31, 2019					$ 10,566
Balance (in shares) at Dec. 31, 2019					1,387,378
Balance at Jun. 30, 2020					$ 10,566
Balance (in shares) at Jun. 30, 2020					1,387,378
Balance at Mar. 31, 2020	(10,657)					$ 9			200,091				(210,757)
Balance (in shares) at Mar. 31, 2020						8,156,618
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	3,020								3,020
Warrants issued to third parties for services	7,390								7,390
Warrants issued in connection with June 2020 Notes	337								337
Beneficial conversion feature of June 2020 Notes		$ 1,163								$ 1,163
Modification of conversion feature for November 2019 Notes, Seller Notes, and ABG Notes			$ 528								$ 528
Modification of warrants	43								43
Net and comprehensive loss available to common stockholders	(18,438)												(18,438)
Balance at Jun. 30, 2020	(16,614)					$ 9			212,572				(229,195)
Balance (in shares) at Jun. 30, 2020						8,156,618
Balance at Mar. 31, 2020					$ 10,566
Balance (in shares) at Mar. 31, 2020					1,387,378
Balance at Jun. 30, 2020					$ 10,566
Balance (in shares) at Jun. 30, 2020					1,387,378
Balance at Dec. 31, 2020	(28,102)					$ 9		$ 0	232,530				(260,641)
Balance (in shares) at Dec. 31, 2020						8,651,400		21,754
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares and warrants issued pursuant to private placement	4,072					$ 1			4,071
Shares and warrants issued pursuant to private placement (in shares)						546,733
Share-based compensation	2,544								2,544
Share-based compensation (in shares)						17,537
Warrant exercises	1,310								1,310
Warrant exercises (in shares)						297,383
Shares issued to third parties for services	46								46
Stock issued to third parties for services (in shares)						5,000
Warrant modifications	0								402				(402)
Conversion of Series F shares to common stock				$ 0			$ 1					$ (1)
Conversion of Series F shares to common stock (in shares)							1,482,672	(4,448)
Net and comprehensive loss available to common stockholders	(12,850)												(12,850)
Balance at Mar. 31, 2021	(32,980)					$ 11		$ 0	240,902				(273,893)
Balance (in shares) at Mar. 31, 2021						11,000,725		17,306
Balance at Dec. 31, 2020	(28,102)					$ 9		$ 0	232,530				(260,641)
Balance (in shares) at Dec. 31, 2020						8,651,400		21,754
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net and comprehensive loss available to common stockholders	11,926
Balance at Jun. 30, 2021	14,260					$ 16		$ 0	263,361				(249,117)
Balance (in shares) at Jun. 30, 2021						15,821,559		17,294
Balance at Mar. 31, 2021	(32,980)					$ 11		$ 0	240,902				(273,893)
Balance (in shares) at Mar. 31, 2021						11,000,725		17,306
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	313								313
Warrant exercises	375								375
Warrant exercises (in shares)						83,333
Conversion of Series F shares to common stock (in shares)							4,000	(12)
Conversion of convertible notes to common stock (in shares)						4,732,420
Conversion of convertible notes to common stock	21,776					$ 5			21,771
Stock issued in lieu of fractional shares, reverse stock split						1,081
Net and comprehensive loss available to common stockholders	24,776												24,776
Balance at Jun. 30, 2021	$ 14,260					$ 16		$ 0	$ 263,361				$ (249,117)
Balance (in shares) at Jun. 30, 2021						15,821,559		17,294

XML

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Cash Flow from Operating Activities:
Net and comprehensive income (loss) available to common stockholders	$ 24,776	$ (12,850)	$ (18,438)	$ (9,488)	$ 11,926	$ (27,926)
Adjustments to reconcile net and comprehensive income (loss) to net cash used in operating activities:
Shares and warrants issued to third parties for services					46	10,182
Depreciation and amortization					824	866
Amortization of debt issuance costs and discounts					1,777	2,353
Share-based compensation					2,857	5,504
Change in fair value of warrant liabilities	(29,356)		3,474		(22,873)	2,095
PIK interest expense on notes payable					1,110	939
Other					(930)	689
Changes in operating assets and liabilities:
Accounts receivable, net					(558)	1,621
Inventories, net					(332)	1,161
Prepaid expenses and other assets					1,256	92
Accounts payable and accrued liabilities					328	5
Other					(93)	251
Cash Used in Operating Activities					(4,662)	(2,168)
Cash Flow from Investing Activities
Acquisition of property and equipment					(54)	(6)
Cash Used in Investing Activities					(54)	(6)
Cash Flow from Financing Activities
Proceeds from shares and warrants issued pursuant to private placement, net					4,012	0
Proceeds from issuance of debt					0	2,352
Proceeds from revolving lines of credit					5,155	1,075
Payments on revolving lines of credit					(5,214)	(300)
Proceeds from term loan					6,000	0
Payments on term loans					(8,229)	0
Cash received for warrant exercises					1,685	0
IPO costs					(19)	0
Debt issuance costs					(116)	0
Cash Provided by Financing Activities					3,274	3,127
Net (decrease) increase in cash and cash equivalents and restricted cash					(1,442)	953
Total cash and cash equivalents and restricted cash, beginning of period		$ 3,989		$ 2,534	3,989	2,534	$ 2,534
Total cash and cash equivalents and restricted cash, end of period	$ 2,547		$ 3,487		2,547	3,487	$ 3,989
Cash paid during the period for:
Interest					221	1,319
Non-cash financing and investing transactions
Stock issued for services					$ 0	$ 125

XML

Nature of business and summary of significant accounting policies

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Nature of business and summary of significant accounting policies

Nature of business and summary of significant accounting policies

Nature of the business

Better Choice Company Inc. is a growing animal health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. The Company sells its product offerings under the Halo and TruDog brands, which have a long history of providing high quality products to pet parents. The Company believes its portfolio of brands are well-positioned to benefit from the trends of growing pet humanization and an increased consumer focus on health and wellness, and the Company has adopted a laser focused, channel-specific approach to growth that is driven by new product innovation. The Company has a broad portfolio of over 100 active premium and super-premium animal health and wellness products for dogs and cats sold under its Halo and TruDog brands across multiple forms, including foods, treats, toppers, dental products, chews, grooming products and supplements. The products consist of naturally formulated premium kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products, supplements and grooming aids. The core products sold under the Halo brand are sustainably sourced, derived from real whole meat and no rendered meat meal and include non-genetically modified fruits and vegetables. The core products sold under the TruDog brand are made according to the Company's nutritional philosophy of fresh, meat-based nutrition and minimal processing.

Reverse stock split

On May 28, 2021, stockholders of the Company holding a majority of the voting power of the Company entitled to vote approved by way of a written consent resolution the authorization of the Company's board of directors, in its sole and absolute discretion, and without further action of the stockholders, to file an amendment to the Company’s amended and restated certificate of incorporation to affect a reverse stock split of its common stock at a ratio in the range of 1-for-3 to 1-for-10 at any time prior to December 31, 2021. On June 10, 2021 the Company's board of directors set the reverse stock split ratio at 1-for-6 (the "Reverse Stock Split") and approved the Reverse Stock Split to be effectuated by the Company immediately following the effectiveness of the Company's registration statement related to the Company's IPO (as defined below), which became effective on June 28, 2021.

As a result of the Reverse Stock Split, every six shares of the Company’s common stock was combined and converted into one share of the Company’s common stock as of June 28, 2021. In addition, the conversion rates of the Company's outstanding preferred stock and convertible notes and the exercise prices of the Company’s underlying common stock purchase warrants and stock options were proportionately adjusted at the applicable reverse stock split ratio in accordance with the terms of such instruments. Proportionate voting rights and other rights of common stockholders were not affected by the Reverse Stock Split, other than as a result of the rounding up of fractional shares. The Company issued 1,081 shares of common stock in lieu of fractional shares in connection with the Reverse Stock Split.

Accordingly, all share and per share amounts related to the Company's common stock and underlying derivatives for all periods presented in the accompanying unaudited condensed consolidated financial statements and notes thereto have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split. The number of authorized shares and the par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.

Initial public offering

On June 28, 2021, the Company’s registration statement on Form S-1 for its underwritten initial public offering (the “IPO”) was declared effective by the SEC, and the Company's common stock commenced trading on the NYSE American ("NYSE") on June 29, 2021. Upon commencement of the trading of the Company's common stock on the NYSE on June 29, 2021, all of the Company's outstanding convertible notes payable automatically converted into 4,732,420 shares of common stock.

In connection with the IPO, which closed on July 1, 2021, the Company issued and sold 8,000,000 shares of its common stock at a price of $5.00 per share. The total net proceeds from the IPO were approximately $36.2 million, after deducting underwriting discounts and commissions of $2.8 million, and offering costs of approximately $1.0 million, of which $0.9 million was incurred as of June 30, 2021. The Company plans to use the net proceeds of this IPO for general corporate purposes. The Company may also elect to use proceeds from the IPO to acquire complimentary technologies, products or businesses, although the Company is not a party to any letters of intent or definitive agreements for any such acquisition. The Company granted the underwriters an option for a period of 30 days from June 29, 2021 to purchase up to 1,200,000 shares of common stock (the "Underwriter Shares") at the public offering price, less the underwriting discounts and commissions, to cover over-allotments, if any. No Underwriter Shares were purchased during the 30 day period.

Upon the consummation of the IPO on July 1, 2021, all shares of the Series F convertible preferred stock were converted into 5,764,533 shares of common stock. Additionally, since the anti-dilution provision of the Series F Warrants were no longer effective upon consummation of the Company's IPO, these warrants met the requirements to be considered equity and the outstanding Series F Warrants were reclassified as such.

The following unaudited pro forma condensed consolidated balance sheet data is presented as if the IPO closed on June 30, 2021, by applying adjustments to the Company’s condensed consolidated balance sheet. It reflects (1) the issuance of 8,000,000 shares of common stock for estimated net proceeds of $36.2 million (of which $0.9 million of offering costs were already included in the June 30, 2021 current asset balance), (2) the conversion of all Series F convertible preferred stock into an aggregate of 5,764,533 shares of common stock and (3) the reclassification of the Series F Warrant liability to equity:

	Actual		Pro Forma Adjustments		Pro Forma
	June 30, 2021				June 30, 2021
Assets
Total Current Assets	$	17,859	$	36,168	$	54,027
Total Non-Current assets	31,321		—		31,321
Total Assets	$	49,180	$	36,168	$	85,348
Liabilities & Stockholders’ Equity (Deficit)
Total Liabilities	$	34,920	$	(16,977)	$	17,943
Common Stock	16		14		30
Series F Preferred Stock	—		—		—
Additional paid-in capital	263,361		53,131		316,492
Accumulated deficit	(249,117)		—		(249,117)
Total Stockholders’ Equity (Deficit)	14,260		53,145		67,405
Total Liabilities and Stockholders’ Equity (Deficit)	$	49,180	$	36,168	$	85,348

Basis of presentation

The Company’s condensed consolidated financial statements are prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reports and accounting principles generally accepted in the United States ("GAAP"). Results of operations for interim periods may not be representative of results to be expected for the full year.

Certain reclassifications have been made to conform the prior period data to the current presentation. These reclassifications had no material effect on the reported results.

These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company’s Annual Report for the year ended December 31, 2020, filed with the SEC.

Consolidation

The financial statements are presented on a consolidated basis subsequent to acquisitions and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Use of estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.

In the opinion of management, the condensed consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations and comprehensive income (loss) for the periods ended June 30, 2021 and 2020, the financial position as of June 30, 2021 and December 31, 2020 and the cash flows for the periods ended June 30, 2021 and 2020.

Summary of significant accounting policies

For additional information, please refer to the most recently filed Annual Report regarding the Company's summary of significant accounting policies.

New accounting standards

Recently adopted

ASU 2020-03 “Codification Improvements to Financial Instruments”

In March 2020, FASB issued Accounting Standards Update ("ASU") 2020-03, Codification Improvement to Financial Instruments. This ASU improves and clarifies various financial instruments topics, including the current expected credit losses standard issued in 2016. The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments have different effective dates, some of which were effective for the Company beginning on January 1, 2021. The amendments adopted did not have a material impact on the Company’s condensed consolidated financial statements.

ASU 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This new guidance was effective for the Company beginning on January 1, 2021 and did not have an impact on the Company’s condensed consolidated financial statements.

Issued but not yet adopted

ASU 2016-13 “Financial Instruments – Credit Losses (Topic 326)”

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326),” a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard is effective for the Company on January 1, 2023, and early adoption is permitted. The Company is currently evaluating the impact the new standard will have on its consolidated financial statements.

ASU 2020-04 “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting”

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional expedient and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. In response to the concerns about structural risks of interbank offered rates (IBORs) and, particularly, the risk of cessation of the London Interbank Offered Rate (LIBOR), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is currently evaluating the impact the standard will have on its consolidated financial statements and related disclosures.

ASU 2020-06 "Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

In August 2020, FASB issued ASU 2020-06, Debt - Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Accounting for Convertible Instruments and Contracts in an Entity's Own Equity. This ASU reduces the number of accounting models for convertible instruments, amends diluted EPS calculations for convertible instruments, and amends the requirements for a contract (or embedded derivative) that is potentially settled in an entity’s own shares to be classified in equity. This standard is effective for the Company beginning on January 1, 2024 with early adoption permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

XML

Revenue

6 Months Ended

Jun. 30, 2021

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

The Company records revenue net of discounts, which primarily consist of early pay discounts, general percentage allowances and contractual trade promotions.

The Company excludes sales taxes collected from revenues. Retail-partner based customers are not subject to sales tax.

The Company’s direct-to-consumer ("DTC") loyalty program enables customers to accumulate points based on their spending. A portion of revenue is deferred at the time of sale when points are earned and recognized when the loyalty points are redeemed.

Shipping costs

Shipping costs associated with moving finished products to customers were $0.9 million and $0.7 million for the six months ended June 30, 2021 and 2020, respectively, and $0.4 million and $0.3 million for the three months ended June 30, 2021 and 2020, respectively. Such shipping costs are recorded as part of general and administrative expenses.

Revenue channels

The Company groups its revenue channels into four distinct categories: E-Commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick & Mortar, which includes the sale of product to pet specialty chains such as Petco, PetSmart, select grocery chains, and neighborhood pet stores; DTC, which includes the sale of product through the Company's online web platform to more than 20,000 unique customers; and International, which includes the sale of product to foreign distribution partners and to select international retailers (transacted in U.S. dollars). Information about the Company’s net sales by revenue channel is as follows (in thousands):

	Six Months Ended June 30,								Three Months Ended June 30,
	2021				2020				2021				2020
E-commerce	$	6,902	32	%	$	7,459	34	%	$	2,892	26	%	$	2,978	30	%
Brick & Mortar	3,592		16	%	4,772		22	%	1,698		16	%	1,875		19	%
DTC	4,777		22	%	5,526		25	%	2,341		21	%	2,722		27	%
International	6,548		30	%	4,410		19	%	4,058		37	%	2,366		24	%
Net Sales	$	21,819	100	%	$	22,167	100	%	$	10,989	100	%	$	9,941	100	%

XML

Inventories

6 Months Ended

Jun. 30, 2021

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories are summarized as follows (in thousands):

	June 30, 2021		December 31, 2020
Food, treats and supplements	$	5,129	$	4,987
Inventory packaging and supplies	499		596
Total Inventories	5,628		5,583
Inventory reserve	(427)		(714)
Inventories, net	$	5,201	$	4,869

XML

Prepaid expenses and other current assets

6 Months Ended

Jun. 30, 2021

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Prepaid expenses and other current assets

Prepaid expenses and other current assets

	June 30, 2021		December 31, 2020
Prepaid advertising contract with iHeart (1)	$	2,985	$	1,788
Other prepaid expenses and other current assets (2)	1,055		2,286
Total Prepaid expenses and other current assets	$	4,040	$	4,074

(1) On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. and issued 166,667 shares of common stock valued at $3.4 million for future advertising services. The Company issued an additional 20,834 shares valued at $0.1 million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. There was a long-term portion of $1.2 million recorded in other non-current assets as of December 31, 2020.

(2) As of June 30, 2021, this amount includes various other prepaid contracts. In December 2020, the Company entered into an agreement for access to an investment platform in exchange for 83,334 shares of common stock valued at $0.6 million and also entered into an agreement for marketing services in exchange for 83,334 shares of common stock valued at $0.5 million, both of which are being amortized over 12 months.

XML

Accrued and other liabilities

6 Months Ended

Jun. 30, 2021

Payables and Accruals [Abstract]

Accrued and other liabilities

Accrued and other liabilities

Accrued and other liabilities consist of the following (in thousands):

	June 30, 2021		December 31, 2020
Accrued professional fees	$	503	$	704
Accrued sales tax	215		1,009
Accrued payroll and benefits	1,018		913
Accrued trade promotions	57		106
Accrued interest	24		86
Deferred revenue	257		350
Other	157		232
Total accrued liabilities	$	2,231	$	3,400

XML

Intangible assets, royalties, and goodwill

6 Months Ended

Jun. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible assets, royalties, and goodwill

Intangible assets, royalties, and goodwill

Intangible assets

The Company’s intangible assets (in thousands) and related useful lives (in years) are as follows:

				June 30, 2021				December 31, 2020
	Estimated useful life	Gross carrying amount		Accumulated amortization		Net carrying amount		Accumulated amortization		Net carrying amount
Customer relationships	7	$	7,190	$	(1,574)	$	5,616	$	(1,059)	$	6,131
Trade name	15	7,500		(766)		6,734		(516)		6,984
Total intangible assets		$	14,690	$	(2,340)	$	12,350	$	(1,575)	$	13,115

Amortization expense was $0.4 million and $0.8 million for both the three and six months ended June 30, 2021 and 2020, respectively.

The estimated future amortization of intangible assets over the remaining weighted average useful life of 9.8 years is as follows (in thousands):

Remainder of 2021	$	764
2022	1,527
2023	1,527
2024	1,527
2025	1,527
Thereafter	5,478
	$	12,350

There were no indicators or impairment of the intangible assets as of June 30, 2021.

Goodwill

Goodwill was $18.6 million as of June 30, 2021 and December 31, 2020, respectfully. The Company performed a quantitative assessment for its annual impairment test as of October 1, 2020. Under the quantitative approach, the Company makes various estimates and assumptions to determine the estimated fair value of the reporting unit using a combination of a discounted cash flow model and earnings multiples for guideline public companies. As of June 30, 2021, there was no accumulated impairment loss and no impairment expense related to goodwill.

XML

Debt

6 Months Ended

Jun. 30, 2021

Debt Disclosure [Abstract]

Debt

Debt

The components of the Company’s debt consist of the following (in thousands):

Dollars in thousands	June 30, 2021					December 31, 2020
	Amount		Rate		Maturity Date	Amount		Rate		Maturity Date
Term loan, net	$	5,703	(1)		1/6/2024	$	7,826	(2)		1/15/2021
Line of credit, net	5,157		(1)		1/6/2024	5,023		(3)		7/5/2022
November 2019 notes payable, net (November 2019 Notes)	—		10	%	6/30/2023	2,830		10	%	6/30/2023
December 2019 senior notes payable, net (Senior Seller Notes)	—		10	%	6/30/2023	10,332		10	%	6/30/2023
December 2019 junior notes payable, net (Junior Seller Notes)	—		10	%	6/30/2023	4,973		10	%	6/30/2023
ABG Notes	—		10	%	6/30/2023	687		10	%	6/30/2023
June 2020 notes payable, net (June 2020 Notes)	—		10	%	6/30/2023	88		10	%	6/30/2023
Halo PPP Loan	—		1	%	5/3/2022	431		1	%	5/3/2022
TruPet PPP Loan	—		0.98	%	4/6/2022	421		0.98	%	4/6/2022
Total debt	10,860					32,611
Less current portion	926					8,016
Total long term debt	$	9,934				$	24,595

(1)Interest at a variable rate of LIBOR plus 250 basis points with an interest rate floor of 2.50% per annum

(2)Interest at Bank of Montreal Prime plus 8.05%

(3)Interest at a variable rate of LIBOR plus 250 basis points with an interest rate floor of 3.25% per annum

Term loans and lines of credit

On December 19, 2019, the Company entered into a Loan Facilities Agreement (the “Facilities Agreement”) by and among the Company, as the borrower, the several lenders from time to time parties thereto (collectively, the “Lenders”) and a private debt lender, as agent (the “Agent”). The Facilities Agreement provided for (i) a term loan facility of $20.5 million and (ii) a revolving loan facility not to exceed $7.5 million. The term loan was scheduled to mature on December 19, 2020 or such earlier date on which a demand was made by the Agent or any Lender, and was extended as discussed below. The remaining revolving credit facility balance of $5.1 million was repaid in full with a portion of the proceeds from the ABL Facility, discussed below, and resulted in a loss on debt extinguishment of $0.1 million.

Certain directors and shareholders of the Company (“Shareholder Guarantors”) agreed to guarantee the Company’s obligations under the Facilities Agreement up to an aggregate amount of $20.0 million pursuant to a Continuing Guarantee between the Shareholder Guarantors and the lender under the Facilities Agreement (the "Shareholder Guaranties"). As consideration for the Shareholder Guaranties, the Company issued common stock purchase warrants to the Shareholder Guarantors in an amount equal to 0.055 warrants for each dollar of debt guaranteed by such Shareholder Guarantors (the “Guarantor Warrants”).

On July 16, 2020, the Company entered into a revolving line of credit with Citizens Business Bank in the aggregate amount of $7.5 million (the “ABL Facility”). The proceeds of the ABL Facility were used (i) to repay all principal, interest and fees outstanding under the Company’s previous revolving credit facility and (ii) for general corporate purposes. Debt issuance costs of less than $0.1 million were incurred related to the Company entering into this revolving line of credit.

The ABL Facility was scheduled to mature on July 5, 2022 and accrued interest at a variable rate of LIBOR plus 250 basis points, with an interest rate floor of 3.25% per annum. Accrued interest on the ABL Facility was payable monthly commencing on August 5, 2020. The ABL Agreement provided for customary financial covenants, such as maintaining a specified adjusted EBITDA and a maximum senior debt leverage ratio, that commenced on December 31, 2020 and customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company prepaid all of the outstanding principal and accrued interest under the ABL Facility in full and did not incur any prepayment charges.

The ABL Facility was secured by a general security interest on the assets of the Company and was personally guaranteed by a member of the Company’s board of directors.

On October 5, 2020, the Company paid down the term loan by $11.0 million using proceeds from the Series F Private Placement. On October 29, 2020, the Company made an additional pay down on the term loan of $1.0 million using additional proceeds from the Series F Private Placement.

On November 25, 2020, the Company entered into the fifth amendment to the Facilities Agreement, extending the maturity date of the term loan to January 15, 2021.

On January 6, 2021, Halo, Purely for Pets, Inc., a wholly owned subsidiary of Better Choice Company Inc. ("Halo") entered into a credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A. (“Wintrust”) consisting of a $6.0 million term loan and a $6.0 million revolving line of credit, each scheduled to mature on January 6, 2024 and each bear interest at a variable rate of LIBOR plus 250 basis points, with an interest rate floor of 2.50% per annum (the "Wintrust Credit Facility"). Accrued interest on the Wintrust Facility is payable monthly commencing on February 1, 2021. Principal payments are required to be made monthly on the term loan commencing February 2021 with a balloon payment upon maturity. The proceeds from the Wintrust Credit Facility were used (i) to repay the principal, interest and fees outstanding under the ABL Facility and (ii) for general corporate purposes. The Company applied extinguishment accounting to the outstanding balances of the ABL Facility and term loan and recorded a loss on extinguishment of debt of $0.4 million during the three months ended March 31, 2021. Debt issuance costs of $0.1 million were incurred related to the Wintrust Credit Facility.

The Wintrust Credit Facility subjects the Company to certain financial covenants, including the maintenance of a fixed charge coverage ratio of no less than 1.25 to 1.00, tested as of the last day of each fiscal quarter. The numerator in the fixed charge coverage ratio is the operating cash flow of Halo, defined as Halo EBITDA less cash paid for unfinanced Halo capital expenditures, income taxes and dividends. The denominator is fixed charges such as interest expense and principal payments paid or payable on other indebtedness attributable to Halo.

The Wintrust Credit Facility is secured by a general guaranty and security interest on the assets, including the intellectual property, of the Company and its subsidiaries. The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral. Furthermore, the Wintrust Credit Facility is supported by a collateral pledge by a member of the Company’s board of directors.

As of June 30, 2021, the term loan and line of credit outstanding under the Wintrust Credit Facility were $5.7 million and $5.2 million, respectively, net of debt issuance costs of less than $0.1 million, respectively. As of December 31, 2020, the previous term loan and line of credit outstanding were $7.8 million and $5.0 million, respectively, net of debt issuance costs and discounts of less than $0.2 million and $0.2 million, respectively. The debt issuance costs and discounts are amortized using the effective interest method.

As of June 30, 2021 and December 31, 2020, the Company was in compliance with its debt covenants.

Notes payable

On November 4, 2019, the Company issued $2.8 million of subordinated convertible notes (the “November 2019 Notes”) which carried a 10% interest rate and mature on November 4, 2021. The interest was payable in kind, in arrears on March 31, June 30, September 30 and December 31 of each year. Payment in kind ("PIK") interest was payable by increasing the aggregate principal amount of the November 2019 Notes. The November 2019 Notes were convertible any time from the date of issuance and carried an initial conversion price of the lower of (a) $24.00 per share or (b) the IPO Price.

The November 2019 Notes were amended on January 6, 2020. The amendment incorporates only the preferable terms of the Seller Notes as noted below, and all other terms and provisions of the November 2019 Notes remained in full force and effect. As amended, for so long as any event of default (as defined in the November 2019 Notes) exists, interest shall accrue on the November 2019 Notes principal at the default interest rate of 12.0% per annum, and such accrued interest shall be immediately due and payable.

The November 2019 Notes were amended for the second time on June 24, 2020 in connection with the issuance of the June 2020 Notes. The amendment lowered the maximum conversion price applicable to the conversion of these notes from $24.00 per share to $22.50 per share and extended the maturity date from November 4, 2021 to June 30, 2023. Under the applicable accounting guidance, the Company accounted for the change in conversion price as a modification of the debt instrument. The Company recognized the increase in the fair value of the conversion option of $0.3 million as a reduction to the carrying amount of the debt instrument by increasing the associated debt discount with a corresponding increase in Additional paid-in capital.

As of June 30, 2021, the November 2019 Notes outstanding were $0 since they were automatically converted to common stock in connection with the Company's IPO, at a price of $5.00 per share. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information. As of December 31, 2020, the November 2019 Notes outstanding were $2.8 million, net of discounts of less than $0.3 million. The discounts were being amortized over the life of the November 2019 Notes using the effective interest method.

On December 19, 2019, the Company issued $10.0 million and $5.0 million in senior subordinated convertible notes (the “Senior Seller Notes”) and junior subordinated convertible notes (the “Junior Seller Notes” and together with the Senior Seller Notes, the “Seller Notes”), respectively, to the sellers of Halo. The Seller Notes were convertible any time from the date of issuance and carried a 10% interest rate and mature on June 30, 2023. Interest was payable in kind, in arrears on March 31, June 30, September 30 and December 31 of each year. PIK interest was payable by increasing the aggregate principal amount of the Seller Notes. The Seller Notes carried a conversion price of the lower of (a) $24.00 per share or (b) the IPO Price. 

The Seller Notes were amended on June 24, 2020 in connection with the issuance of the June 2020 Notes. The amendment lowered the maximum conversion price applicable to the conversion of these notes from $24.00 per share to $22.50 per share. The Company accounted for the change in the conversion price as a modification of the debt instrument. The Company recognized the increase in the fair value of the conversion option of less than $0.3 million as a reduction to the carrying amounts of the debt instruments by increasing the associated debt discounts with a corresponding increase in Additional paid-in capital.

As of June 30, 2021, the Senior Seller Notes and Junior Seller Notes outstanding were $0 since they were automatically converted to common stock in connection with the Company's IPO, at a price of $5.00 per share. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information. As of December 31, 2020, the Senior Seller Notes outstanding were $10.3 million, net of discounts of $0.8 million, and the Junior Seller Notes outstanding were $5.0 million, net of discounts of $0.5 million. The discounts were being amortized over the life of the Seller Notes using the effective interest method.

On January 13, 2020, the Company issued $0.6 million in senior subordinated convertible notes to Authentic Brands and Elvis Presley Enterprises (“ABG”) in connection with the termination of a previous licensing agreement (the "ABG Notes"). The terms of the ABG Notes match those of the Seller Notes, including conversion features convertible any time after the date of issuance, a 10% interest rate and maturity date of June 30, 2023. The interest was payable in kind, in arrears on March 31, June 30, September 30 and December 31 of each year. PIK interest was payable by increasing the aggregate principal amount of the ABG Notes. The ABG Notes carried an initial conversion price of the lower of (a) $24.00 per share or (b) the IPO Price.

In addition to issuing the ABG Notes, as part of the ABG termination on January 13, 2020, the Company paid ABG $0.1 million in cash, issued ABG 12,120 shares of the Company’s common stock, agreed to pay ABG $0.1 million in cash in four equal installments each month from July 31, 2020 through October 31, 2020 and issued ABG common stock purchase warrants (the “ABG Warrants”) equal to a fair value of $0.2 million.

The ABG Notes were amended on June 24, 2020 in connection with the issuance of the June 2020 Notes. The amendment lowered the maximum conversion price applicable to the conversion of these notes from $24.00 per share to $22.50 per share. The Company accounted for the change in the conversion price as a modification of the debt instrument. The Company recognized the increase in the fair value of the conversion option of less than $0.1 million as a reduction to the carrying amount of the debt instrument by decreasing the associated debt premium with a corresponding increase in Additional paid-in capital.

As of June 30, 2021, the ABG Notes outstanding were $0 since they were automatically converted to common stock in connection with the Company's IPO, at a price of $5.00 per share. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information. As of December 31, 2020, the ABG Notes outstanding were $0.7 million, including a debt premium of less than $0.1 million. The debt premium was being amortized over the life of the ABG Notes using the effective interest method.

On June 24, 2020, the Company issued $1.5 million in subordinated convertible promissory notes (the “June 2020 Notes”) which carried a 10% interest rate and matures on June 30, 2023. The interest was payable quarterly in kind, in arrears on March 31, June 30, September 30, and December 31 of each year. PIK interest was payable by increasing the aggregate principal amount of the June 2020 Notes. The June 2020 Notes were convertible any time from the date of issuance and carried a conversion price $4.50 per share.

The Company evaluated the conversion option within the June 2020 Notes to determine whether the conversion price was beneficial to the note holders. The Company recorded a beneficial conversion feature (“BCF”) related to the issuance of the June 2020 Notes. The BCF for the June 2020 Notes was recognized and measured by allocating a portion of the proceeds to the beneficial conversion feature, based on relative fair value, and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion feature limited to the proceeds amount allocated to the instrument. The discount recorded in connection with the BCF valuation was being accreted as interest expense over the term of the June 2020 Notes, using the effective interest rate method. Upon the conversion of the June 2020 Notes discussed below, the remaining discount of $1.4 million associated with the June 2020 Notes was fully accreted through interest expense.

As of June 30, 2021, the June 2020 Notes outstanding were $0 since they were automatically converted to common stock in connection with the Company's IPO, at a price of $4.50 per share. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information. As of December 31, 2020, the June 2020 Notes outstanding were less than $0.1 million, net of discounts of less than $1.5 million. The discounts were being amortized over the life of the June 2020 Notes using the effective interest method.

Previously, $0.1 million of the Seller Notes were held by an executive of the Company; these convertible notes were converted to common stock as described above. Additionally, $2.2 million of the subordinated convertible notes were held by a member of the board of directors and were converted to common stock as described above. PIK interest related to these notes was less than $0.1 million and $0.1 million for both the three and six months ended June 30, 2021 and 2020, respectively.

As of June 30, 2021 and December 31, 2020, the Company was in compliance with all covenant requirements and there were no events of default.

PPP loans

On April 10, 2020, TruPet, LLC, a wholly owned subsidiary of Better Choice Company Inc., was granted a loan from JPMorgan Chase Bank, N.A. in the aggregate amount of $0.4 million, pursuant to the Paycheck Protection Program ("PPP") under Division A, Title I of the CARES Act (the “TruPet PPP Loan”). The loan matured on April 6, 2022 and had an interest rate of 0.98% per annum, with interest and principal payable monthly, commencing on November 6, 2020. During the three months ended June 30, 2021, the TruPet PPP loan was fully forgiven and the Company recognized a gain on extinguishment of debt of $0.4 million.

On May 7, 2020, Halo, Purely for Pets, Inc., a wholly owned subsidiary of Better Choice Company Inc., was granted a loan from Wells Fargo Bank, N.A. in the aggregate amount of $0.4 million, pursuant to the PPP (the “Halo PPP Loan”). The loan matured on May 3, 2022 and had an interest rate of 1.00% per annum, with interest and principal payable monthly, commencing on November 1, 2020. During the three months ended June 30, 2021 the Halo PPP loan was fully forgiven and the Company recognized a gain on extinguishment of debt of $0.4 million.

The Company recorded interest expense related to its outstanding indebtedness of $3.1 million and $4.7 million for the six months ended June 30, 2021 and June 30, 2020, respectively, and $2.2 million and $2.4 million for the three months ended June 30, 2021 and June 30, 2020, respectively.

The carrying amount for the Company’s term loan and line of credit approximate fair value as the instruments have variable interest rates that approximate market rates.

XML

Commitments and contingencies

6 Months Ended

Jun. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and contingencies

Commitments and contingencies

The Company had no material purchase obligations as of June 30, 2021 or December 31, 2020.

The Company may be involved in legal proceedings, claims, and regulatory, tax, or government inquiries and investigations that arise in the ordinary course of business resulting in loss contingencies. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability. Legal costs such as outside counsel fees and expenses are charged to expense in the period incurred and are recorded in general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The Company does not accrue for contingent losses that are considered to be reasonably possible, but not probable; however, the Company discloses the range of such reasonably possible losses. Loss contingencies considered remote are generally not disclosed. 

Litigation is subject to numerous uncertainties and the outcome of individual claims and contingencies is not predictable. It is possible that some legal matters for which reserves have or have not been established could result in an unfavorable outcome for the Company and any such unfavorable outcome could be of a material nature or have a material adverse effect on the Company's consolidated financial condition, results of operations and cash flows. Management is not aware of any claims or lawsuits that may have a material adverse effect on the consolidated financial position or results of operations of the Company.

XML

Convertible preferred stock

6 Months Ended

Jun. 30, 2021

Equity [Abstract]

Convertible preferred stock

Convertible preferred stockDuring October, 2020, the Company consummated an insider-led equity financing, including the transactions contemplated by a securities purchase agreement (the “Securities Purchase Agreement”) between the Company and certain accredited and sophisticated investors (the “Purchasers”) and an exchange agreement (the “Series E Exchange Agreement”) between the Company and Cavalry Fund LP ("Cavalry"), the holder of all of the Company’s previously outstanding Series E preferred stock.

Pursuant to the Securities Purchase Agreement, the Company, in a private placement (the “Series F Private Placement”), issued and sold units (the “Series F Units”) to the Purchasers for a purchase price of $1,000 per Unit. Each Unit consists of: (i) one share of the Company’s Series F convertible preferred stock, par value $0.001 per share (the “Series F Preferred Stock”), which is convertible into shares of the Company’s common stock, par value $0.001 per share, at a value per share of common stock of $3.00; and (ii) a warrant to purchase for a six year period such number of shares of common stock (the “Series F Warrant Shares”) into which such share of Series F Preferred Stock is convertible at an exercise price per Warrant Share of $4.50. Pursuant to the Series F Private Placement, the Company raised approximately $18.2 million in gross cash proceeds, approximately $6.5 million of which was invested by certain officers, directors, employees and associated related parties thereto of the Company. The Series F Shares were recorded at fair value on the date of issuance on an as converted basis.

Concurrently with the execution of the Securities Purchase Agreement, the Company and the Purchasers entered into a registration rights agreement, (as amended by a certain first amendment dated October 29, 2020, the "Registration Rights Agreement"), pursuant to which the Company filed a registration statement which was declared effective by the SEC on February 16, 2021 to register the Warrant Shares and the shares of common stock issuable upon conversion of the Series F Preferred Stock.

In connection with the consummation of the Series F Private Placement, on October 1, 2020, the Company filed with the Secretary of State of Delaware a Certificate of Designations which authorizes a total of 30,000 shares of Series F Preferred Stock and sets forth the designations, preferences, and rights of the Company's Series F Preferred Stock.

On October 1, 2020, the Company issued 14,264 Series F Units in conjunction with money received for the Series F Private Placement. In addition, pursuant to the Series E Exchange Agreement, on October 1, 2020, the Company issued 3,500 Series F Units to Cavalry in exchange for all of its outstanding Series E Preferred Stock. The exchange of Series E Preferred Shares resulted in a $5.4 million gain and was recorded to Accumulated deficit on the Company's Condensed Consolidated Balance Sheets.

On October 12, 2020 and October 23, 2020, the Company issued 1,106 and 2,832 Series F Units, respectively, in conjunction with the Series F Private Placement. In addition, on October 23, 2020, the Company issued an additional 100 shares of Series F Preferred Stock in conjunction with a marketing agreement.

The Company evaluated the conversion option within the Series F Preferred Stock on the dates of issuance to determine whether the conversion price was beneficial to the holders. The Company recorded a BCF related to the issuance of the Series F Preferred Stock. The BCF was recognized and measured by allocating a portion of the proceeds to the beneficial conversion feature, based on fair value and was recorded to Accumulated deficit on the Company's Condensed Consolidated Balance Sheets limited to the proceeds amount allocated to the instrument.

On July 1, 2021, all outstanding shares of convertible preferred stock were converted to common stock in connection with the consummation of the Company's IPO. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information.

Stockholders’ equity (deficit)

On January 22, 2021, the Company consummated a private placement of common stock units (the “January 2021 Private Placement”) in which the Company raised approximately $4.1 million, including an investment by certain officers, directors, employees and associated related parties thereto of approximately $1.6 million. Each common stock unit was sold at a per unit price of $7.50 and consisted of (i) one share of the Company’s common stock, par value $0.001 per share; and (ii) a warrant to purchase one share of common stock. The proceeds were used to pay expenses related to the offering and for general corporate purposes. In connection with the January 2021 Private Placement, the Company entered into a registration rights agreement (the “January 2021 Registration Rights Agreement”) pursuant to which the Company filed a registration statement that was declared effective by the SEC on February 16, 2021 to register the shares of common stock issued, and issuable upon the exercise of the warrants issued, in the January 2021 Private Placement.

See "Note 1 - Nature of business and summary of significant accounting policies" for additional information regarding the impacts to the Company's Stockholders’ equity (deficit) related to the commencement of its common stock trading on the NYSE and the consummation of its IPO.

The Company has reserved common stock for future issuance as follows:

	June 30, 2021	December 31, 2020
Conversion of Series F Preferred Stock	5,764,533	7,251,189
Exercise of options to purchase common stock	2,200,244	1,302,574
Exercise of warrants to purchase common stock	9,433,584	9,916,997
Conversion of notes payable	—	1,255,039
Total	17,398,361	19,725,799

XML

Stockholders' equity (deficit)

6 Months Ended

Jun. 30, 2021

Stockholders' Equity Note [Abstract]

Stockholders' equity (deficit)

Convertible preferred stockDuring October, 2020, the Company consummated an insider-led equity financing, including the transactions contemplated by a securities purchase agreement (the “Securities Purchase Agreement”) between the Company and certain accredited and sophisticated investors (the “Purchasers”) and an exchange agreement (the “Series E Exchange Agreement”) between the Company and Cavalry Fund LP ("Cavalry"), the holder of all of the Company’s previously outstanding Series E preferred stock.

Pursuant to the Securities Purchase Agreement, the Company, in a private placement (the “Series F Private Placement”), issued and sold units (the “Series F Units”) to the Purchasers for a purchase price of $1,000 per Unit. Each Unit consists of: (i) one share of the Company’s Series F convertible preferred stock, par value $0.001 per share (the “Series F Preferred Stock”), which is convertible into shares of the Company’s common stock, par value $0.001 per share, at a value per share of common stock of $3.00; and (ii) a warrant to purchase for a six year period such number of shares of common stock (the “Series F Warrant Shares”) into which such share of Series F Preferred Stock is convertible at an exercise price per Warrant Share of $4.50. Pursuant to the Series F Private Placement, the Company raised approximately $18.2 million in gross cash proceeds, approximately $6.5 million of which was invested by certain officers, directors, employees and associated related parties thereto of the Company. The Series F Shares were recorded at fair value on the date of issuance on an as converted basis.

Concurrently with the execution of the Securities Purchase Agreement, the Company and the Purchasers entered into a registration rights agreement, (as amended by a certain first amendment dated October 29, 2020, the "Registration Rights Agreement"), pursuant to which the Company filed a registration statement which was declared effective by the SEC on February 16, 2021 to register the Warrant Shares and the shares of common stock issuable upon conversion of the Series F Preferred Stock.

In connection with the consummation of the Series F Private Placement, on October 1, 2020, the Company filed with the Secretary of State of Delaware a Certificate of Designations which authorizes a total of 30,000 shares of Series F Preferred Stock and sets forth the designations, preferences, and rights of the Company's Series F Preferred Stock.

On October 1, 2020, the Company issued 14,264 Series F Units in conjunction with money received for the Series F Private Placement. In addition, pursuant to the Series E Exchange Agreement, on October 1, 2020, the Company issued 3,500 Series F Units to Cavalry in exchange for all of its outstanding Series E Preferred Stock. The exchange of Series E Preferred Shares resulted in a $5.4 million gain and was recorded to Accumulated deficit on the Company's Condensed Consolidated Balance Sheets.

On October 12, 2020 and October 23, 2020, the Company issued 1,106 and 2,832 Series F Units, respectively, in conjunction with the Series F Private Placement. In addition, on October 23, 2020, the Company issued an additional 100 shares of Series F Preferred Stock in conjunction with a marketing agreement.

The Company evaluated the conversion option within the Series F Preferred Stock on the dates of issuance to determine whether the conversion price was beneficial to the holders. The Company recorded a BCF related to the issuance of the Series F Preferred Stock. The BCF was recognized and measured by allocating a portion of the proceeds to the beneficial conversion feature, based on fair value and was recorded to Accumulated deficit on the Company's Condensed Consolidated Balance Sheets limited to the proceeds amount allocated to the instrument.

On July 1, 2021, all outstanding shares of convertible preferred stock were converted to common stock in connection with the consummation of the Company's IPO. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information.

Stockholders’ equity (deficit)

On January 22, 2021, the Company consummated a private placement of common stock units (the “January 2021 Private Placement”) in which the Company raised approximately $4.1 million, including an investment by certain officers, directors, employees and associated related parties thereto of approximately $1.6 million. Each common stock unit was sold at a per unit price of $7.50 and consisted of (i) one share of the Company’s common stock, par value $0.001 per share; and (ii) a warrant to purchase one share of common stock. The proceeds were used to pay expenses related to the offering and for general corporate purposes. In connection with the January 2021 Private Placement, the Company entered into a registration rights agreement (the “January 2021 Registration Rights Agreement”) pursuant to which the Company filed a registration statement that was declared effective by the SEC on February 16, 2021 to register the shares of common stock issued, and issuable upon the exercise of the warrants issued, in the January 2021 Private Placement.

See "Note 1 - Nature of business and summary of significant accounting policies" for additional information regarding the impacts to the Company's Stockholders’ equity (deficit) related to the commencement of its common stock trading on the NYSE and the consummation of its IPO.

The Company has reserved common stock for future issuance as follows:

	June 30, 2021	December 31, 2020
Conversion of Series F Preferred Stock	5,764,533	7,251,189
Exercise of options to purchase common stock	2,200,244	1,302,574
Exercise of warrants to purchase common stock	9,433,584	9,916,997
Conversion of notes payable	—	1,255,039
Total	17,398,361	19,725,799

XML

Warrants

6 Months Ended

Jun. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Warrants

Warrants

The following summarizes the Company's outstanding warrants to purchase shares of the Company's common stock as of and for the periods ended June 30, 2021 and December 31, 2020:

	Warrants	Exercise Price
Warrants outstanding as of December 31, 2019	2,830,309	$	19.38
Issued	8,321,412	$	4.62
Exercised	(322,949)	$	3.48
Terminated/Expired	(911,776)	$	18.42
Warrants outstanding as of December 31, 2020	9,916,996	$	7.32
Issued	548,111	$	8.70
Exercised	(389,881)	$	4.52
Terminated/Expired	(641,642)	$	24.64
Warrants outstanding as of June 30, 2021	9,433,584	$	5.92

The intrinsic value of outstanding warrants was $0.0 million and $23.8 million as of June 30, 2021 and December 31, 2020, respectively. The following discussion provides details on the various types of outstanding warrants and the related relevant disclosures around each type.

Warrant derivative liability

During May 2019, the Company acquired 118,804 warrants with a weighted average exercise price of $23.40 (the "May Acquisitions Warrants"). These warrants included an option to settle in cash in the event of a change of control of the Company and a reset feature if the Company issues shares of common stock with a strike price below the exercise price of the warrants, which required the Company to record the warrants as a derivative liability. The Company calculates the fair value of the derivative liability through a Monte Carlo Model that values the warrants based upon a probability weighted discounted cash flow model.

During January 2020, the Company issued shares below the exercise price of the May Acquisitions Warrants. As such, the Company issued an additional 167,206 warrants on March 17, 2020 to certain of its warrant holders at an exercise price of $9.72 and modified the exercise price of the existing May Acquisitions Warrants to $9.72.

During June 2020, the Company issued common stock equivalents below the exercise price of the warrants issued on March 17, 2020. As such, the Company issued an additional 331,771 warrants to certain of its warrant holders at an exercise price of $4.50 and modified the exercise price of the existing warrants to $4.50.

During September 2020, the Company amended all of these warrants to eliminate certain anti-dilution rights, fix the number of shares of common stock purchasable under each warrant, and set the exercise price thereof at $3.90 per share. As such, the Company issued an additional 95,043 warrants to certain of its warrant holders at an exercise price of $3.90.

During the fourth quarter of 2020, holders exercised a total 281,282 warrants for which the Company issued shares of common stock. During December 2020, 418,721 of these warrants expired and an immaterial amount remained outstanding as of December 31, 2020, all of which expired during January 2021.

The following schedule shows the fair value of the warrant derivative liability as of June 30, 2021 and December 31, 2020, and the change in fair value during the periods ended June 30, 2021 and year ended December 31, 2020 (in thousands):

	Warrant Derivative Liability
Balance as of December 31, 2019	$	2,220
Change in fair value of  warrant derivative liability	(2,220)
Balance as of December 31, 2020	$	—
Change in fair value of  warrant derivative liability (1)	—
Balance as of June 30, 2021	$	—

(1) All of the May Acquisition Warrants expired during January 2021.

Series F warrant liability

During October 2020, the Company issued 7,233,855 warrants to purchase common stock in connection with the Series F Private Placement (defined below) with an exercise price of $4.50 (the "Series F Warrants"). The warrants are exercisable commencing on the date of issuance and expire 72 months after the date of issuance. These warrants included a reset feature if the Company issues common stock, options, or convertible securities with a strike price below the exercise price of the warrants. During the second quarter of 2021, a Series F warrant holder exercised 83,334 warrants, resulting in the Company’s receipt of approximately $0.4 million. Initially, these warrants did not meet the definition of a derivative or the requirements to be considered equity; as such, the Company recorded these as a liability. Due to changes in certain terms of the warrant agreements in connection with the Company's IPO whereby the warrants did meet the requirements to be considered equity, the outstanding Series F warrants were reclassified to equity upon consummation of the IPO on July 1, 2021. See "Note 9 - Convertible preferred stock" for more information on Series F and see "Note 1 - Nature of business and summary of significant accounting policies" for additional information on the Company's IPO.

The warrant liability was remeasured at fair value each reporting period and upon the Company's IPO and represented a Level 3 financial instrument. The Company calculates the fair value of the warrant liability through a Monte Carlo Model and a Black Scholes Option Model. The total value of the consideration received in connection with the Series F Private Placement was first allocated to the warrant liability at fair value, with the remainder allocated to the preferred stock, which led to a discount ascribed to the Series F Preferred Stock. Accordingly, the Company recorded a discount of $14.6 million on the Series F Preferred Stock by adjusting Additional paid-in capital.

The following schedule shows the fair value of the warrant liability upon issuance, and the change in fair value during the periods ended June 30, 2021 and December 31, 2020 (in thousands):

	Warrant liability
Issuance of Series F warrants	$	14,952
Change in fair value of  warrant liability	24,898
Balance as of December 31, 2020	$	39,850
Change in fair value of warrant liability	(22,873)
Balance as of June 30, 2021	$	16,977

The following schedule shows the inputs used to measure the fair value of the warrant liability:

Warrant Liability	June 30, 2021	December 31, 2020
Stock Price	$4.30	$7.62
Exercise Price	$4.50	$4.50
Expected remaining term (in years)	5.25 - 5.31	5.75 - 5.81
Volatility	60.0%	67.5%
Risk-free interest rate	0.92%	0.5%

The valuation of the warrants is subject to uncertainty as a result of the unobservable inputs. If the volatility rate or risk-free interest rate were to change, the value of the warrants would be impacted.

Equity-classified warrants

On May 6, 2019, the Company issued 957,499 warrants to purchase common stock with an exercise price of $25.50 (the "May 2019 PIPE Warrants"). Additionally, in connection with the May 2019 PIPE transaction, the Company issued 36,757 warrants to brokers with an exercise price of $18.00. The warrants were exercisable commencing on the issuance date and expire 24 months after the issuance date. In March 2021, the Company offered to a limited number of holders the opportunity to exercise, in full or in part, these warrants to purchase shares of Common Stock at a reduced exercise price of $7.50 per share. The Company received exercise notices for a total of 174,602 warrants, resulting in the Company’s receipt of approximately $1.3 million. The Company recognized the increase in the fair value of the modified warrants on the date of exercise of $0.2 million as a deemed dividend through Accumulated deficit with a corresponding increase in Additional paid-in capital. The remainder of the outstanding and unexercised May 2019 PIPE Warrants expired during May 2021.

On November 4, 2019, the Company issued 1,834 warrants in connection with the November 2019 Notes. The warrants are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of an IPO, which commenced on June 29, 2021. The warrants carried an initial exercise price equal to the greater of (i) $30.00 per share or (ii) the price at which the common stock of the Company was sold in the IPO.

On December 19, 2019 the Company issued 1,083,334 warrants with an exercise price of $10.92 in conjunction with the term loan (the "Guarantor Warrants"), which are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of an IPO, which commenced on June 29, 2021. The Guarantor Warrants had a fair value of $4.2 million on the date of issuance.

On December 19, 2019, the Company issued 156,250 warrants in connection with the Seller Notes. The warrants are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of an IPO, which commenced on June 29, 2021. The warrants carried an initial exercise price equal to the greater of (i) $30.00 per share or (ii) the price at which the common stock of the Company was sold in the IPO.

On January 13, 2020, the Company issued the ABG Warrants, which are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of an IPO, which commenced on June 29, 2021 and carried an initial exercise price equal to the greater of (i) $30.00 per share or (ii) the price at which the common stock was sold in the IPO.

On June 24, 2020, the warrants related to the November 2019 Notes, the Seller Notes and the ABG Notes were amended in connection with the issuance of the June 2020 Notes to lower the maximum exercise price applicable to these warrants from $30.00 to $25.50 per share. The decrease in the exercise price resulted in an increase to the fair value of the warrants of $0.1 million which the Company recognized in general and administrative expense.

On June 24, 2020, the Company issued 166,667 warrants to a member of the board of directors with an exercise price of $7.50 per share in connection with the June 2020 Notes (the “June 2020 Warrants”), which are exercisable commencing on the date of issuance and expire 84 months from the date of the consummation of an IPO, which commenced on June 29, 2021.

On July 20, 2020, the Company issued 50,000 warrants to a member of the board of directors with an exercise price of $6.30 per share in consideration for a personal guarantee by a member of the Company's board of directors on the ABL Facility (the "July 2020 Guarantor Warrants"), which are exercisable commencing on the date of issuance and expire 84 months from the date of the consummation of an IPO, which commenced on June 29, 2021.

On January 22, 2021, the Company issued 548,067 warrants in connection with the January 2021 PIPE transaction. The warrants are exercisable at an exercise price per share of $8.70 commencing on the date of issuance and expire after a six year period, subject to beneficial ownership limitations (the “January 2021 Warrants”). Due to the discounted warrant exercise associated with the May 2019 PIPE warrants as discussed above, the down round provision on the January 2021 Warrants was triggered such that these warrants could be exercised at a price of $7.50 per share. The Company recognized the increase in the fair value of the modified warrants of $0.2 million as a deemed dividend through Accumulated deficit with a corresponding increase in Additional paid-in capital.

Warrants issued as compensation

On September 17, 2019, a Company advisor was issued 416,667 warrants with an exercise price of $0.60 per share and 250,000 warrants with an exercise price of $60.00 per share; 208,334 of the $0.60 exercise price warrants (the "Tranche 1 Warrants") were exercisable on the earlier of twelve-months after issuance date or immediately prior to a change in control subject to the advisor’s continued service and 208,334 of the $0.60 exercise price warrants (the "Tranche 2 Warrants") and the 250,000 warrants with the $60.00 exercise price (the "Tranche 3 Warrants") were exercisable on the earlier of eighteen-months after issuance or immediately prior to a change in control subject to the advisor’s continued service.

On June 1, 2020, the Company entered into a termination agreement (the “Termination Agreement”) with the advisor. Pursuant to the terms of the Termination Agreement, the Tranche 1 Warrants were amended to reduce the number of shares of common stock purchasable thereunder to 173,611 shares, and the Tranche 2 Warrants and Tranche 3 Warrants were cancelled. The Tranche 1 Warrants (as amended pursuant to the Termination Agreement) were fully vested as of the date of the termination of the agreement and will remain exercisable until September 17, 2029. Furthermore, if the Company engages in any restricted business line as defined in the Termination Agreement, the Company will issue to the former advisor additional shares of common stock based on formulas intended to compensate the former advisor for the warrants that were reduced or terminated. In connection with the Termination Agreement, the Company recorded expense of $5.7 million during the year ended December 31, 2020 in general and administrative expense. During the first quarter of 2021, the former advisor exercised 131,945 of his remaining warrants outstanding in a cashless exercise resulting in 122,782 shares of common stock issued.

On June 24, 2020, the Company issued 166,667 warrants with an exercise price of $7.50 per share to two non-employee directors, which are exercisable commencing on the date of issuance and expire 84 months from the date of the consummation of an IPO, which commenced on June 29, 2021. On July 20, 2020, the Company issued 33,334 warrants to two non-employee directors at a price of $6.30 per share (the "July 2020 Director Warrants"), which are exercisable commencing on the date of issuance and expire 84 months from the date of the consummation of an IPO, which commenced on June 29, 2021. The warrants issued to the non-employee directors were immediately vested and as such, the Company recorded $1.0 million of share-based compensation expense upon issuance.

On November 30, 2020, the Company issued 66,667 warrants to a third-party for services with an exercise price of $6.00 and an expiration date 72 months after issuance. These warrants were immediately vested and as such, the Company recorded $0.1 million in general and administrative expense.

XML

Share-based compensation

6 Months Ended

Jun. 30, 2021

Share-based Payment Arrangement [Abstract]

Share-based compensation

Share-based compensation

During the three and six months ended June 30, 2021 the Company recognized $0.3 million and $2.9 million, respectively, of share-based compensation expense. During the three and six months ended June 30, 2020, the Company recognized $3.0 million and $5.5 million, respectively, of share-based compensation expense.

On November 11, 2019, the Company received shareholder approval for the Amended and Restated 2019 Incentive Award Plan (the “Amended 2019 Plan”). The Amended 2019 Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, other stock or cash-based awards or a dividend equivalent award. The Amended 2019 Plan authorized the issuance 1,083,334 shares of common stock which was increased to 1,500,000 after the Halo acquisition; the Amended 2019 Plan also provides for an annual increase on the first day of each calendar year beginning on January 1, 2021 and ending on and including January 1, 2029, equal to the lesser of (A) 10% of the shares of common stock outstanding (on an as-converted basis) on the last day of the immediately preceding fiscal year and (B) such smaller number of shares of common stock as determined by the Board. The total number of shares currently authorized for issuance under the Amended 2019 Plan is 2,700,000.

Stock options

During the six months ended June 30, 2021 and June 30, 2020, the Company granted 955,688 and 50,002 stock options, respectively. During the three months ended June 30, 2021 and June 30, 2020, the Company granted 25,834 and 33,334 stock options, respectively.

Restricted stock

In March 2020, the Company issued 75,000 shares of restricted common stock to three non-employee directors in return for services provided in their capacity as directors and issued 993 restricted shares of common stock to an officer of the Company. The restricted shares were immediately vested and as such, the Company recorded share-based compensation expense of $0.5 million upon issuance.

XML

Income taxes	6 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income taxes	Income taxesFor the three and six months ended June 30, 2021, and June 30, 2020, the Company recorded no income tax expense. For the three and six months ended June 30, 2021 and June 30, 2020, the Company’s effective tax rate was 0%. The Company’s effective tax rate of 0% differs from the United States federal statutory rate of 21% due to permanent differences attributable to the change in the fair value of the warrant liabilities and because the Company’s losses have been fully offset by a valuation allowance due to uncertainty of realizing the tax benefit of net operating losses ("NOLs”) for the six months ended June 30, 2021, and year ended December 31, 2020.

XML

Concentrations

6 Months Ended

Jun. 30, 2021

Risks and Uncertainties [Abstract]

Concentrations

Concentrations

Major suppliers

The Company sourced approximately 68% of its inventory purchases from two vendors for the six months ended June 30, 2021. The Company sourced approximately 77% of its inventory purchases from three vendors for the six months ended June 30, 2020.

Major customers

Accounts receivable from three customers represented 72% of accounts receivable as of June 30, 2021. Accounts receivable from two customers represented 72% of accounts receivable as of December 31, 2020. Three customers represented 50% of gross sales for the six months ended June 30, 2021. Two customers represented 39% of gross sales for the six months ended June 30, 2020. 

Credit risk

At June 30, 2021 and December 31, 2020, the Company’s cash and cash equivalents were deposited in accounts at several financial institutions and may maintain some balances in excess of federally insured limits. The Company maintains its cash and cash equivalents with high-quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses historically in these accounts and believes it is not exposed to significant credit risk in its cash and cash equivalents.

XML

Net income (loss) per share

6 Months Ended

Jun. 30, 2021

Earnings Per Share [Abstract]

Net income (loss) per share

Net income (loss) per share

The Company presents earnings (loss) per share on a basic and diluted basis. Basic earnings (loss) per share is computed by dividing net and comprehensive income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share includes the dilutive effect of common stock equivalents, consisting of stock options and warrants using the treasury stock method and convertible notes and preferred stock using the if-converted method. Under the treasury stock method, the amount the holder must pay for exercising stock options or warrants and the amount of average compensation cost for future service that has not yet been recognized are collectively assumed to be used to repurchase shares.

As the Company reported net income for the three and six months ended June 30, 2021, basic and diluted earnings per share are calculated as outlined above. For the three and six months ended June 30, 2021, the weighted average diluted common shares had 3,471,245 and 4,474,577 common stock equivalents excluded, respectively, based on the fact that their inclusion would have had an anti-dilutive effect on earnings per share. For the three and six months ended June 30, 2020, the Company’s basic and diluted net and comprehensive loss per share attributable to common stockholders are the same because the Company generated a net loss and common stock equivalents are excluded from diluted net loss per share as they have an antidilutive impact.

The following table sets forth basic and diluted net income (loss) per share attributable to common stockholders for the three and six months ended June 30, 2021 and 2020 (in thousands, except share and per share amounts):

	Six Months Ended June 30,				Three Months Ended June 30,
Common stockholders	2021		2020		2021		2020
Basic net income (loss) per share:
Numerator:
Net and comprehensive income (loss)	$	11,926	$	(27,858)	$	24,776	$	(18,404)
Less: Preferred stock dividends	—		68		—		34
Less: Adjustment due to warrant modifications	402		—		—		—
Adjusted net and comprehensive income (loss) available to common stockholders	$	11,524	$	(27,926)	$	24,776	$	(18,438)
Denominator:
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, basic	10,361,462		8,122,176		11,126,909		8,156,618
Net earnings (loss) per share attributable to common stockholders, basic	$	1.11	$	(3.44)	$	2.23	$	(2.26)
Dilutive net income (loss) per share:
Numerator:
Net and comprehensive income (loss)	$	11,926	$	(27,858)	$	24,776	$	(18,404)
Less: Preferred stock dividends	—		68		—		34
Less: Adjustment due to warrant modifications	402		—		—		—
Add: Interest expense on convertible notes, net	—		—		656		—
Adjusted net and comprehensive income (loss) available to common stockholders	$	11,524	$	(27,926)	$	25,432	$	(18,438)
Denominator:
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, diluted	20,498,829		8,122,176		21,389,413		8,156,618
Net earnings (loss) per share attributable to common stockholders, diluted	$	0.56	$	(3.44)	$	1.19	$	(2.26)

XML

Nature of business and summary of significant accounting policies (Policies)

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Basis of presentation

Basis of presentation

The Company’s condensed consolidated financial statements are prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reports and accounting principles generally accepted in the United States ("GAAP"). Results of operations for interim periods may not be representative of results to be expected for the full year.

Certain reclassifications have been made to conform the prior period data to the current presentation. These reclassifications had no material effect on the reported results.

These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company’s Annual Report for the year ended December 31, 2020, filed with the SEC.

Consolidation

Consolidation

The financial statements are presented on a consolidated basis subsequent to acquisitions and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Use of estimates

Use of estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.

In the opinion of management, the condensed consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations and comprehensive income (loss) for the periods ended June 30, 2021 and 2020, the financial position as of June 30, 2021 and December 31, 2020 and the cash flows for the periods ended June 30, 2021 and 2020.

New accounting standards

New accounting standards

Recently adopted

ASU 2020-03 “Codification Improvements to Financial Instruments”

In March 2020, FASB issued Accounting Standards Update ("ASU") 2020-03, Codification Improvement to Financial Instruments. This ASU improves and clarifies various financial instruments topics, including the current expected credit losses standard issued in 2016. The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments have different effective dates, some of which were effective for the Company beginning on January 1, 2021. The amendments adopted did not have a material impact on the Company’s condensed consolidated financial statements.

ASU 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This new guidance was effective for the Company beginning on January 1, 2021 and did not have an impact on the Company’s condensed consolidated financial statements.

Issued but not yet adopted

ASU 2016-13 “Financial Instruments – Credit Losses (Topic 326)”

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326),” a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard is effective for the Company on January 1, 2023, and early adoption is permitted. The Company is currently evaluating the impact the new standard will have on its consolidated financial statements.

ASU 2020-04 “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting”

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional expedient and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. In response to the concerns about structural risks of interbank offered rates (IBORs) and, particularly, the risk of cessation of the London Interbank Offered Rate (LIBOR), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is currently evaluating the impact the standard will have on its consolidated financial statements and related disclosures.

ASU 2020-06 "Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

In August 2020, FASB issued ASU 2020-06, Debt - Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Accounting for Convertible Instruments and Contracts in an Entity's Own Equity. This ASU reduces the number of accounting models for convertible instruments, amends diluted EPS calculations for convertible instruments, and amends the requirements for a contract (or embedded derivative) that is potentially settled in an entity’s own shares to be classified in equity. This standard is effective for the Company beginning on January 1, 2024 with early adoption permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

XML

Nature of business and summary of significant accounting policies (Tables)

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Pro Forma Information

The following unaudited pro forma condensed consolidated balance sheet data is presented as if the IPO closed on June 30, 2021, by applying adjustments to the Company’s condensed consolidated balance sheet. It reflects (1) the issuance of 8,000,000 shares of common stock for estimated net proceeds of $36.2 million (of which $0.9 million of offering costs were already included in the June 30, 2021 current asset balance), (2) the conversion of all Series F convertible preferred stock into an aggregate of 5,764,533 shares of common stock and (3) the reclassification of the Series F Warrant liability to equity:

	Actual		Pro Forma Adjustments		Pro Forma
	June 30, 2021				June 30, 2021
Assets
Total Current Assets	$	17,859	$	36,168	$	54,027
Total Non-Current assets	31,321		—		31,321
Total Assets	$	49,180	$	36,168	$	85,348
Liabilities & Stockholders’ Equity (Deficit)
Total Liabilities	$	34,920	$	(16,977)	$	17,943
Common Stock	16		14		30
Series F Preferred Stock	—		—		—
Additional paid-in capital	263,361		53,131		316,492
Accumulated deficit	(249,117)		—		(249,117)
Total Stockholders’ Equity (Deficit)	14,260		53,145		67,405
Total Liabilities and Stockholders’ Equity (Deficit)	$	49,180	$	36,168	$	85,348

XML

Revenue (Tables)

6 Months Ended

Jun. 30, 2021

Revenue from Contract with Customer [Abstract]

Information about Revenue Channels

Information about the Company’s net sales by revenue channel is as follows (in thousands):

	Six Months Ended June 30,								Three Months Ended June 30,
	2021				2020				2021				2020
E-commerce	$	6,902	32	%	$	7,459	34	%	$	2,892	26	%	$	2,978	30	%
Brick & Mortar	3,592		16	%	4,772		22	%	1,698		16	%	1,875		19	%
DTC	4,777		22	%	5,526		25	%	2,341		21	%	2,722		27	%
International	6,548		30	%	4,410		19	%	4,058		37	%	2,366		24	%
Net Sales	$	21,819	100	%	$	22,167	100	%	$	10,989	100	%	$	9,941	100	%

XML

Inventories (Tables)

6 Months Ended

Jun. 30, 2021

Inventory Disclosure [Abstract]

Inventories

Inventories are summarized as follows (in thousands):

	June 30, 2021		December 31, 2020
Food, treats and supplements	$	5,129	$	4,987
Inventory packaging and supplies	499		596
Total Inventories	5,628		5,583
Inventory reserve	(427)		(714)
Inventories, net	$	5,201	$	4,869

XML

Prepaid expenses and other current assets (Tables)

6 Months Ended

Jun. 30, 2021

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Prepaid expenses and other current assets

	June 30, 2021		December 31, 2020
Prepaid advertising contract with iHeart (1)	$	2,985	$	1,788
Other prepaid expenses and other current assets (2)	1,055		2,286
Total Prepaid expenses and other current assets	$	4,040	$	4,074

(1) On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. and issued 166,667 shares of common stock valued at $3.4 million for future advertising services. The Company issued an additional 20,834 shares valued at $0.1 million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that the Company expects to utilize within the twelve months following the reporting period date, unless the term is extended. There was a long-term portion of $1.2 million recorded in other non-current assets as of December 31, 2020.

(2) As of June 30, 2021, this amount includes various other prepaid contracts. In December 2020, the Company entered into an agreement for access to an investment platform in exchange for 83,334 shares of common stock valued at $0.6 million and also entered into an agreement for marketing services in exchange for 83,334 shares of common stock valued at $0.5 million, both of which are being amortized over 12 months.

XML

Accrued and other liabilities (Tables)

6 Months Ended

Jun. 30, 2021

Payables and Accruals [Abstract]

Accrued and Other Liabilities

Accrued and other liabilities consist of the following (in thousands):

	June 30, 2021		December 31, 2020
Accrued professional fees	$	503	$	704
Accrued sales tax	215		1,009
Accrued payroll and benefits	1,018		913
Accrued trade promotions	57		106
Accrued interest	24		86
Deferred revenue	257		350
Other	157		232
Total accrued liabilities	$	2,231	$	3,400

XML

Intangible assets, royalties, and goodwill (Tables)

6 Months Ended

Jun. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of intangible assets

The Company’s intangible assets (in thousands) and related useful lives (in years) are as follows:

				June 30, 2021				December 31, 2020
	Estimated useful life	Gross carrying amount		Accumulated amortization		Net carrying amount		Accumulated amortization		Net carrying amount
Customer relationships	7	$	7,190	$	(1,574)	$	5,616	$	(1,059)	$	6,131
Trade name	15	7,500		(766)		6,734		(516)		6,984
Total intangible assets		$	14,690	$	(2,340)	$	12,350	$	(1,575)	$	13,115

Schedule of future amortization of intangible assets

The estimated future amortization of intangible assets over the remaining weighted average useful life of 9.8 years is as follows (in thousands):

Remainder of 2021	$	764
2022	1,527
2023	1,527
2024	1,527
2025	1,527
Thereafter	5,478
	$	12,350

There were no indicators or impairment of the intangible assets as of June 30, 2021.

XML

Debt (Tables)

6 Months Ended

Jun. 30, 2021

Debt Disclosure [Abstract]

Components of debt

The components of the Company’s debt consist of the following (in thousands):

Dollars in thousands	June 30, 2021					December 31, 2020
	Amount		Rate		Maturity Date	Amount		Rate		Maturity Date
Term loan, net	$	5,703	(1)		1/6/2024	$	7,826	(2)		1/15/2021
Line of credit, net	5,157		(1)		1/6/2024	5,023		(3)		7/5/2022
November 2019 notes payable, net (November 2019 Notes)	—		10	%	6/30/2023	2,830		10	%	6/30/2023
December 2019 senior notes payable, net (Senior Seller Notes)	—		10	%	6/30/2023	10,332		10	%	6/30/2023
December 2019 junior notes payable, net (Junior Seller Notes)	—		10	%	6/30/2023	4,973		10	%	6/30/2023
ABG Notes	—		10	%	6/30/2023	687		10	%	6/30/2023
June 2020 notes payable, net (June 2020 Notes)	—		10	%	6/30/2023	88		10	%	6/30/2023
Halo PPP Loan	—		1	%	5/3/2022	431		1	%	5/3/2022
TruPet PPP Loan	—		0.98	%	4/6/2022	421		0.98	%	4/6/2022
Total debt	10,860					32,611
Less current portion	926					8,016
Total long term debt	$	9,934				$	24,595

(1)Interest at a variable rate of LIBOR plus 250 basis points with an interest rate floor of 2.50% per annum

(2)Interest at Bank of Montreal Prime plus 8.05%

(3)Interest at a variable rate of LIBOR plus 250 basis points with an interest rate floor of 3.25% per annum

XML

Stockholders' equity (deficit) (Tables)

6 Months Ended

Jun. 30, 2021

Stockholders' Equity Note [Abstract]

Common Stock Reserved for Future Issuance

The Company has reserved common stock for future issuance as follows:

	June 30, 2021	December 31, 2020
Conversion of Series F Preferred Stock	5,764,533	7,251,189
Exercise of options to purchase common stock	2,200,244	1,302,574
Exercise of warrants to purchase common stock	9,433,584	9,916,997
Conversion of notes payable	—	1,255,039
Total	17,398,361	19,725,799

XML

Warrants (Tables)

6 Months Ended

Jun. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Activity of Warrants

The following summarizes the Company's outstanding warrants to purchase shares of the Company's common stock as of and for the periods ended June 30, 2021 and December 31, 2020:

	Warrants	Exercise Price
Warrants outstanding as of December 31, 2019	2,830,309	$	19.38
Issued	8,321,412	$	4.62
Exercised	(322,949)	$	3.48
Terminated/Expired	(911,776)	$	18.42
Warrants outstanding as of December 31, 2020	9,916,996	$	7.32
Issued	548,111	$	8.70
Exercised	(389,881)	$	4.52
Terminated/Expired	(641,642)	$	24.64
Warrants outstanding as of June 30, 2021	9,433,584	$	5.92

The following schedule shows the fair value of the warrant derivative liability as of June 30, 2021 and December 31, 2020, and the change in fair value during the periods ended June 30, 2021 and year ended December 31, 2020 (in thousands):

	Warrant Derivative Liability
Balance as of December 31, 2019	$	2,220
Change in fair value of  warrant derivative liability	(2,220)
Balance as of December 31, 2020	$	—
Change in fair value of  warrant derivative liability (1)	—
Balance as of June 30, 2021	$	—

(1) All of the May Acquisition Warrants expired during January 2021.

The following schedule shows the fair value of the warrant liability upon issuance, and the change in fair value during the periods ended June 30, 2021 and December 31, 2020 (in thousands):

	Warrant liability
Issuance of Series F warrants	$	14,952
Change in fair value of  warrant liability	24,898
Balance as of December 31, 2020	$	39,850
Change in fair value of warrant liability	(22,873)
Balance as of June 30, 2021	$	16,977

Schedule of fair value measurement inputs

The following schedule shows the inputs used to measure the fair value of the warrant liability:

Warrant Liability	June 30, 2021	December 31, 2020
Stock Price	$4.30	$7.62
Exercise Price	$4.50	$4.50
Expected remaining term (in years)	5.25 - 5.31	5.75 - 5.81
Volatility	60.0%	67.5%
Risk-free interest rate	0.92%	0.5%

XML

Net income (loss) per share (Tables)

6 Months Ended

Jun. 30, 2021

Earnings Per Share [Abstract]

Basic and Diluted Net Loss per Share Attributable to Common Stockholders

The following table sets forth basic and diluted net income (loss) per share attributable to common stockholders for the three and six months ended June 30, 2021 and 2020 (in thousands, except share and per share amounts):

	Six Months Ended June 30,				Three Months Ended June 30,
Common stockholders	2021		2020		2021		2020
Basic net income (loss) per share:
Numerator:
Net and comprehensive income (loss)	$	11,926	$	(27,858)	$	24,776	$	(18,404)
Less: Preferred stock dividends	—		68		—		34
Less: Adjustment due to warrant modifications	402		—		—		—
Adjusted net and comprehensive income (loss) available to common stockholders	$	11,524	$	(27,926)	$	24,776	$	(18,438)
Denominator:
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, basic	10,361,462		8,122,176		11,126,909		8,156,618
Net earnings (loss) per share attributable to common stockholders, basic	$	1.11	$	(3.44)	$	2.23	$	(2.26)
Dilutive net income (loss) per share:
Numerator:
Net and comprehensive income (loss)	$	11,926	$	(27,858)	$	24,776	$	(18,404)
Less: Preferred stock dividends	—		68		—		34
Less: Adjustment due to warrant modifications	402		—		—		—
Add: Interest expense on convertible notes, net	—		—		656		—
Adjusted net and comprehensive income (loss) available to common stockholders	$	11,524	$	(27,926)	$	25,432	$	(18,438)
Denominator:
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, diluted	20,498,829		8,122,176		21,389,413		8,156,618
Net earnings (loss) per share attributable to common stockholders, diluted	$	0.56	$	(3.44)	$	1.19	$	(2.26)

XML

Nature of business and summary of significant accounting policies (Details) $ / shares in Units, $ in Thousands					6 Months Ended
	Jul. 01, 2021 $ / shares shares	Jun. 29, 2021 shares	Jun. 28, 2021 shares	May 28, 2021	Jul. 01, 2021 USD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)
Subsidiary, Sale of Stock [Line Items]
Reverse stock split ratio				0.1667
Stock issued in lieu of fractional shares, reverse stock split			1,081
Offering costs | $						$ 19	$ 0
Redeemable Convertible Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Shares issued upon conversion of notes (in shares)		4,732,420
IPO
Subsidiary, Sale of Stock [Line Items]
Offering costs | $						$ 900
Subsequent events | IPO
Subsidiary, Sale of Stock [Line Items]
Number of shares sold	8,000,000
Offering price (in dollars per share) | $ / shares	$ 5.00				$ 5.00
Total net proceeds | $					$ 36,200
Underwriting discounts and commissions | $					2,800
Offering costs | $					$ 1,000
Shares issued upon conversion of preferred stock (in shares)	5,764,533				5,764,533
Subsequent events | Underwriters option
Subsidiary, Sale of Stock [Line Items]
Number of shares sold	0
Underwriters option, term	30 days
Stock issuable (in shares)	1,200,000
Maximum
Subsidiary, Sale of Stock [Line Items]
Reverse stock split ratio				0.3333
Minimum
Subsidiary, Sale of Stock [Line Items]
Reverse stock split ratio				0.10

XML

Nature of business and summary of significant accounting policies - Pro Forma Information (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
Assets
Total Current Assets	$ 17,859		$ 17,563
Total Non-Current assets	31,321
Total Assets	49,180		51,253
Liabilities & Stockholders’ Equity (Deficit)
Total Liabilities	34,920		79,355
Common Stock	16		9
Series F Preferred Stock	0		0
Additional paid-in capital	263,361		232,530
Accumulated deficit	(249,117)		(260,641)
Total Stockholders’ Equity (Deficit)	14,260	$ (32,980)	(28,102)	$ (16,614)	$ (10,657)	$ (7,071)
Total Liabilities and Stockholders’ Equity (Deficit)	49,180		$ 51,253
Pro Forma Adjustments
Assets
Total Current Assets	36,168
Total Non-Current assets	0
Total Assets	36,168
Liabilities & Stockholders’ Equity (Deficit)
Total Liabilities	(16,977)
Common Stock	14
Series F Preferred Stock	0
Additional paid-in capital	53,131
Accumulated deficit	0
Total Stockholders’ Equity (Deficit)	53,145
Total Liabilities and Stockholders’ Equity (Deficit)	36,168
Pro Forma
Assets
Total Current Assets	54,027
Total Non-Current assets	31,321
Total Assets	85,348
Liabilities & Stockholders’ Equity (Deficit)
Total Liabilities	17,943
Common Stock	30
Series F Preferred Stock	0
Additional paid-in capital	316,492
Accumulated deficit	(249,117)
Total Stockholders’ Equity (Deficit)	67,405
Total Liabilities and Stockholders’ Equity (Deficit)	$ 85,348

XML

Revenue - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue Concentration [Abstract]
Revenue	$ 10,989	$ 9,941	$ 21,819	$ 22,167
Shipping costs
Revenue Concentration [Abstract]
Revenue	$ 400	$ 300	$ 900	$ 700

XML

Revenue - Information about Revenue Channels (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Net sales	$ 10,989	$ 9,941	$ 21,819	$ 22,167
Revenue from Contract with Customer Benchmark | Sales Channel Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	100.00%	100.00%	100.00%	100.00%
E-commerce
Disaggregation of Revenue [Line Items]
Net sales	$ 2,892	$ 2,978	$ 6,902	$ 7,459
E-commerce | Revenue from Contract with Customer Benchmark | Sales Channel Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	26.00%	30.00%	32.00%	34.00%
Brick & Mortar
Disaggregation of Revenue [Line Items]
Net sales	$ 1,698	$ 1,875	$ 3,592	$ 4,772
Brick & Mortar | Revenue from Contract with Customer Benchmark | Sales Channel Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	16.00%	19.00%	16.00%	22.00%
DTC
Disaggregation of Revenue [Line Items]
Net sales	$ 2,341	$ 2,722	$ 4,777	$ 5,526
DTC | Revenue from Contract with Customer Benchmark | Sales Channel Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	21.00%	27.00%	22.00%	25.00%
International
Disaggregation of Revenue [Line Items]
Net sales	$ 4,058	$ 2,366	$ 6,548	$ 4,410
International | Revenue from Contract with Customer Benchmark | Sales Channel Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	37.00%	24.00%	30.00%	19.00%

XML

Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Food, treats and supplements	$ 5,129	$ 4,987
Inventory packaging and supplies	499	596
Total Inventories	5,628	5,583
Inventory reserve	(427)	(714)
Inventories, net	$ 5,201	$ 4,869

XML

Prepaid expenses and other current assets (Details) - USD ($) $ in Thousands			1 Months Ended	3 Months Ended
	Mar. 05, 2020	Aug. 28, 2019	Dec. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2021
Prepaid Expenses and Other Current Assets [Line Items]
Prepaid advertising contract with iHeart			$ 1,788			$ 2,985
Other prepaid expenses and other current assets			2,286			1,055
Total Prepaid expenses and other current assets			4,074			$ 4,040
Shares issued to third parties for services				$ 46	$ 125
Other Noncurrent Assets | IHeartMedia
Prepaid Expenses and Other Current Assets [Line Items]
Prepaid advertising contract with iHeart			$ 1,200
Common Stock
Prepaid Expenses and Other Current Assets [Line Items]
Stock issued to third parties for services (in shares)				5,000	20,833
Common Stock | IHeartMedia
Prepaid Expenses and Other Current Assets [Line Items]
Stock issued to third parties for services (in shares)	20,834	166,667
Shares issued to third parties for services	$ 100	$ 3,400
Common Stock | Other Counterparty | Access to investment platform
Prepaid Expenses and Other Current Assets [Line Items]
Stock issued to third parties for services (in shares)			83,334
Shares issued to third parties for services			$ 600
Common Stock | Other Counterparty | Marketing services
Prepaid Expenses and Other Current Assets [Line Items]
Stock issued to third parties for services (in shares)			83,334
Shares issued to third parties for services			$ 500

XML

Accrued and other liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Accrued Liabilities Current [Abstract]
Accrued professional fees	$ 503	$ 704
Accrued sales tax	215	1,009
Accrued payroll and benefits	1,018	913
Accrued trade promotions	57	106
Accrued interest	24	86
Deferred revenue	257	350
Other	157	232
Total accrued liabilities	$ 2,231	$ 3,400

XML

Intangible assets, royalties, and goodwill - Additional information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 400,000	$ 400,000	$ 800,000	$ 800,000
Goodwill	18,614,000		18,614,000		$ 18,614,000
Goodwill, accumulated impairment loss	$ 0		0
Goodwill, impairment expense			$ 0
Weighted Average
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives of intangible assets			9 years 9 months 18 days

XML

Intangible assets, royalties, and goodwill - Intangible assets (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 14,690	$ 14,690
Accumulated amortization	(2,340)	(1,575)
Net carrying amount	$ 12,350	13,115
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Estimated useful life	7 years
Gross carrying amount	$ 7,190	7,190
Accumulated amortization	(1,574)	(1,059)
Net carrying amount	$ 5,616	6,131
Trade name
Finite-Lived Intangible Assets [Line Items]
Estimated useful life	15 years
Gross carrying amount	$ 7,500	7,500
Accumulated amortization	(766)	(516)
Net carrying amount	$ 6,734	$ 6,984

XML

Intangible assets, royalties, and goodwill - Estimated future amortization of amortizable intangible assets (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Remainder of 2021	$ 764
2022	1,527
2023	1,527
2024	1,527
2025	1,527
Thereafter	5,478
Net carrying amount	$ 12,350	$ 13,115

XML

Debt - Components of debt (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020	Jun. 24, 2020	Nov. 04, 2019
Debt Instruments [Abstract]
Long term debt	$ 10,860	$ 32,611
Less current portion	926	8,016
Total long term debt	9,934	24,595
Line of credit, net
Debt Instruments [Abstract]
Long term debt	$ 5,157	$ 5,023
Basis spread on variable interest rate	2.50%
Floor interest rate	2.50%	3.25%
Term loan, net
Debt Instruments [Abstract]
Long term debt	$ 5,703	$ 7,826
Basis spread on variable interest rate	2.50%
Floor interest rate	2.50%
Bank of Montreal Prime | Term loan, net
Debt Instruments [Abstract]
Basis spread on variable interest rate		8.05%
LIBOR | Line of credit, net
Debt Instruments [Abstract]
Basis spread on variable interest rate		2.50%
November 2019 notes payable, net (November 2019 Notes)
Debt Instruments [Abstract]
Long term debt	$ 0	$ 2,830
Rate	10.00%	10.00%		10.00%
December 2019 notes payable, net (Senior Seller Notes)
Debt Instruments [Abstract]
Long term debt	$ 0	$ 10,332
Rate	10.00%	10.00%
December 2019 notes payable, net (Junior Seller Notes)
Debt Instruments [Abstract]
Long term debt	$ 0	$ 4,973
Rate	10.00%	10.00%
ABG notes payable, net (ABG Notes)
Debt Instruments [Abstract]
Long term debt	$ 0	$ 687
Rate	10.00%	10.00%
June 2020 notes payable, net (June 2020 Notes)
Debt Instruments [Abstract]
Long term debt	$ 0	$ 88
Rate	10.00%	10.00%	10.00%
Halo PPP Loan
Debt Instruments [Abstract]
Long term debt	$ 0	$ 431
Rate	1.00%	1.00%
TruPet PPP Loan
Debt Instruments [Abstract]
Long term debt	$ 0	$ 421
Rate	0.98%	0.98%

XML

Debt - Term loan and line of credit (Details)					3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 06, 2021 USD ($)	Oct. 29, 2020 USD ($)	Oct. 05, 2020 USD ($)	Jul. 16, 2020 USD ($)	Jun. 30, 2021 USD ($) $ / shares	Jun. 30, 2020 USD ($)	Jun. 30, 2021 USD ($) $ / shares	Jun. 30, 2020 USD ($)	Dec. 31, 2020 USD ($)	Dec. 19, 2019 USD ($)
Debt Instruments [Abstract]
Gain on extinguishment of debt, net					$ (851,000)	$ 0	$ (457,000)	$ 0
Debt issuance costs incurred							116,000	$ 0
Long term debt					$ 10,860,000		10,860,000		$ 32,611,000
Short-term debt
Debt Instruments [Abstract]
Maximum borrowing capacity										$ 20,500,000
Repayments of debt		$ 1,000,000.0	$ 11,000,000.0
Revolving Credit Agreement
Debt Instruments [Abstract]
Maximum borrowing capacity										$ 7,500,000
Line of credit, net
Debt Instruments [Abstract]
Gain on extinguishment of debt, net							(400,000)
Line of credit, net | Old Plank Trail Community Bank, N.A.
Debt Instruments [Abstract]
Maximum borrowing capacity	$ 6,000,000.0
Debt issuance costs incurred							$ 100,000
Floor interest rate					2.50%		2.50%
Fixed Charge Coverage Ratio	1.25
Term Loan | Old Plank Trail Community Bank, N.A.
Debt Instruments [Abstract]
Maximum borrowing capacity	$ 6,000,000.0
Line of credit, net
Debt Instruments [Abstract]
Basis spread on variable interest rate							2.50%
Floor interest rate					2.50%		2.50%		3.25%
Long term debt					$ 5,157,000		$ 5,157,000		$ 5,023,000
Shareholder Guaranties
Debt Instruments [Abstract]
Guaranty obligations					$ 20,000,000.0		$ 20,000,000.0
Warrants per share (in dollars per share) | $ / shares					$ 0.055		$ 0.055
Facilities Agreement
Debt Instruments [Abstract]
Repayment of line of credit				$ 5,100,000
Facilities Agreement | Term loan, net
Debt Instruments [Abstract]
Long term debt					$ 5,700,000		$ 5,700,000		7,800,000
Debt issuance costs and discounts					100,000		100,000		200,000
Facilities Agreement | Line of credit, net
Debt Instruments [Abstract]
Gain on extinguishment of debt, net				100,000
Long term debt					$ 5,200,000		$ 5,200,000		5,000,000.0
Debt issuance costs and discounts									$ 200,000
ABL Facility | Line of credit, net
Debt Instruments [Abstract]
Maximum borrowing capacity				7,500,000
Debt issuance costs incurred				$ 100,000
Floor interest rate					3.25%		3.25%
LIBOR | Line of credit, net | Old Plank Trail Community Bank, N.A.
Debt Instruments [Abstract]
Basis spread on variable interest rate							2.50%
LIBOR | Line of credit, net
Debt Instruments [Abstract]
Basis spread on variable interest rate									2.50%
LIBOR | ABL Facility | Line of credit, net
Debt Instruments [Abstract]
Basis spread on variable interest rate							2.50%

XML

Debt - Notes payable (Details) - USD ($)					3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 24, 2020	Jan. 13, 2020	Nov. 14, 2019	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 19, 2019	Nov. 04, 2019
Debt Instruments [Abstract]
Debt outstanding	$ 10,860,000				$ 10,860,000		$ 10,860,000		$ 32,611,000
Common stock or units, issued (in shares)	15,821,559				15,821,559		15,821,559		8,651,400
Accretion of debt discount	$ 1,400,000
Notes payable, net	$ 0				$ 0		$ 0		$ 18,910,000
Licensing arrangement
Debt Instruments [Abstract]
Termination fee paid			$ 100,000
Common stock or units, issued (in shares)			12,120
Termination fee payable			$ 100,000
Common stock purchase warrant issuable			200,000
November 2019 Notes
Debt Instruments [Abstract]
Default interest rate				12.00%
Subordinated convertible notes | Executive Officer
Debt Instruments [Abstract]
Notes payable, net										$ 100,000
Interest expense (less than)					$ 100,000	$ 100,000	$ 100,000	$ 100,000
Subordinated convertible notes | Director
Debt Instruments [Abstract]
Notes payable, net										$ 2,200,000
November 2019 Notes
Debt Instruments [Abstract]
Face amount												$ 2,800,000
Long-term debt, interest rate	10.00%				10.00%		10.00%		10.00%			10.00%
Conversion price (in dollars per share)	$ 5.00	$ 22.50			$ 5.00		$ 5.00					$ 24.00
Increase in fair value, adjustment to paid in capital		$ 300,000
Debt outstanding	$ 0				$ 0		$ 0		$ 2,830,000
Debt issuance costs and discounts									$ 300,000
Seller Notes
Debt Instruments [Abstract]
Long-term debt, interest rate											10.00%
Conversion price (in dollars per share)		$ 22.50									$ 24.00
Increase in fair value, adjustment to paid in capital		$ 300,000
Senior Seller Notes
Debt Instruments [Abstract]
Face amount											$ 10,000,000.0
Long-term debt, interest rate	10.00%				10.00%		10.00%		10.00%
Conversion price (in dollars per share)	$ 5.00				$ 5.00		$ 5.00
Debt outstanding	$ 0				$ 0		$ 0		$ 10,332,000
Debt issuance costs and discounts									$ 800,000
Junior Seller Notes
Debt Instruments [Abstract]
Face amount											$ 5,000,000.0
Long-term debt, interest rate	10.00%				10.00%		10.00%		10.00%
Debt outstanding	$ 0				$ 0		$ 0		$ 4,973,000
Debt issuance costs and discounts									$ 500,000
ABG Notes
Debt Instruments [Abstract]
Face amount			$ 600,000
Long-term debt, interest rate	10.00%				10.00%		10.00%		10.00%
Conversion price (in dollars per share)	$ 5.00	$ 22.50	$ 24.00		$ 5.00		$ 5.00
Increase in fair value, adjustment to paid in capital		$ 100,000
Debt outstanding	$ 0				$ 0		$ 0		$ 687,000
Debt issuance costs and discounts	$ 100,000				$ 100,000		$ 100,000		$ 100,000
ABG Notes | Licensing arrangement
Debt Instruments [Abstract]
Long-term debt, interest rate			10.00%
June 2020 Notes
Debt Instruments [Abstract]
Face amount		$ 1,500,000
Long-term debt, interest rate	10.00%	10.00%			10.00%		10.00%		10.00%
Conversion price (in dollars per share)	$ 4.50	$ 4.50			$ 4.50		$ 4.50
Debt outstanding	$ 0				$ 0		$ 0		$ 88,000
Debt issuance costs and discounts	$ 1,500,000				$ 1,500,000		$ 1,500,000		$ 1,500,000

XML

Debt - PPP loans (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	May 07, 2020	Apr. 10, 2020
Debt Instrument [Line Items]
Debt outstanding	$ 10,860,000		$ 10,860,000		$ 32,611,000
Interest expense	2,200,000	$ 2,400,000	3,100,000	$ 4,700,000
Gain on extinguishment of debt	$ 851,000	$ 0	$ 457,000	$ 0
TruPet PPP Loan
Debt Instrument [Line Items]
Face amount							$ 400,000
Long-term debt, interest rate	0.98%		0.98%		0.98%
Debt outstanding	$ 0		$ 0		$ 421,000
Gain on extinguishment of debt	$ 400,000
Halo PPP Loan
Debt Instrument [Line Items]
Face amount						$ 400,000
Long-term debt, interest rate	1.00%		1.00%		1.00%
Debt outstanding	$ 0		$ 0		$ 431,000
Gain on extinguishment of debt	$ 400,000

XML

Commitments and contingencies (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Purchase obligations	$ 0	$ 0

XML

Convertible preferred stock (Details) - USD ($) $ / shares in Units, $ in Thousands				1 Months Ended	3 Months Ended
	Oct. 23, 2020	Oct. 12, 2020	Oct. 01, 2020	Oct. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 17, 2020	Dec. 19, 2019	Nov. 04, 2019
Subsidiary, Sale of Stock [Line Items]
Stated value (in dollars per share)							$ 0.001	$ 0.001
Common stock, par value (in dollars per share)							$ 0.001	$ 0.001
Term of warrants												24 months	24 months
Warrants, exercise price (in dollars per share)									$ 3.90	$ 4.50	$ 9.72	$ 30.00	$ 30.00
Preferred stock, authorized (in shares)							30,000	30,000
Stock issued during period					$ 4,072	$ 500
Series F Unit
Subsidiary, Sale of Stock [Line Items]
Stock issued during period (in shares)			14,264
Series F Unit | Cavalry
Subsidiary, Sale of Stock [Line Items]
Stock issued during period (in shares)			3,500
Series F Convertible Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, authorized (in shares)			30,000
Stock issued during period (in shares)	100
Series F Convertible Preferred Stock | Accumulated Deficit
Subsidiary, Sale of Stock [Line Items]
Stock issued during period			$ 5,400
Series F private placement
Subsidiary, Sale of Stock [Line Items]
Common stock, par value (in dollars per share)				$ 0.001
Value per share (in dollars per share)				$ 3.00
Number of warrants included in each unit (in shares)				1
Term of warrants				6 years
Warrants, exercise price (in dollars per share)				$ 4.50
Gross cash proceeds				$ 18,200
Series F private placement | Officers and directors
Subsidiary, Sale of Stock [Line Items]
Gross cash proceeds				$ 6,500
Series F private placement | Series F Unit
Subsidiary, Sale of Stock [Line Items]
Purchase price (in dollars per share)				$ 1,000
Stock issued during period (in shares)	2,832	1,106
Series F private placement | Series F Convertible Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Number of shares of stock included in each unit (in shares)				1
Stated value (in dollars per share)				$ 0.001

XML

Stockholders' equity (deficit) - Equity transactions (Details) - USD ($) $ / shares in Units, $ in Millions	Jan. 22, 2021	Jun. 30, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Common stock, par value (in dollars per share)		$ 0.001	$ 0.001
PIPE transaction
Class of Stock [Line Items]
Gross consideration	$ 4.1
Purchase price (in dollars per share)	$ 7.50
Number of shares of stock included in each unit (in shares)	1
Common stock, par value (in dollars per share)	$ 0.001
Number of warrants included in each unit (in shares)	1
Number of shares issuable per warrant (in shares)	1
PIPE transaction | Officers and directors
Class of Stock [Line Items]
Proceeds from shares and warrants issued pursuant to private placement, net	$ 1.6

XML

Stockholders' equity (deficit) - Common stock reserved for future issuance (Details) - shares	Jun. 30, 2021	Dec. 31, 2020
Equity [Abstract]
Conversion of Series F Preferred Stock (in shares)	5,764,533	7,251,189
Exercise of options to purchase common stock (in shares)	2,200,244	1,302,574
Exercise of warrants to purchase common stock (in shares)	9,433,584	9,916,997
Conversion of notes payable (in shares)	0	1,255,039
Total (in shares)	17,398,361	19,725,799

XML

Warrants - Outstanding (Details) - USD ($) $ / shares in Units, $ in Millions				1 Months Ended				3 Months Ended	6 Months Ended	12 Months Ended
	Mar. 17, 2020	Dec. 19, 2019	Nov. 04, 2019	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	May 31, 2019	Dec. 31, 2020	Jun. 30, 2021	Dec. 31, 2020
Warrants
Warrants outstanding (in shares)									9,916,996	2,830,309
Warrants acquired (in shares)							118,804
Issued (in shares)	167,206	156,250	1,834		95,043	331,771			548,111	8,321,412
Exercised (in shares)								(281,282)	(389,881)	(322,949)
Terminated/Expired (in shares)				(418,721)					(641,642)	(911,776)
Warrants outstanding (in shares)				9,916,996				9,916,996	9,433,584	9,916,996
Exercise Price
Warrants outstanding (in dollars per share)									$ 7.32	$ 19.38
Warrants acquired (in dollars per share)							$ 23.40
Issued (in dollars per share)									8.70	4.62
Warrants exercised (in dollars per share)									4.52	3.48
Terminated/Expired (in dollars per share)									24.64	18.42
Warrants outstanding (in dollars per share)				$ 7.32				$ 7.32	$ 5.92	$ 7.32
Warrants outstanding, intrinsic value				$ 23.8				$ 23.8	$ 0.0	$ 23.8

XML

Warrants - Warrant derivative liability (Details) - $ / shares					1 Months Ended				3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 24, 2020	Mar. 17, 2020	Dec. 19, 2019	Nov. 04, 2019	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	May 31, 2019	Dec. 31, 2020	Jun. 30, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Warrants acquired (in shares)								118,804
Warrants acquired (in dollars per share)								$ 23.40
Issued (in shares)		167,206	156,250	1,834		95,043	331,771			548,111	8,321,412
Warrants, exercise price (in dollars per share)		$ 9.72	$ 30.00	$ 30.00		$ 3.90	$ 4.50
Warrants, modified exercise price (in dollars per share)	$ 25.50	$ 9.72				$ 3.90	$ 4.50
Warrants exercised (in shares)									281,282	389,881	322,949
Warrants expired (in shares)					418,721					641,642	911,776

XML

Warrants - Change in warrant derivative liability (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Balance, beginning of period	$ 0	$ 2,220
Change in fair value of warrant derivative liability	0	(2,220)
Balance, end of period	$ 0	$ 0

XML

Warrants - Series F warrant liability (Details) - USD ($) $ / shares in Units, $ in Thousands				1 Months Ended			3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 17, 2020	Dec. 19, 2019	Nov. 04, 2019	Oct. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Class of Warrant or Right [Line Items]
Issued (in shares)	167,206	156,250	1,834		95,043	331,771			548,111		8,321,412
Warrants, exercise price (in dollars per share)	$ 9.72	$ 30.00	$ 30.00		$ 3.90	$ 4.50				$ 4.50
Term of warrants		24 months	24 months
Warrants exercised (in shares)								281,282	389,881		322,949
Cash received for warrant exercises									$ 1,685	$ 0
Series F Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Adjustment to additional paid-in capital for discount on preferred stock				$ 14,600
Series F Warrants
Class of Warrant or Right [Line Items]
Issued (in shares)				7,233,855
Warrants, exercise price (in dollars per share)				$ 4.50
Term of warrants				72 months
Warrants exercised (in shares)							83,334
Cash received for warrant exercises							$ 400

XML

Warrants - Change in warrant liability (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 24, 2020	Oct. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Class of Warrant or Right [Line Items]
Balance					$ 39,850
Change in fair value of warrant liabilities	$ 100		$ (29,356)	$ 3,474	(22,873)	$ 2,095
Balance			$ 16,977		16,977		$ 39,850
Series F Warrants
Class of Warrant or Right [Line Items]
Issuance of Series F warrants		$ 14,952
Change in fair value of warrant liabilities					$ (22,873)		$ 24,898

XML

Warrants - Fair value measurements and valuation techniques (Details) - Warrant	Jun. 30, 2021 $ / shares	Dec. 31, 2020 $ / shares
Stock price
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Warrants, measurement input	4.30	7.62
Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Warrants, measurement input	4.50	4.50
Expected remaining term | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Warrants, measurement input	5.25	5.75
Expected remaining term | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Warrants, measurement input	5.31	5.81
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Warrants, measurement input	0.600	0.675
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Warrants, measurement input	0.0092	0.005

XML

Warrants - Equity-classified warrants (Details) - USD ($) $ / shares in Units, $ in Thousands								1 Months Ended			3 Months Ended			6 Months Ended		12 Months Ended
	Jan. 22, 2021	Jul. 20, 2020	Jun. 24, 2020	Mar. 17, 2020	Dec. 19, 2019	Nov. 04, 2019	May 06, 2019	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Jan. 13, 2020
Class of Warrant or Right [Line Items]
Issued (in shares)				167,206	156,250	1,834			95,043	331,771				548,111		8,321,412
Warrants exercised (in dollars per share)														$ 4.52		$ 3.48
Term of warrants					24 months	24 months
Warrants, modified exercise price (in dollars per share)			$ 25.50	$ 9.72					$ 3.90	$ 4.50
Warrants exercised (in shares)												281,282		389,881		322,949
Cash received for warrant exercises														$ 1,685	$ 0
Change in fair value of warrant liabilities			$ 100								$ (29,356)		$ 3,474	$ (22,873)	$ 2,095
Warrants, exercise price (in dollars per share)				$ 9.72	$ 30.00	$ 30.00			$ 3.90	$ 4.50			$ 4.50		$ 4.50
Shareholder Guaranties
Class of Warrant or Right [Line Items]
Fair value of warrants issued					$ 4,200
Exercise Price $5.00
Class of Warrant or Right [Line Items]
Warrants, exercise price (in dollars per share)					$ 30.00
Guarantor Warrants
Class of Warrant or Right [Line Items]
Issued (in shares)					1,083,334
Term of warrants					24 months
Warrants, exercise price (in dollars per share)					$ 10.92
ABG Warrants | Licensing arrangement
Class of Warrant or Right [Line Items]
Term of warrants																	24 months
Warrants, exercise price (in dollars per share)																	$ 30.00
June 2020 Warrants
Class of Warrant or Right [Line Items]
Issued (in shares)			166,667
Term of warrants			84 months
Warrants, exercise price (in dollars per share)			$ 7.50
July 2020 Guarantor Warrants
Class of Warrant or Right [Line Items]
Issued (in shares)		50,000
Term of warrants		84 months
Warrants, exercise price (in dollars per share)		$ 6.30
Broker
Class of Warrant or Right [Line Items]
Issued (in shares)							36,757
Warrants exercised (in dollars per share)							$ 18.00
PIPE Transaction
Class of Warrant or Right [Line Items]
Issued (in shares)							957,499
Warrants exercised (in dollars per share)							$ 25.50
Term of warrants							24 months
Warrants, modified exercise price (in dollars per share)								$ 7.50
Warrants exercised (in shares)								174,602
Cash received for warrant exercises								$ 1,300
Change in fair value of warrant liabilities								$ 200
January 2021 PIPE
Class of Warrant or Right [Line Items]
Issued (in shares)	548,067
Warrants exercised (in dollars per share)	$ 8.70
Term of warrants	6 years
Warrants, modified exercise price (in dollars per share)	$ 7.50
Change in fair value of warrant liabilities	$ 200

XML

Warrants - Warrants issued as compensation (Details) $ / shares in Units, $ in Thousands								1 Months Ended		3 Months Ended			6 Months Ended		12 Months Ended
	Nov. 30, 2020 USD ($) $ / shares shares	Jul. 20, 2020 USD ($) director $ / shares shares	Jun. 24, 2020 director $ / shares shares	Mar. 17, 2020 $ / shares shares	Dec. 19, 2019 $ / shares shares	Nov. 04, 2019 $ / shares shares	Sep. 17, 2019 $ / shares shares	Sep. 30, 2020 $ / shares shares	Jun. 30, 2020 $ / shares shares	Jun. 30, 2021 USD ($)	Dec. 31, 2020 shares	Jun. 30, 2020 USD ($) $ / shares	Jun. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2020 USD ($) $ / shares	Dec. 31, 2020 USD ($) $ / shares shares	Jun. 01, 2020 shares
Class of Warrant or Right [Line Items]
Issued (in shares)				167,206	156,250	1,834		95,043	331,771				548,111		8,321,412
Warrants exercised (in dollars per share) | $ / shares													$ 4.52		$ 3.48
Warrants exercised (in shares)											281,282		389,881		322,949
Warrants, exercise price (in dollars per share) | $ / shares				$ 9.72	$ 30.00	$ 30.00		$ 3.90	$ 4.50			$ 4.50		$ 4.50
Term of warrants					24 months	24 months
Share-based compensation | $										$ 332		$ 3,020	$ 2,857	$ 5,504
July 2020 Guarantor Warrants
Class of Warrant or Right [Line Items]
Issued (in shares)		50,000
Warrants, exercise price (in dollars per share) | $ / shares		$ 6.30
Term of warrants		84 months
Compensation Warrants
Class of Warrant or Right [Line Items]
Issued (in shares)	66,667	33,334	166,667
Shares issuable upon exercise of warrants (in shares)																173,611
Warrants exercised (in shares)													131,945
Issuance of stock for exercise of warrants (in shares)													122,782
Warrants, exercise price (in dollars per share) | $ / shares	$ 6.00	$ 6.30	$ 7.50
Number of individuals received warrants | director		2	2
Term of warrants	72 months	84 months	84 months
Share-based compensation | $		$ 1,000
General and administrative expense | Compensation Warrants
Class of Warrant or Right [Line Items]
Total cost of contract termination | $															$ 5,700
General and administrative expense for warrants issued for services | $	$ 100
Warrant Exercise Period One | Compensation Warrants
Class of Warrant or Right [Line Items]
Period from issuance date after which warrants become exercisable							12 months
Warrant Exercise Period One | Advisor | Exercise Price $0.10 | Compensation Warrants
Class of Warrant or Right [Line Items]
Issued (in shares)							416,667
Warrants exercised (in dollars per share) | $ / shares							$ 0.60
Warrants exercisable (in shares)							208,334
Warrant Exercise Period One | Advisor | Exercise Price $10.00 | Compensation Warrants
Class of Warrant or Right [Line Items]
Issued (in shares)							250,000
Warrants exercised (in dollars per share) | $ / shares							$ 60.00
Warrant Exercise Period Two | Compensation Warrants
Class of Warrant or Right [Line Items]
Period from issuance date after which warrants become exercisable							18 months
Warrant Exercise Period Two | Advisor | Exercise Price $0.10 | Compensation Warrants
Class of Warrant or Right [Line Items]
Warrants exercised (in dollars per share) | $ / shares							$ 0.60
Warrants exercisable (in shares)							208,334
Warrant Exercise Period Two | Advisor | Exercise Price $10.00 | Compensation Warrants
Class of Warrant or Right [Line Items]
Warrants exercised (in dollars per share) | $ / shares							$ 60.00
Warrants exercisable (in shares)							250,000

XML

Share-based compensation (Details) $ in Thousands		1 Months Ended	3 Months Ended		6 Months Ended
	Nov. 11, 2019 shares	Mar. 31, 2020 USD ($) director shares	Jun. 30, 2021 USD ($) shares	Jun. 30, 2020 USD ($) shares	Jun. 30, 2021 USD ($) shares	Jun. 30, 2020 USD ($) shares	Nov. 10, 2019 shares
Stock Awards [Abstract]
Share-based compensation | $			$ 332	$ 3,020	$ 2,857	$ 5,504
Number of non-employee directors | director		3
Stock options
Stock Awards [Abstract]
Options granted (in shares)			25,834	33,334	955,688	50,002
Restricted Stock
Stock Awards [Abstract]
Share-based compensation | $		$ 500
Restricted Stock | Director
Stock Awards [Abstract]
Awards granted (in shares)		75,000
Restricted Stock | Officer
Stock Awards [Abstract]
Awards granted (in shares)		993
2019 Plan
Stock Awards [Abstract]
Awards available for issuance (in shares)							1,083,334
Amended 2019 Plan
Stock Awards [Abstract]
Awards available for issuance (in shares)	1,500,000		2,700,000		2,700,000
Annual percentage increase in awards authorized	10.00%

XML

Income taxes (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income tax expense	$ 0	$ 0	$ 0	$ 0
Effective tax rate	0.00%	0.00%	0.00%	0.00%

XML

Concentrations (Details)	6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Inventory purchases | Supplier concentration risk | Two vendors
Concentration Risk [Line Items]
Concentration risk, percentage	68.00%
Inventory purchases | Supplier concentration risk | Three vendors
Concentration Risk [Line Items]
Concentration risk, percentage		77.00%
Accounts receivable | Customer concentration risk | Three customers
Concentration Risk [Line Items]
Concentration risk, percentage	72.00%
Accounts receivable | Customer concentration risk | Two customers
Concentration Risk [Line Items]
Concentration risk, percentage			72.00%
Gross sales | Customer concentration risk | Three customers
Concentration Risk [Line Items]
Concentration risk, percentage	50.00%
Gross sales | Customer concentration risk | Two customers
Concentration Risk [Line Items]
Concentration risk, percentage		39.00%

XML

Net income (loss) per share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Earnings Per Share [Abstract]
Antidilutive shares (in shares)	3,471,245		4,474,577
Numerator:
Net and comprehensive income (loss)	$ 24,776	$ (18,404)	$ 11,926	$ (27,858)
Less: Preferred stock dividends	0	34	0	68
Less: Adjustment due to warrant modifications	0	0	402	0
Adjusted net and comprehensive income (loss) available to common stockholders	$ 24,776	$ (18,438)	$ 11,524	$ (27,926)
Denominator:
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, basic (in shares)	11,126,909	8,156,618	10,361,462	8,122,176
Net earnings (loss) per share attributable to common stockholders, basic (in dollars per share)	$ 2.23	$ (2.26)	$ 1.11	$ (3.44)
Numerator:
Net and comprehensive income (loss)	$ 24,776	$ (18,404)	$ 11,926	$ (27,858)
Less: Preferred stock dividends	0	34	0	68
Less: Adjustment due to warrant modifications	0	0	402	0
Add: Interest expense on convertible notes, net	656	0	0	0
Adjusted net and comprehensive income (loss) available to common stockholders	$ 25,432	$ (18,438)	$ 11,524	$ (27,926)
Denominator:
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, diluted (in shares)	21,389,413	8,156,618	20,498,829	8,122,176
Net earnings (loss) per share attributable to common stockholders, diluted (in shares)	$ 1.19	$ (2.26)	$ 0.56	$ (3.44)